Processing 00000000.tx.1: The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration Olga Corti1,, Cornelia Hampe1,, Hana Koutnikova1, Frdric Darios1, Sandrine Jacquier1, Annick Prigent1, Jean-Charles Robinson2, Laurent Pradier3, Merle Ruberg1, Marc Mirande2, Etienne Hirsch1, Thomas Rooney3, Alain Fournier3 and Alexis Brice1,* 1INSERM U289, Hpital de la Salptrire, Btiment Pharmacie, 47 boulevard de l'Hpital, 75651 Paris Cedex 13, France, 2Laboratoire d'Enzymologie et Biochimie Structurales, CNRS, 91190 Gif-sur-Yvette, France and 3CNS Department and Yeast Genomics, Aventis-Pharma, 94400 Vitry, France Received January 22, 2003; 

Phrase: "The p38 subunit of the aminoacyl-tRNA synthetase complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "a Parkin substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: ":"

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "protein biosynthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597295:Protein Biosynthesis [Molecular Function]
   861   C0005572:biosynthesis [Functional Concept]
   861   C0220781:Biosynthesis [Biologic Function]

Phrase: "and"

Phrase: "neurodegeneration Olga Corti1,"

Phrase: ", Cornelia Hampe1,"

Phrase: ", Hana Koutnikova1,"

Phrase: "Frdric Darios1,"

Phrase: "Sandrine Jacquier1,"

Phrase: "Annick Prigent1,"

Phrase: "Jean-Charles Robinson2,"

Phrase: "Laurent Pradier3,"

Phrase: "Merle Ruberg1,"

Phrase: "Marc Mirande2,"

Phrase: "Etienne Hirsch1,"

Phrase: "Thomas Rooney3,"

Phrase: "Alain Fournier3"

Phrase: "and"

Phrase: "Alexis Brice1,"

Phrase: "* 1INSERM U289,"

Phrase: "Hpital de la Salptrire,"

Phrase: "Btiment Pharmacie,"

Phrase: "47 boulevard de l'Hpital,"

Phrase: "75651 Paris Cedex 13,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0030561:Paris [Geographic Area]
   812   C0331677:Paris [Plant]
   812   C0591239:Cedex [Antibiotic,Organic Chemical]
   812   C1824032:PARIS [Gene or Genome]
   779 E C1824369:PARI [Gene or Genome]

Phrase: "France,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "2Laboratoire"

Phrase: "d'"

Phrase: "Enzymologie et Biochimie Structurales,"

Phrase: "CNRS,"

Phrase: "91190 Gif-sur-Yvette,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "and"

Phrase: "3CNS Department"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Yeast Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "Aventis-Pharma,"

Phrase: "94400 Vitry,"

Phrase: "France Received January 22,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0016674:France [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.2: Revised April 4, 2003; 

Phrase: "Revised April 4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "2003"

Phrase: ";"
Processing 00000000.tx.3: Accepted April 22, 2003  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Parkinson's disease (PD) is a severe neurological disorder, characterized by the progressive degeneration of the dopaminergic nigrostriatal pathway and the presence of Lewy bodies (LBs). 

Phrase: "Accepted April 22,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2003  ABSTRACT TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD)"

Phrase: "is"

Phrase: "a severe neurological disorder,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1836348:Severe disorder [Finding]
   901   C0027765:Neurological disorder [Disease or Syndrome]
   827   C0012634:Disorder [Disease or Syndrome]

Phrase: "characterized by the progressive degeneration of the dopaminergic nigrostriatal pathway"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   757   C2750821:Nigrostriatal degeneration [Finding]
   739   C0011164:Degeneration [Pathologic Function]
   739   C0205329:Progressive [Functional Concept]
   739   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   739   C1704259:Pathway [Molecular Function]
   739   C1705987:Pathway [Conceptual Entity]
   739   C1880022:Characterized [Activity]
   739   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "the presence of Lewy bodies (LBs)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.4: The discovery of genes responsible for familial forms of the disease has provided insights into its pathogenesis. 

Phrase: "The discovery of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C2717881:Gene Discovery [Molecular Biology Research Technique]
   770   C1880355:Discovery [Activity]

Phrase: "responsible for familial forms of the disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "has"

Phrase: "provided insights into its pathogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0233820:insights [Mental Process]
Processing 00000000.tx.5: Mutations in the parkin gene, which encodes an E3 ubiquitinprotein ligase involved in the ubiquitylation and proteasomal degradation of specific protein substrates, have been found in nearly 50% of patients with autosomal-recessive early-onset parkinsonism. 

Phrase: "Mutations in the parkin gene,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "which"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "an E3 ubiquitinprotein ligase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0077678:E3 Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "involved in the ubiquitylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1314939:Involved [Functional Concept]
   770   C1519751:Ubiquitylation [Molecular Function]

Phrase: "and"

Phrase: "proteasomal degradation of specific protein substrates,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0597297:Protein Degradation [Molecular Function]
   783   C0597304:Protein Degradation [Molecular Function]
   783   C1623036:Protein Degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "have"

Phrase: "been"

Phrase: "found in nearly 50% of patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0150312:Found [Quantitative Concept]
   719 E C0243095:Find [Finding]

Phrase: "with autosomal-recessive early-onset parkinsonism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   911   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   884   C1838631:Parkinsonism, early-onset [Finding]
   804   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.6: The abnormal accumulation of substrates due to loss of Parkin function may be the cause of neurodegeneration in parkin-related parkinsonism. 

Phrase: "The abnormal accumulation of substrates"

Phrase: "due to loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517945:Loss [Quantitative Concept]

Phrase: "of Parkin function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "the cause of neurodegeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015127:cause [Functional Concept]
   770   C1524003:Cause [Conceptual Entity]

Phrase: "in parkin-related parkinsonism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.7: Here, we demonstrate that Parkin interacts with, ubiquitylates and promotes the degradation of p38, a key structural component of the mammalian aminoacyl-tRNA synthetase complex. 

Phrase: "Here,"

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with,"

Phrase: "ubiquitylates"

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the degradation of p38,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "a key structural component of the mammalian aminoacyl-tRNA synthetase complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0449432:Component [Manufactured Object]
   738   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.8: We found that the ubiquitylation of p38 is abrogated by truncated variants of Parkin lacking essential functional domains, but not by the pathogenic Lys161Asn point mutant. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the ubiquitylation of p38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519751:Ubiquitylation [Molecular Function]

Phrase: "is"

Phrase: "abrogated by truncated variants of Parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205419:variants [Qualitative Concept]
   753   C1418270:PARKIN [Gene or Genome]
   753   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "essential functional domains,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "but"

Phrase: "not by the pathogenic Lys161Asn point mutant."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0450254:Pathogenic [Organism]
   748   C0596988:Mutant [Cell or Molecular Dysfunction]
   748   C1518422:Not [Functional Concept]
   748   C1552961:Point [Quantitative Concept]
   748   C2347617:point [Quantitative Concept]
Processing 00000000.tx.9: Expression of p38 in COS7 cells resulted in the formation of aggresome-like inclusions in which Parkin was systematically sequestered. 

Phrase: "Expression of p38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in COS7 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "resulted in the formation of aggresome-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1167059:aggresome [Cell Component]
   753   C1522492:Formation [Functional Concept]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "like inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]

Phrase: "in which Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "systematically"

Phrase: "sequestered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333312:Sequestered [Functional Concept]
Processing 00000000.tx.10: In the human dopaminergic neuroblastoma-derived SH-SY5Y cell line, Parkin promoted the formation of ubiquitylated p38-positive inclusions. 

Phrase: "In the human dopaminergic neuroblastoma-derived SH-SY5Y cell line,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   897   C0682523:Human Cell Line [Cell]
   878   C0427861:human cell [Laboratory or Test Result]
   864   C1512035:Dopaminergic cell [Cell]
   850   C0815000:neuroblastoma cell [Cell]
   812   C0007600:Cell Line [Cell]
   793   C0007634:Cell [Cell]
   793   C0205132:Line [Spatial Concept]
   793   C1269647:Cell [Cell]
   793   C1550648:Line [Substance]
   793   C1552960:Line [Quantitative Concept]
   793   C1704653:Cell [Medical Device]
   793   C1948049:Cell [Spatial Concept]

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "the formation of ubiquitylated p38-positive inclusions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
Processing 00000000.tx.11: Moreover, the overexpression of p38 in SH-SY5Y cells caused significant cell death against which Parkin provided protection. 

Phrase: "Moreover,"

Phrase: "the overexpression of p38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "significant cell death against which Parkin provided protection."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0007587:Cell Death [Cell Function]
   767   C0524828:Cell Protection [Physiologic Function]
   744   C0007634:Cell [Cell]
   744   C0011065:Death [Organism Function]
   744   C1269647:Cell [Cell]
   744   C1306577:Death, NOS [Finding]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.12: Analysis of p38 expression in the human adult midbrain revealed strong immunoreactivity in normal dopaminergic neurons and the labeling of LBs in idiopathic PD. 

Phrase: "Analysis of p38 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in the human adult midbrain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   827   C1280997:Midbrain [Body Part, Organ, or Organ Component]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "strong immunoreactivity in normal dopaminergic neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "the labeling of LBs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1167624:Labeling [Mental Process]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "in idiopathic PD."
Processing 00000000.tx.13: This suggests that p38 plays a role in the pathogenesis of PD, opening the way for a detailed examination of its potential non-canonical role in neurodegeneration.  

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that p38"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in the pathogenesis of PD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "opening"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175566:Opening [Spatial Concept]
  1000   C1882151:Opening [Spatial Concept]

Phrase: "the way for a detailed examination of its potential non-canonical role"

Phrase: "in neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.14: INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Parkinson's disease (PD) is a common neurodegenerative disorder clinically characterized by resting tremor, rigidity and bradykinesia. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD)"

Phrase: "is"

Phrase: "a common neurodegenerative disorder clinically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   812   C0012634:Disorder [Disease or Syndrome]

Phrase: "characterized by resting tremor,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0234379:Resting Tremor [Sign or Symptom]
   770   C0035253:Resting [Daily or Recreational Activity]
   770   C0040822:Tremor [Sign or Symptom]
   770   C1512899:resting [Cell]
   770   C1880022:Characterized [Activity]
   770   C1963252:Tremor [Finding]
   737 E C1622890:ResT [Molecular Function]

Phrase: "rigidity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0026837:Rigidity, NOS [Sign or Symptom]
  1000   C0700109:rigidity [Natural Phenomenon or Process]
   928 E C0231517:Rigid [Individual Behavior]
   928 E C1882952:RIGID [Phenomenon or Process]

Phrase: "and"

Phrase: "bradykinesia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0233565:Bradykinesia [Sign or Symptom]
Processing 00000000.tx.15: These severe neurological symptoms are caused by the progressive and selective degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc). 

Phrase: "These severe neurological symptoms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0436345:severe symptoms [Finding]
   901   C0235031:neurological symptoms [Sign or Symptom]
   827   C0683368:symptoms [Functional Concept]
   827   C1457887:Symptoms [Sign or Symptom]

Phrase: "are"

Phrase: "caused by the progressive"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205329:Progressive [Functional Concept]
   737   C0015127:cause [Functional Concept]
   737   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "selective degeneration of dopaminergic neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   760   C0011164:Degeneration [Pathologic Function]
   760   C1880269:Degeneration [Functional Concept]

Phrase: "in the substantia nigra pars compacta (SNc)."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0175412:Substantia nigra pars compacta [Body Part, Organ, or Organ Component]
           Pars compacta
   902   C0222661:Substantia compacta [Tissue]
   861   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   861   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   812   C0032405:PARS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1414437:PARS [Gene or Genome]
   812   C3283876:Compacta [Eukaryote]
   779 E C1417826:PAR [Gene or Genome]
   779 E C1514229:PAR [Quantitative Concept]
   779 E C1705885:PAR [Gene or Genome]
Processing 00000000.tx.16: Lewy bodies (LBs), which are ubiquitylated neuronal cytoplasmic inclusions, are a pathological hallmark of PD (1). 

Phrase: "Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "(LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "are"

Phrase: "ubiquitylated neuronal cytoplasmic inclusions,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   890   C3546443:neuronal cytoplasmic inclusion [Cell Component]
   861   C0205708:Cytoplasmic Inclusions [Cell Component]
   812   C0010834:Cytoplasmic [Cell Component]
   812   C0521390:Neuronal [Immunologic Factor]
   812   C0521449:Cytoplasmic [Body Location or Region]
   779   C1512693:Inclusion [Qualitative Concept]
   741 E C0027882:Neuron [Cell]

Phrase: "are"

Phrase: "a pathological hallmark of PD (1"

Phrase: ")."
Processing 00000000.tx.17: Insights into the molecular mechanisms of the pathogenesis of PD were provided by the discovery of genes implicated in rare monogenic forms (2). 

Phrase: "Insights into the molecular mechanisms of the pathogenesis of PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0233820:insights [Mental Process]

Phrase: "were"

Phrase: "provided by the discovery of genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C2717881:Gene Discovery [Molecular Biology Research Technique]
   753   C0017337:Genes [Gene or Genome]
   753   C1880355:Discovery [Activity]
   753   C1999230:Provided [Activity]

Phrase: "implicated in rare monogenic forms"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   760   C0521114:Rare [Temporal Concept]
   760   C0522498:Rare [Qualitative Concept]
   760   C1514917:RARE [Gene or Genome]
   726 E C1522492:Form [Functional Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.18: Missense mutations in the -synuclein gene (A30P, A53T), encoding a presynaptic protein of unknown function, have been described in a few families with autosomal dominant PD (3,4). 

Phrase: "Missense mutations in the -synuclein gene"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0599155:Mutations, Missense [Genetic Function]
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(A30P,"

Phrase: "A53T"

Phrase: ")"

Phrase: ","

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a presynaptic protein of unknown function,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "described in a few families"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0015576:Families [Family Group]
   760   C1552738:described [Idea or Concept]
   760   C1704727:Family [Conceptual Entity]

Phrase: "with autosomal dominant PD (3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443147:Autosomal dominant [Intellectual Product]
   812   C0596142:autosomal [Cell Component]
   812   C1527180:Dominant [Functional Concept]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.19: Alpha-synuclein is a major component of LBs, suggesting that this protein plays a more general role in the pathogenesis of sporadic PD (5,6). 

Phrase: "Alpha-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "is"

Phrase: "a major component of LBs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a more general role in the pathogenesis of sporadic PD (5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.20: A point mutation (I93M) has been found in the gene encoding the de-ubiquitylating enzyme, UCHL-1, another component of LBs, in two members of a family with autosomal-dominant PD (7). 

Phrase: "A point mutation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutation [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
   861   C2347617:point [Quantitative Concept]

Phrase: "(I93M"

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "found in the gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0017337:Gene [Gene or Genome]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the de-ubiquitylating enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "UCHL-1,"

Phrase: "another component of LBs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "in two members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680022:members [Population Group]
   827 E C2698041:Member [Professional or Occupational Group]

Phrase: "of a family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "with autosomal-dominant PD (7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443147:Autosomal dominant [Intellectual Product]
   812   C0596142:autosomal [Cell Component]
   812   C1527180:Dominant [Functional Concept]

Phrase: ")."
Processing 00000000.tx.21: More recently, a deletion and a point mutation (L166P) in DJ-1, which encodes a protein thought to be involved in the oxidative stress response, were shown to be linked to autosomal-recessive early-onset parkinsonism in two European families (8). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "a deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "a point mutation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutation [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]
   861   C2347617:point [Quantitative Concept]

Phrase: "(L166P"

Phrase: ")"

Phrase: "in DJ-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1424222:DJ-1 [Gene or Genome]
  1000   C3541418:DJ-1 [Gene or Genome]
   861   C0012836:DJ [Geographic Area]

Phrase: "which"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "involved in the oxidative stress response,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0149784:stress response [Physiologic Function]
   790   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   753   C0038435:Stress [Finding]
   753   C0311404:Oxidative [Functional Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1314939:Involved [Functional Concept]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "linked to autosomal-recessive early-onset parkinsonism"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C1838631:Parkinsonism, early-onset [Finding]
   804   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   778   C0441748:Autosomal recessive [Intellectual Product]
   778   C1833334:Early-onset [Finding]
   748   C0242422:Parkinsonism [Disease or Syndrome]
   748   C0332162:Onset [Qualitative Concept]
   748   C0596142:autosomal [Cell Component]
   748   C1279919:Early [Temporal Concept]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "in two European families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.22: In 1998, the parkin gene was shown to be responsible for a distinct clinical and genetic entity in Japan, defined as autosomal-recessive juvenile parkinsonism (9). 

Phrase: "In 1998,"

Phrase: "the parkin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "responsible for a distinct clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "genetic entity in Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1551338:Entity [Entity]

Phrase: "defined as autosomal-recessive juvenile parkinsonism"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   820   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   790   C0441748:Autosomal recessive [Intellectual Product]
   790   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   753   C0242422:Parkinsonism [Disease or Syndrome]
   753   C0596142:autosomal [Cell Component]
   753   C1704788:Defined [Conceptual Entity]
   753   C3146221:Juvenile [Age Group]
   753   C3539106:Defined [Intellectual Product]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.23: It was subsequently demonstrated that almost 50% of patients with familial autosomal-recessive early-onset parkinsonism from various populations carry a series of parkin exon rearrangements and point mutations (1012). 

Phrase: "It"

Phrase: "was"

Phrase: "subsequently"

Phrase: "demonstrated"

Phrase: "that almost 50% of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "with familial autosomal-recessive early-onset parkinsonism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   885   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C1838631:Parkinsonism, early-onset [Finding]
   799   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "from various populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "a series of parkin exon rearrangements"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205549:Series [Quantitative Concept]
   753   C2348044:Series [Intellectual Product]

Phrase: "and"

Phrase: "point mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(1012"

Phrase: ")."
Processing 00000000.tx.24: These mutations are associated with a wide range of ages at onset and a broad phenotypic spectrum, including cases that are clinically indistinguishable from idiopathic PD (12,13). 

Phrase: "These mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "associated with a wide range of ages at onset"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   781   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0001779:Age [Organism Attribute]
   742   C0332162:Onset [Qualitative Concept]
   742   C0332464:Wide [Spatial Concept]
   742   C1514721:Range [Quantitative Concept]
   742   C2348147:Range [Quantitative Concept]
   742   C3542016:Range [Intellectual Product]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "a broad phenotypic spectrum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1883073:Spectrum [Quantitative Concept]
   827   C2827424:Spectrum [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "that"

Phrase: "are"

Phrase: "clinically indistinguishable from idiopathic PD (12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.25: The general lack of LBs in patients with parkin-related PD suggests that Parkin plays a role in the biogenesis of these inclusions (1416). 

Phrase: "The general lack of LBs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332268:lack [Qualitative Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with parkin-related PD"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in the biogenesis of these inclusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "(1416"

Phrase: ")."
Processing 00000000.tx.26: This hypothesis is supported by the presence of Parkin immunoreactivity in LBs from patients with sporadic and familial PD (17). 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "supported by the presence of Parkin immunoreactivity"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0597879:immunoreactivity [Molecular Function]
   748   C1418270:PARKIN [Gene or Genome]
   748   C1521721:Supported [Conceptual Entity]
   748   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   714 E C0183683:Support [Medical Device]

Phrase: "in LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with sporadic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]

Phrase: "and"

Phrase: "familial PD (17"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.27: Parkin is a 465 amino acid protein homologous to ubiquitin at its N-terminus (ubiquitin-like domain) and with a C-terminal cysteine-rich RING-IBR-RING motif common to proteins and protein complexes with ubiquitinprotein ligase activity (9,18). 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a 465 amino acid protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1874187:amino acid protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "homologous to ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1334043:Homologous [Gene or Genome]

Phrase: "at its N-terminus"

Phrase: "(ubiquitin-like domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "with a C-terminal cysteine-rich RING-IBR-RING motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C1514562:Motif [Amino Acid Sequence]

Phrase: "common to proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205214:Common [Quantitative Concept]
   790   C1522138:Common [Functional Concept]
   790   C3245511:common [Intellectual Product]

Phrase: "and"

Phrase: "protein complexes with ubiquitinprotein ligase activity"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   783   C1537044:protein activity [Molecular Function]
   767   C1180347:complex protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C1523872:protein complex [Cell Component]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1704241:Complexes [Chemical Viewed Structurally]
   719 E C0439855:Complex [Qualitative Concept]

Phrase: "(9,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.28: Parkin has E3 ubiquitinprotein ligase activity (1921), which enables it to interact with the cytoplasmic ubiquitin-conjugating E2 enzymes, UbcH7 and UbcH8, and with the endoplasmic reticulum resident E2 enzymes, UBC6 and UBC7, thus promoting the ubiquitylation and proteasomal degradation of specific protein substrates (1922). 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "E3 ubiquitinprotein ligase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1150651:ligase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   708   C0077678:E3 Ligase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1921"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "enables"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "it to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with the cytoplasmic ubiquitin-conjugating E2 enzymes,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   807   C0084913:Ubiquitin-Conjugating Enzyme E2 [Amino Acid, Peptide, or Protein,Enzyme]
           Ubiquitin-Conjugating Enzymes
   744   C0010834:Cytoplasmic [Cell Component]
   744   C0014442:Enzymes [Enzyme,Organic Chemical]
   744   C0014445:enzymes [Functional Concept]
   744   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0521449:Cytoplasmic [Body Location or Region]
   744   C3539520:E2 [Gene or Genome]
   711   C0301869:Conjugate [Immunologic Factor]

Phrase: "UbcH7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1421286:UBCH7 [Gene or Genome]

Phrase: "and"

Phrase: "UbcH8,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1421277:UbcH8 [Gene or Genome]
  1000   C1421288:UBCH8 [Gene or Genome]

Phrase: "and with the endoplasmic reticulum resident E2 enzymes,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0014239:Endoplasmic Reticulum [Cell Component]
   744   C0014442:Enzymes [Enzyme,Organic Chemical]
   744   C0014445:enzymes [Functional Concept]
   744   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   744   C1320928:Resident [Professional or Occupational Group]
   744   C1515981:And [Idea or Concept]
   744   C1549439:Resident [Intellectual Product]
   744   C2347958:Resident [Human]
   744   C3539520:E2 [Gene or Genome]

Phrase: "UBC6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425009:UBC6 [Gene or Genome]

Phrase: "and"

Phrase: "UBC7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1421280:UBC7 [Gene or Genome]
  1000   C1421281:UBC7 [Gene or Genome]

Phrase: "thus"

Phrase: "promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "the ubiquitylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitylation [Molecular Function]

Phrase: "and"

Phrase: "proteasomal degradation of specific protein substrates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0597297:Protein Degradation [Molecular Function]
   783   C0597304:Protein Degradation [Molecular Function]
   783   C1623036:Protein Degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "(1922"

Phrase: ")."
Processing 00000000.tx.29: Loss of Parkin function is thought to result in the gradual accumulation of non-ubiquitylated, potentially toxic, substrates, leading to neurodegeneration. 

Phrase: "Loss of Parkin function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in the gradual accumulation of non-ubiquitylated,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0439833:Gradual [Qualitative Concept]
   744   C1274040:Result [Functional Concept]
   744   C1518422:Non [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "potentially toxic, substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]

Phrase: "leading to neurodegeneration."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   790   C0332152:Leading [Temporal Concept]
   790   C1522538:Leading [Functional Concept]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.30: Parkin ubiquitylates five cellular proteins with distinct putative functions: the synaptic vesicle associated protein, CDCrel-1; 

Phrase: "Parkin ubiquitylates five cellular proteins with distinct putative functions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C0815043:functions proteins [Amino Acid, Peptide, or Protein]
   745   C0673396:parkin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   728 E C1527118:Protein Function [Molecular Function]

Phrase: ":"

Phrase: "the synaptic vesicle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0039065:Synaptic vesicle [Cell Component]
   861   C0333262:Vesicle [Acquired Abnormality]
   861   C1622418:vesicle [Cell Component]
   789 E C0205378:Vesicular [Qualitative Concept]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "CDCrel-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
  1000   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   861   C1539748:CDCREL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.31: the -synuclein interacting protein, synphilin; 

Phrase: "the -synuclein interacting protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synphilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420277:synphilin [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.32: the putative G-protein-coupled transmembrane protein, Pael R; 

Phrase: "the putative G-protein-coupled transmembrane protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   799   C1167322:transmembrane [Cell Component]
   799   C2752508:transmembrane [Cell Component]

Phrase: "Pael R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.33: an O-glycosylated isoform of -synuclein; 

Phrase: "an O-glycosylated isoform of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.34: and the pro-apoptotic cyclin E (2125). 

Phrase: "and"

Phrase: "the pro-apoptotic cyclin E (2125"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   840   C0111429:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1259807:Cyclin E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1332697:CYCLIN E [Gene or Genome]
   804   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0072108:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0079183:Cyclin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1150565:cyclin [Molecular Function]
   804   C1516044:Apoptotic [Qualitative Concept]
   804   C2987124:PRO [Intellectual Product]
   804   C3546359:pro-apoptosis [Cell Function]
   733 E C0162638:Apoptosis [Cell Function]

Phrase: ")."
Processing 00000000.tx.35: The specific pathological roles of these substrates remain to be established, but it is likely that the alteration of the degradation rates of several Parkin substrates act synergistically to compromise dopaminergic cell survival. 

Phrase: "The specific pathological roles of these substrates"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0035820:Roles [Social Behavior]
   714 E C1705810:Role [Conceptual Entity]

Phrase: "remain"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the alteration of the degradation rates of several Parkin substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1515926:Alteration [Idea or Concept]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "synergistically to"

Phrase: "compromise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "dopaminergic cell survival."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007620:Cell Survival [Cell Function]
   901   C1512035:Dopaminergic cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0038952:Survival [Activity]
   827   C0220921:survival [Functional Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.36: We performed a yeast two-hybrid screen to isolate further Parkin substrates and identified p38, which is a key structural component of the macromolecular aminoacyl-tRNA synthetase (ARS) complex involved in protein biosynthesis (26,27).  

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a yeast two-hybrid screen to"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0599647:Two Hybrid [Molecular Biology Research Technique]
   804   C0020205:Hybrid [Organism]
   804   C0036025:yeast [Fungus]
   804   C0043392:Yeast [Food]
   804   C0043393:Yeast [Fungus]
   804   C0205448:Two [Quantitative Concept]
   804   C0220908:screen [Health Care Activity]
   804   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   804   C1305399:screen [Functional Concept]
   804   C1705053:Screen [Medical Device]

Phrase: "isolate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370215:Isolate [Substance]
  1000   C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "further Parkin substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "identified p38,"

Phrase: "which"

Phrase: "is"

Phrase: "a key structural component of the macromolecular aminoacyl-tRNA synthetase (ARS) complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0449432:Component [Manufactured Object]
   738   C1705248:Component [Conceptual Entity]

Phrase: "involved in protein biosynthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0597295:Protein Biosynthesis [Molecular Function]
   770   C0005572:biosynthesis [Functional Concept]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0220781:Biosynthesis [Biologic Function]
   770   C1314939:Involved [Functional Concept]

Phrase: "(26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.37: RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  The scaffold p38 subunit of the mammalian ARS complex is a Parkin substrate To identify novel Parkin substrates, we performed a yeast two-hybrid screen of a HeLa cDNA library using a human Parkin sequence corresponding to amino acids 135290 as bait (Fig.1A). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The scaffold p38 subunit of the mammalian ARS complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "a Parkin substrate To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "identify"

Phrase: "novel Parkin substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a yeast two-hybrid screen of a HeLa cDNA library"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0599647:Two Hybrid [Molecular Biology Research Technique]
   739   C0020205:Hybrid [Organism]
   739   C0036025:yeast [Fungus]
   739   C0043392:Yeast [Food]
   739   C0043393:Yeast [Fungus]
   739   C0205448:Two [Quantitative Concept]
   739   C0220908:screen [Health Care Activity]
   739   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   739   C1305399:screen [Functional Concept]
   739   C1705053:Screen [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a human Parkin sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "corresponding to amino acids 135290"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   773 E C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acids [Chemical]
   726 E C0202406:Acid [Laboratory Procedure]

Phrase: "as bait"

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.38: This led to the isolation of a 1141bp cDNA clone encoding the 320 amino acids of p38, a central scaffold component of the multiARS complex (2628). 

Phrase: "This"

Phrase: "led to the isolation of a 1141bp cDNA clone"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   742   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0009013:Clone [Cell]
   742   C0204727:Isolation [Therapeutic or Preventive Procedure]
   742   C0205409:Isolation [Functional Concept]
   742   C0220862:isolation [Laboratory Procedure]
   742   C1522642:Clone [Tissue]
   742   C1708698:LED [Manufactured Object]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C1522538:Lead [Functional Concept]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the 320 amino acids of p38,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "a central scaffold component of the multiARS complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449432:Component [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]

Phrase: "(2628"

Phrase: ")."
Processing 00000000.tx.39: The interaction between Parkin and p38 was specific, as p38 failed to interact with the unrelated protein Ras or with the cytoplasmic domain of the amyloid precursor protein (data not shown). 

Phrase: "The interaction between Parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "p38"

Phrase: "was"

Phrase: "specific,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: "as"

Phrase: "p38"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with the unrelated protein Ras"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0242853:Ras protein [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0034678:RAS [Gene or Genome]
   753   C0445356:Unrelated [Finding]
   753   C1704623:Unrelated [Qualitative Concept]

Phrase: "or with the cytoplasmic domain of the amyloid precursor protein"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1511625:Cytoplasmic Domain [Cell Component]
   757   C0162808:Protein Domain [Spatial Concept]
   757   C1333198:Cytoplasmic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C1514562:Protein Domain [Amino Acid Sequence]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0010834:Cytoplasmic [Cell Component]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0521449:Cytoplasmic [Body Location or Region]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1709634:Precursor [Idea or Concept]
   739   C1880389:Domain [Functional Concept]
   739   C1883221:Domain [Conceptual Entity]
   739   C3541951:Domain [Intellectual Product]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.40: To confirm these results, we carried out co-immunoprecipitation experiments in COS7 cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "these results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "we"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out co-immunoprecipitation experiments in COS7 cells."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0681814:Experiments [Research Activity]
   714 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.41: Myc epitope-tagged p38 (myc-p38) was overexpressed alone or with an HA epitope-tagged variant of Parkin devoid of its N-terminal ubiquitin-like motif (Fig.1A; HA-Parkin77-465). 

Phrase: "Myc epitope-tagged p38"

Phrase: "(myc-p38"

Phrase: ")"

Phrase: "was"

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or with an HA epitope-tagged variant of Parkin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   742   C0003316:Epitope [Immunologic Factor]
   742   C0205419:Variant [Qualitative Concept]
   742   C1418270:PARKIN [Gene or Genome]
   742   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   742   C1708632:Tagged [Qualitative Concept]
   742   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   708 E C0037293:Tag [Neoplastic Process]
   708 E C0181496:Tag [Manufactured Object]
   708 E C1710492:TAG [Gene or Genome]

Phrase: "devoid of its N-terminal ubiquitin-like motif"

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "; HA-Parkin77-465"

Phrase: ")."
Processing 00000000.tx.42: Myc-p38 specifically co-immunoprecipitated with HA-Parkin77-465 using anti-HA antibodies (Fig.1B). 

Phrase: "Myc-p38 specifically"

Phrase: "co-immunoprecipitated with HA-Parkin77-465"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-HA antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig.1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.43: View larger version (30K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.44: Parkin interacts with and ubiquitylates p38. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "interacts with"

Phrase: "and"

Phrase: "ubiquitylates p38."
Processing 00000000.tx.45: (A) Schematic representation of human Parkin, showing its functional domains (Ubl, ubiquitin-like). 

Phrase: "(A) Schematic representation of human Parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1514861:Representation [Conceptual Entity]
   753   C1882932:Representation [Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "its functional domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(Ubl,"

Phrase: "ubiquitin-like"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.46: (B) Co-immunoprecipitation of myc-p38 with HA-Parkin77-465 in COS7 cells. 

Phrase: "(B) Co-immunoprecipitation of myc-p38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   753   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "with HA-Parkin77-465"

Phrase: "in COS7 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.47: Immunoprecipitates obtained with anti-HA antibodies (anti-HA IP) or aliquots of cell lysates were analyzed by western blot (WB) using anti-HA or anti-myc antibodies. 

Phrase: "Immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "obtained with anti-HA antibodies"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   797   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1301820:Obtained [Functional Concept]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726 E C1706701:Obtain [Activity]

Phrase: "(anti-HA IP)"

Phrase: "or"

Phrase: "aliquots of cell lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by western blot (WB)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-HA"

Phrase: "or"

Phrase: "anti-myc antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.48: (C) Analysis of the ubiquitylation of myc-p38, HA-CDCrel-1 and EGFP in SH-SY5Y and SH-SY5Y-HA-Parkin1-465 cells transfected with expression vectors encoding the indicated proteins. 

Phrase: "(C) Analysis of the ubiquitylation of myc-p38,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "HA-CDCrel-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1825516:HA-1 [Gene or Genome]
   913   C1825747:Ha-1 [Gene or Genome]
   901   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
   901   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   827   C1539748:CDCREL [Gene or Genome]

Phrase: "and"

Phrase: "EGFP in SH-SY5Y"

Phrase: "and"

Phrase: "SH-SY5Y-HA-Parkin1-465 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with expression vectors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0599566:expression vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0442335:Vectors [Spatial Concept]
   737 E C1705099:Vector [Idea or Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the indicated proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.49: His-ubi, his-tagged ubiquitin. 

Phrase: "His-ubi,"

Phrase: "his-tagged ubiquitin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.50: Purified his-ubi proteins or cell lysates were analyzed by WB using anti-myc, anti-HA, anti-GFP or anti-Parkin (54) antibodies. 

Phrase: "Purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "his-ubi proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "analyzed by WB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-myc,"

Phrase: "anti-HA,"

Phrase: "anti-GFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "anti-Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(54"

Phrase: ")"

Phrase: "antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.51: (D, E) Analysis of p38 ubiquitylation in SH-SY5Y cells transiently transfected with vectors encoding myc-p38, his-ubi and HA-Parkin1-86, HA-Parkin77-465, HA-ParkinLys161Asn or HA-Parkin1-465. 

Phrase: "(D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "E) Analysis of p38 ubiquitylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in SH-SY5Y cells transiently"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0442335:Vectors [Spatial Concept]
   756 E C1705099:Vector [Idea or Concept]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "myc-p38,"

Phrase: "his-ubi"

Phrase: "and"

Phrase: "HA-Parkin1-86,"

Phrase: "HA-Parkin77-465,"

Phrase: "HA-ParkinLys161Asn"

Phrase: "or"

Phrase: "HA-Parkin1-465."
Processing 00000000.tx.52: Results of representative experiments are shown. 

Phrase: "Results of representative experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   761   C2825142:Experimental Result [Finding]
           Result
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.53: The asterisks indicate the non-specific binding of non-ubiquitylated myc-p38 to the Probond affinity resin.  

Phrase: "The asterisks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisks [Conceptual Entity]

Phrase: "indicate"

Phrase: "the non-specific binding of non-ubiquitylated myc-p38"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0205370:Non-specific [Qualitative Concept]
   742   C0205369:Specific [Qualitative Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1518422:Non [Functional Concept]
   742   C1552740:specific [Intellectual Product]

Phrase: "to the Probond affinity resin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035191:Resin [Biomedical or Dental Material]
Processing 00000000.tx.54: We then determined whether Parkin is involved in the ubiquitylation of p38 in a human dopaminergic neuroblastoma-derived cell line stably expressing full-length HA-Parkin (SH-SY5Y-HA-Parkin1-465). 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "determined"

Phrase: "whether"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "involved in the ubiquitylation of p38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1314939:Involved [Functional Concept]
   753   C1519751:Ubiquitylation [Molecular Function]

Phrase: "in a human dopaminergic neuroblastoma-derived cell line stably"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0682523:Human Cell Line [Cell]
   861   C0427861:human cell [Laboratory or Test Result]
   845   C1512035:Dopaminergic cell [Cell]
   829   C0815000:neuroblastoma cell [Cell]
   818   C0007600:Cell Line [Cell]
   795   C0007634:Cell [Cell]
   795   C0205132:Line [Spatial Concept]
   795   C1269647:Cell [Cell]
   795   C1550648:Line [Substance]
   795   C1552960:Line [Quantitative Concept]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "full-length HA-Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1418270:PARKIN [Gene or Genome]
   812   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(SH-SY5Y-HA-Parkin1-465"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0038108:SH [Geographic Area]

Phrase: ")."
Processing 00000000.tx.55: Myc-p38, an HA-tagged Parkin substrate CDCrel-1 (positive control) and EGFP (enhanced green fluorescent protein; negative control) were overexpressed alone or with his-tagged ubiquitin in SH-SY5Y or SH-SY5Y-HA-Parkin1-465 cells. 

Phrase: "Myc-p38,"

Phrase: "an HA-tagged Parkin substrate CDCrel-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   895   C1825516:HA-1 [Gene or Genome]
   895   C1825747:Ha-1 [Gene or Genome]
   859   C1413560:TAG-1 [Gene or Genome]
   827   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
   827   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   799   C1539748:CDCREL [Gene or Genome]

Phrase: "(positive control"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1883676:Positive Control [Conceptual Entity]
   861   C0243148:control [Qualitative Concept]
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825490:Positive [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "EGFP"

Phrase: "(enhanced green fluorescent protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1258415:enhanced green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   923   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0332583:Green [Qualitative Concept]

Phrase: "; negative control"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or with his-tagged ubiquitin"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0019602:His [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1412323:HIS [Gene or Genome]
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1708632:Tagged [Qualitative Concept]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]

Phrase: "in SH-SY5Y"

Phrase: "or"

Phrase: "SH-SY5Y-HA-Parkin1-465 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.56: His-ubiquitylated proteins were purified by affinity chromatography and the covalent modification of p38, CDCrel-1 and EGFP by ubiquitin was examined by western blotting using anti-myc, anti-HA and anti-EGFP antibodies, respectively. 

Phrase: "His-ubiquitylated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "purified by affinity chromatography"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008551:Chromatography, Affinity [Laboratory Procedure]
   770   C0008550:Chromatography [Laboratory Procedure]
   770   C1510827:Affinity [Natural Phenomenon or Process]
   770   C1998793:Purified [Functional Concept]

Phrase: "and"

Phrase: "the covalent modification of p38,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392747:Modification [Functional Concept]
   760   C1554963:modification [Qualitative Concept]

Phrase: "CDCrel-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
  1000   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   861   C1539748:CDCREL [Gene or Genome]

Phrase: "and"

Phrase: "EGFP by ubiquitin"

Phrase: "was"

Phrase: "examined by western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0332128:Examined [Finding]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-myc,"

Phrase: "anti-HA"

Phrase: "and"

Phrase: "anti-EGFP antibodies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.57: We observed high molecular weight proteins corresponding to ubiquitylated p38 and CDCrel-1 in cells overexpressing Parkin, but not in native SH-SY5Y cells, consistent with the Parkin-mediated ubiquitylation of these proteins (Fig.1C). 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "high molecular weight proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1979900:High molecular weight [Qualitative Concept]
   708   C0948775:high weight [Sign or Symptom]

Phrase: "corresponding to ubiquitylated p38"

Phrase: "and"

Phrase: "CDCrel-1 in cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
   833   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   770   C1539748:CDCREL [Gene or Genome]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "Parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "not in native SH-SY5Y cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0007634:Cells [Cell]
   753   C0038108:SH [Geographic Area]
   753   C0302891:Native [Functional Concept]
   753   C1518422:Not [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "consistent with the Parkin-mediated ubiquitylation of these proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Fig.1C"

Phrase: ")."
Processing 00000000.tx.58: In contrast, EGFP was not ubiquitylated in native SH-SY5Y or in SH-SY5Y-HA-Parkin1-465 cells. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "EGFP"

Phrase: "was"

Phrase: "not ubiquitylated in native SH-SY5Y"

Phrase: "or in SH-SY5Y-HA-Parkin1-465 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C0007634:Cells [Cell]
   744   C0038108:SH [Geographic Area]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.59: We next evaluated whether the deletion of the functional domains involved in the E3 ubiquitinprotein ligase activity of Parkin affects the Parkin-mediated ubiquitylation of p38 in SH-SY5Y cells (19,20). 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "whether"

Phrase: "the deletion of the functional domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "involved in the E3 ubiquitinprotein ligase activity of Parkin"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C1150651:ligase activity [Molecular Function]
   762   C0077678:E3 Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1314939:Involved [Functional Concept]
   742   C1418270:PARKIN [Gene or Genome]
   742   C1537525:E3 [Gene or Genome]
   742   C1561536:*Activity [Idea or Concept]
   742   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the Parkin-mediated ubiquitylation of p38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1519751:Ubiquitylation [Molecular Function]

Phrase: "in SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(19,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.60: Myc-p38 and his-ubiquitin were transiently overexpressed in native SH-SY5Y cells, alone or together with HA-Parkin1-465 or truncated isoforms lacking a large portion of the linker region and the entire RING-IBR-RING domain (HA-Parkin1-86) or the ubiquitin-like motif (HA-Parkin77-465) (Fig.1A). 

Phrase: "Myc-p38"

Phrase: "and"

Phrase: "his-ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "transiently"

Phrase: "overexpressed in native SH-SY5Y cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0007634:Cells [Cell]
   753   C0038108:SH [Geographic Area]
   753   C0302891:Native [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719   C1514559:overexpress [Genetic Function]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or together with HA-Parkin1-465"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1883357:Together [Qualitative Concept]

Phrase: "or"

Phrase: "truncated isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "a large portion of the linker region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449719:Portion [Spatial Concept]

Phrase: "and"

Phrase: "the entire RING-IBR-RING domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: "(HA-Parkin1-86"

Phrase: ")"

Phrase: "or"

Phrase: "the ubiquitin-like motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "(HA-Parkin77-465"

Phrase: ")"

Phrase: "(Fig.1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.61: Consistent with the results obtained in SH-SY5Y-HA-Parkin1-465 cells, full-length Parkin promoted the ubiquitylation of p38 (Fig.1D). 

Phrase: "Consistent with the results"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "obtained in SH-SY5Y-HA-Parkin1-465 cells,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   744   C0007634:Cells [Cell]
   744   C0038108:SH [Geographic Area]
   744   C1301820:Obtained [Functional Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1706701:Obtain [Activity]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "full-length Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "the ubiquitylation of p38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1519751:Ubiquitylation [Molecular Function]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]

Phrase: "1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416886:1D [Gene or Genome]
  1000   C1442449:1D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.62: In contrast, p38 was not ubiquitylated when it was overexpressed with Parkin1-86 or Parkin77-465. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "p38"

Phrase: "was"

Phrase: "not ubiquitylated"

Phrase: "when"

Phrase: "it"

Phrase: "was"

Phrase: "overexpressed with Parkin1-86"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1514559:overexpress [Genetic Function]

Phrase: "or"

Phrase: "Parkin77-465."
Processing 00000000.tx.63: In a similar experiment, we evaluated the ability of the pathogenic Parkin mutant Lys161Asn (HA-ParkinLys161Asn) to ubiquitylate p38 in SH-SY5Y cells (Fig.1E). 

Phrase: "In a similar experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the ability of the pathogenic Parkin mutant Lys161Asn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0085732:Ability [Organism Attribute]

Phrase: "(HA-ParkinLys161Asn"

Phrase: ")"

Phrase: "to ubiquitylate p38 in SH-SY5Y cells"

Phrase: "(Fig.1E"

Phrase: ")."
Processing 00000000.tx.64: This mutant affects the central domain of Parkin used as bait for the yeast two hybrid screen, which directly interacts with p38. 

Phrase: "This mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the central domain of Parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: "used as bait"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "for the yeast two hybrid screen,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0599647:Two Hybrid [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0220908:screen [Health Care Activity]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C1305399:screen [Functional Concept]
   812   C1705053:Screen [Medical Device]

Phrase: "which directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "interacts with p38."
Processing 00000000.tx.65: Surprisingly, ParkinLys161Asn ubiquitylated p38 to the same extent as normal Parkin. 

Phrase: "Surprisingly,"

Phrase: "ParkinLys161Asn ubiquitylated p38 to the same extent"

Phrase: "as normal Parkin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.66: To investigate whether the Parkin-mediated ubiquitylation of p38 accelerates its degradation, we carried out pulse-chase experiments to examine the turnover of myc-p38 in native SH-SY5Y and SH-SY5Y-HA-Parkin1-465 cells. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "the Parkin-mediated ubiquitylation of p38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1519751:Ubiquitylation [Molecular Function]

Phrase: "accelerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "its degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "we"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out pulse-chase experiments to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]

Phrase: "examine"

Phrase: "the turnover of myc-p38"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0031227:turnover [Quantitative Concept]
   760   C0243127:turnover [Functional Concept]
   760   C0443331:Turnover [Health Care Activity]

Phrase: "in native SH-SY5Y"

Phrase: "and"

Phrase: "SH-SY5Y-HA-Parkin1-465 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.67: Parkin significantly promoted myc-p38 degradation in SH-SY5Y-HA-Parkin1-465 cells (Fig.2). 

Phrase: "Parkin significantly promoted myc-p38 degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0243125:degradation [Functional Concept]
   799   C0699900:Degradation [Organism Function]

Phrase: "in SH-SY5Y-HA-Parkin1-465 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.68: Accordingly, about 50% of de novo synthesized myc-p38 was degraded after a 0.5h chase in SH-SY5Y-HA-Parkin1-465 cells, whereas a chase of 1.75h was required for the degradation of a similar amount of myc-p38 in SH-SY5Y cells. 

Phrase: "Accordingly,"

Phrase: "about 50% of de novo synthesized myc-p38"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1515568:de novo [Idea or Concept]
   744   C0011198:DE [Geographic Area]
   744   C0017480:DE [Geographic Area]
   744   C1883254:Synthesized [Activity]
   744   C3541240:DE [Idea or Concept]

Phrase: "was"

Phrase: "degraded after a 0.5h chase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1442467:5H [Temporal Concept]
   753   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "in SH-SY5Y-HA-Parkin1-465 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "whereas"

Phrase: "a chase of 1.75h"

Phrase: "was"

Phrase: "required for the degradation of a similar amount of myc-p38"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   738   C0243125:degradation [Functional Concept]
   738   C0699900:Degradation [Organism Function]
   738   C1265611:Amount [Quantitative Concept]
   738   C1514873:Required [Functional Concept]
   738   C2348205:Similar [Qualitative Concept]

Phrase: "in SH-SY5Y cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.69: View larger version (29K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.70: Parkin promotes the degradation of p38. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the degradation of p38."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
Processing 00000000.tx.71: Pulse-chase analysis of the turnover of myc-p38 in SH-SY5Y and SH-SY5Y-HA-Parkin1-465 cells. 

Phrase: "Pulse-chase analysis of the turnover of myc-p38"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "in SH-SY5Y"

Phrase: "and"

Phrase: "SH-SY5Y-HA-Parkin1-465 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.72: Data from three independent experiments are expressed as meansSEM. 

Phrase: "Data from three independent experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as meansSEM."
Processing 00000000.tx.73: Asterisks indicate statistical significance; 

Phrase: "Asterisks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisks [Conceptual Entity]

Phrase: "indicate"

Phrase: "statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.74: P0.003 versus SH-SY5Y-HA-Parkin1-465.  

Phrase: "P0.003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417248:P0 [Gene or Genome]
   861   C1419691:P0 [Gene or Genome]

Phrase: "versus"

Phrase: "SH-SY5Y-HA-Parkin1-465."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0038108:SH [Geographic Area]
Processing 00000000.tx.75: Parkin is recruited into p38-positive aggresome-like inclusions in COS7 cells We further analyzed the functional interaction between Parkin and p38 by examining their intracellular distribution and potential co-localization in COS7 cells (Fig.3). 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "recruited into p38-positive aggresome-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0439178:% Positive [Quantitative Concept]
   760   C1167059:aggresome [Cell Component]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C2825490:Positive [Qualitative Concept]

Phrase: "like inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]

Phrase: "in COS7 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the functional interaction between Parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "p38 by examining"

Phrase: "their intracellular distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "potential co-localization in COS7 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1660153:cell localization [Biologic Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.76: When full-length Parkin was overexpressed alone, Parkin immunoreactivity displayed a homogeneous punctuate distribution throughout the cell body and processes and was particularly intense in the perinuclear region; 

Phrase: "When"

Phrase: "full-length Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "alone, Parkin immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a homogeneous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881065:Homogeneous [Qualitative Concept]

Phrase: "punctuate"

Phrase: "distribution throughout the cell body"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "was"

Phrase: "particularly intense in the perinuclear region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0522510:Intense [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.77: frequently, immunoreactivity was also present in the nucleus (Fig.3). 

Phrase: "frequently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "also"

Phrase: "present in the nucleus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007610:Nucleus [Cell Component]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "(Fig.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.78: A similar pattern of immunoreactivity was observed for endogenous Parkin (data not shown). 

Phrase: "A similar pattern of immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "observed for endogenous Parkin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205227:Endogenous [Functional Concept]
   770   C1418270:PARKIN [Gene or Genome]
   770   C1441672:Observed [Functional Concept]
   770   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.79: Importantly, there was a striking overlap in the distribution of Parkin and that of endogenous p38, in particular in the perinuclear region and the cell processes, and less frequently in the nucleus of COS7 cells. 

Phrase: "Importantly,"

Phrase: "there"

Phrase: "was"

Phrase: "a striking overlap in the distribution of Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0185027:overlap [Therapeutic or Preventive Procedure]
   744   C1948020:Overlap [Conceptual Entity]

Phrase: "and"

Phrase: "that of endogenous p38,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205227:Endogenous [Functional Concept]

Phrase: "in particular"

Phrase: "in the perinuclear region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "the cell processes,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0230625:cell processes [Cell Component]
   983 E C0007613:Cell Process [Cell Function]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "less frequently in the nucleus of COS7 cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   782   C0007610:Nucleus of cell [Cell Component]
           Cell Nucleus
           Nucleus
   744   C0007634:Cells [Cell]
   744   C0332183:Frequently [Temporal Concept]
   744   C0439092:less [Intellectual Product]
   744   C0547044:Less [Qualitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.80: Occasionally, endogenous p38 immunostaining was also associated with discrete cytoplasmic granules (Fig.3A). 

Phrase: "Occasionally,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Occasionally [Temporal Concept]

Phrase: "endogenous p38 immunostaining"

Phrase: "was"

Phrase: "also"

Phrase: "associated with discrete cytoplasmic granules"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0010837:Cytoplasmic Granules [Cell Component]
           Granules
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0010834:Cytoplasmic [Cell Component]
   760   C0521449:Cytoplasmic [Body Location or Region]
   760   C0993609:Granules [Biomedical or Dental Material]
   760   C2699782:Discrete [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Fig.3A"

Phrase: ")."
Processing 00000000.tx.81: The overexpression of p38 alone led to formation of large p38-immunoreactive perinuclear inclusions in 30% of the transfected cells in basal conditions, and in most cells when proteasome activity was inhibited by epoxomicin (data not shown) (29). 

Phrase: "The overexpression of p38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "led to formation of large p38-immunoreactive perinuclear inclusions"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C0549177:Large [Quantitative Concept]
   742   C1522492:Formation [Functional Concept]
   742   C1708698:LED [Manufactured Object]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708   C1512693:Inclusion [Qualitative Concept]
   708 E C1522538:Lead [Functional Concept]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in 30%"

Phrase: "of the transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in basal conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and in most cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1515981:And [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "when"

Phrase: "proteasome activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1622946:proteasome activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "inhibited by epoxomicin"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0311403:Inhibited [Qualitative Concept]
   790   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.82: When overexpressed with p38, full-length Parkin was systematically sequestered in large p38-positive inclusions (Fig.3B). 

Phrase: "When"

Phrase: "overexpressed with p38,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1514559:overexpress [Genetic Function]

Phrase: "full-length Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "systematically"

Phrase: "sequestered in large p38-positive inclusions"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0333312:Sequestered [Functional Concept]
   753   C0439178:% Positive [Quantitative Concept]
   753   C0549177:Large [Quantitative Concept]
   753   C1446409:Positive [Qualitative Concept]
   753   C1514241:Positive [Finding]
   753   C2825490:Positive [Qualitative Concept]
   719   C1512693:Inclusion [Qualitative Concept]

Phrase: "(Fig.3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.83: Such a redistribution was also observed for Parkin77-465 and ParkinLys161Asn (Fig.3B), but not when EGFP was overexpressed with p38 (data not shown). 

Phrase: "Such"

Phrase: "a redistribution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332620:Redistribution [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "observed for Parkin77-465"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "ParkinLys161Asn"

Phrase: "(Fig.3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "when"

Phrase: "EGFP"

Phrase: "was"

Phrase: "overexpressed with p38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1514559:overexpress [Genetic Function]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.84: View larger version (58K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(58K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.85: p38 co-localizes with Parkin in COS7 cells. 

Phrase: "p38"

Phrase: "co-localizes with Parkin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392752:localize [Spatial Concept]
   770   C1418270:PARKIN [Gene or Genome]
   770   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in COS7 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.86: (A) Analysis of the localization of endogenous p38 and overexpressed HA-Parkin1-465 revealed with anti-HA and anti-p38 antibodies. 

Phrase: "(A) Analysis of the localization of endogenous p38"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "overexpressed HA-Parkin1-465"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1514559:overexpress [Genetic Function]

Phrase: "revealed with anti-HA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443289:Revealed [Qualitative Concept]

Phrase: "and"

Phrase: "anti-p38 antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.87: (B) HA-Parkin1-465, HA-Parkin77-465 and HA-ParkinLys161Asn are recruited in aggregates formed by overexpressed myc-p38. 

Phrase: "(B) HA-Parkin1-465,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347469:/B [Quantitative Concept]

Phrase: "HA-Parkin77-465"

Phrase: "and"

Phrase: "HA-ParkinLys161Asn"

Phrase: "are"

Phrase: "recruited in aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205418:aggregates [Qualitative Concept]

Phrase: "formed by overexpressed myc-p38."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0205431:Formed [Functional Concept]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726   C1514559:overexpress [Genetic Function]
   726 E C1522492:Form [Functional Concept]
Processing 00000000.tx.88: Immunocytochemistry using anti-Parkin (54) and anti-myc antibodies. 

Phrase: "Immunocytochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(54"

Phrase: ")"

Phrase: "and"

Phrase: "anti-myc antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.89: Cells were analyzed by laser-scanning confocal microscopy.  

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "analyzed by laser-scanning confocal microscopy."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   882   C0242841:Microscopy, Confocal, Laser Scanning [Laboratory Procedure]
           confocal scanning microscopy
   851 E C0242842:Confocal Laser Scanning Microscopy [Laboratory Procedure]
           Microscopy, Confocal
   820   C0600396:Laser Scanning Microscopy [Laboratory Procedure]
   783   C0600395:Laser Microscopy [Laboratory Procedure]
   753   C0023089:Laser [Manufactured Object]
   753   C0026018:Microscopy [Laboratory Procedure]
   753   C0034606:Scanning [Diagnostic Procedure]
   753   C0441633:Scanning [Diagnostic Procedure]
   753   C0458142:Laser [Phenomenon or Process]
   753   C0936012:Analyzed [Research Activity]
   753   C1023865:Laser [Plant]
   753   C1706315:Laser [Medical Device]
   719 E C2826292:SCAN [Finding]
Processing 00000000.tx.90: We next characterized the p38 immunoreactive inclusions to determine whether they were related to aggresomes, which are pericentriolar structures formed by cells in response to the presence of misfolded proteins (30,31). 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "the p38 immunoreactive inclusions to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1512693:Inclusion [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "they"

Phrase: "were"

Phrase: "related to aggresomes,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   756 E C0163712:Relate [Organic Chemical]
   756   C1167059:aggresome [Cell Component]

Phrase: "which"

Phrase: "are"

Phrase: "pericentriolar structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "formed by cells"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0205431:Formed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C0348078:Form [Qualitative Concept]
   756 E C0376315:Form [Manufactured Object]
   756 E C1269647:Cell [Cell]
   756 E C1522492:Form [Functional Concept]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of misfolded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: Double immunofluorescence for the centrosome marker -tubulin and p38 revealed that, similarly to aggresomes, the inclusions assembled at the microtubule organizing center (Fig.4A, upper panel). 

Phrase: "Double immunofluorescence for the centrosome marker -tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0016318:Immunofluorescence [Laboratory Procedure]
   748   C0079603:Immunofluorescence [Laboratory Procedure]

Phrase: "and"

Phrase: "p38"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that,"

Phrase: "similarly to aggresomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1167059:aggresome [Cell Component]

Phrase: "the inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]

Phrase: "assembled at the microtubule organizing center"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0242607:Microtubule-Organizing Center [Cell Component]
   753   C0026046:Micro-tubule [Cell Component]
   753   C0205099:Center [Spatial Concept]
   753   C1300196:organizing [Functional Concept]
   719   C1706853:Assemble [Activity]

Phrase: "(Fig.4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.92: This process was dependent on intact microtubules, since treatment of the transfected cells with the microtubule depolymerizing agent nocodazole caused the generation of smaller p38 aggregates that were dispersed throughout the cell body (Fig.4A, upper panel). 

Phrase: "This process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "was"

Phrase: "dependent on intact microtubules,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "since"

Phrase: "treatment of the transfected cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with the microtubule depolymerizing agent nocodazole"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0028247:Nocodazole [Organic Chemical,Pharmacologic Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "the generation of smaller p38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "dispersed throughout the cell body"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0599444:Cell body [Cell Component]
   806   C2752549:cell body [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0242821:body [Human]
   760   C0332624:Dispersed [Spatial Concept]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "(Fig.4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.93: In contrast, cytochalasin D, a compound that destabilizes actin filaments, had no effect on the formation of the inclusions (data not shown). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "cytochalasin D,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010738:Cytochalasin D [Biologically Active Substance,Organic Chemical]
   861   C0010739:Cytochalasin [Biologically Active Substance,Pharmacologic Substance]

Phrase: "a compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205198:Compound [Qualitative Concept]
  1000   C1706082:Compound [Chemical]

Phrase: "that"

Phrase: "destabilizes"

Phrase: "actin filaments,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0025979:Actin Filaments [Cell Component]
   958 E C1622186:Actin.filamentous [Cell Component]
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0010851:Filament [Cell Component]
   789 E C0439681:Actinic [Qualitative Concept]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "had"

Phrase: "no effect on the formation of the inclusions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.94: The assembly of the inclusions caused the reorganization of the intermediate filament vimentin such that it formed a ring-like structure at the periphery of aggregates, as reported for aggresomes (Fig.4A, lower panel). 

Phrase: "The assembly of the inclusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1706853:Assembly [Activity]
   760   C1879748:Assembly [Manufactured Object]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "the reorganization of the intermediate filament vimentin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0680829:reorganization [Idea or Concept]

Phrase: "such"

Phrase: "that"

Phrase: "it"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "a ring-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0521164:Ring [Spatial Concept]
   861   C1260969:Ring [Medical Device]
   861   C1705184:Ring [Medical Device]

Phrase: "like structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "at the periphery"

Phrase: "of aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:aggregates [Qualitative Concept]

Phrase: "as"

Phrase: "reported for aggresomes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756   C1167059:aggresome [Cell Component]
   756 E C3273238:Report [Intellectual Product]

Phrase: "(Fig.4A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.95: Most inclusions were ubiquitin-positive and co-localized with the proteasomal 20S subunit and the cytoplasmic chaperones, Hsp70 and Hdj-2 (Fig.4B). 

Phrase: "Most inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]

Phrase: "were"

Phrase: "ubiquitin-positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "co-localized with the proteasomal 20S subunit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0392752:Localized [Spatial Concept]
   748   C1552134:20s [Body Part, Organ, or Organ Component]
   748   C1711351:Subunit [Quantitative Concept]
   738   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   738   C1166808:20S proteasome [Cell Component]

Phrase: "and"

Phrase: "the cytoplasmic chaperones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Hsp70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "Hdj-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415754:hdj-2 [Gene or Genome]

Phrase: "(Fig.4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.96: View larger version (48K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(48K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.97: p38 positive inclusions in COS7 cells overexpressing myc-p38 are related to aggresomes. 

Phrase: "p38 positive inclusions in COS7 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0205708:cells inclusions [Cell Component]
   719   C1512693:Inclusion [Qualitative Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "myc-p38"

Phrase: "are"

Phrase: "related to aggresomes."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   756 E C0163712:Relate [Organic Chemical]
   756   C1167059:aggresome [Cell Component]
Processing 00000000.tx.98: Laser confocal scanned images illustrating (A, upper panel) the co-localization of p38-positive inclusions and the centrosome marker -tubulin; 

Phrase: "Laser confocal scanned images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1704254:Image [Intellectual Product]
   779   C1704922:Image [Entity]
   779   C3542466:Image [Intellectual Product]

Phrase: "illustrating"

Phrase: "(A,"

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "the co-localization of p38-positive inclusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "the centrosome marker -tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2937342:tubulin [Cell Component]

Phrase: ";"
Processing 00000000.tx.99: the effect of nocodazole treatment on the appearance of p38-positive aggregates; 

Phrase: "the effect of nocodazole treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1518681:Treatment Effect [Finding]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the appearance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0233426:Appearance [Organism Attribute]
  1000   C0700364:Appearance [Qualitative Concept]

Phrase: "of p38-positive aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.100: (lower panel) the redistribution of vimentin at the periphery of inclusions. 

Phrase: "(lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "the redistribution of vimentin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332620:Redistribution [Functional Concept]

Phrase: "at the periphery"

Phrase: "of inclusions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.101: (B) Double immunofluorescence for p38 and endogenous ubiquitin, the proteasomal 20S complex, the cytoplasmic chaperone, Hsp70 and the co-factor, Hdj-2.  

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "immunofluorescence for p38"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0016318:Immunofluorescence [Laboratory Procedure]
   790   C0079603:Immunofluorescence [Laboratory Procedure]
   734 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   718 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "endogenous ubiquitin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the proteasomal 20S complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "the cytoplasmic chaperone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Hsp70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "the co-factor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "Hdj-2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415754:hdj-2 [Gene or Genome]
Processing 00000000.tx.102: Parkin promotes the formation of ubiquitylated p38-positive inclusion bodies and protects from p38-induced toxicity in the dopaminergic SH-SY5Y cell line To characterize the functional relationship between Parkin and p38 further, we examined the intracellular distribution of myc-p38 in SH-SY5Y and SH-SY5Y-HA-Parkin1-465 cells. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the formation of ubiquitylated p38-positive inclusion bodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "protects from p38-induced toxicity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0205263:Induced [Functional Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "in the dopaminergic SH-SY5Y cell line To"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   858   C1512035:Dopaminergic cell [Cell]
   827   C0007600:Cell Line [Cell]
   799   C0007634:Cell [Cell]
   799   C0205132:Line [Spatial Concept]
   799   C1269647:Cell [Cell]
   799   C1550648:Line [Substance]
   799   C1552960:Line [Quantitative Concept]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "characterize"

Phrase: "the functional relationship between Parkin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2700217:Functional Relationship [Conceptual Entity]
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "p38 further,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the intracellular distribution of myc-p38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "in SH-SY5Y"

Phrase: "and"

Phrase: "SH-SY5Y-HA-Parkin1-465 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.103: In SH-SY5Y cells, p38 was homogeneously distributed throughout the cytoplasm and the processes (data not shown). 

Phrase: "In SH-SY5Y cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "p38"

Phrase: "was"

Phrase: "homogeneously"

Phrase: "distributed throughout the cytoplasm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010834:Cytoplasm [Cell Component]
   770   C1704711:Distributed [Functional Concept]

Phrase: "and"

Phrase: "the processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.104: p38-positive ubiquitylated cytoplasmic inclusions were also observed in about 2% of the transfected cells (Fig.5A and B). 

Phrase: "p38-positive ubiquitylated cytoplasmic inclusions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0205708:Cytoplasmic Inclusions [Cell Component]
   804   C0010834:Cytoplasmic [Cell Component]
   804   C0521449:Cytoplasmic [Body Location or Region]
   771   C1512693:Inclusion [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "observed in about 2% of the transfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   744   C0007634:Cells [Cell]
   744   C1441672:Observed [Functional Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig.5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.105: The percentage of cells displaying these inclusions was significantly higher when p38 was overexpressed in SH-SY5Y-HA-Parkin1-465 cells (about 9%; Fig.5B). 

Phrase: "The percentage of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439165:Percentage [Quantitative Concept]
   770   C1549488:Percentage [Idea or Concept]
   770   C1561533:Percentage [Idea or Concept]

Phrase: "displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "these inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]

Phrase: "was"

Phrase: "significantly higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: "when"

Phrase: "p38"

Phrase: "was"

Phrase: "overexpressed in SH-SY5Y-HA-Parkin1-465 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0007634:Cells [Cell]
   744   C0038108:SH [Geographic Area]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711   C1514559:overexpress [Genetic Function]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(about 9%"

Phrase: "; Fig.5B"

Phrase: ")."
Processing 00000000.tx.106: The aggregation of p38 was considerably enhanced in the presence of epoxomicin: p38-positive inclusions were observed in 6 and 14% of the transfected SH-SY5Y and SH-SY5Y-HA-Parkin1-465 cells, respectively (Fig.5B). 

Phrase: "The aggregation of p38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "was"

Phrase: "considerably"

Phrase: "enhanced in the presence of epoxomicin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C2349975:Enhanced [Activity]

Phrase: ":"

Phrase: "p38-positive inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1512693:Inclusion [Qualitative Concept]

Phrase: "were"

Phrase: "observed in 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "14% of the transfected SH-SY5Y"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0038108:SH [Geographic Area]

Phrase: "and"

Phrase: "SH-SY5Y-HA-Parkin1-465 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "respectively"

Phrase: "(Fig.5B"

Phrase: ")."
Processing 00000000.tx.107: Similar results were obtained with an EGFP-p38 fusion protein. 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained with an EGFP-p38 fusion protein."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   774   C1258415:EGFP protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332466:Fusion [Functional Concept]
   748   C1293131:Fusion [Therapeutic or Preventive Procedure]
   748   C1301820:Obtained [Functional Concept]
   714 E C1706701:Obtain [Activity]
Processing 00000000.tx.108: In contrast, the control protein EGFP did not form visible aggregates in SH-SY5Y or SH-SY5Y-HA-Parkin1-465 cells (data not shown). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the control protein EGFP"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "visible aggregates in SH-SY5Y"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205418:aggregates [Qualitative Concept]

Phrase: "or"

Phrase: "SH-SY5Y-HA-Parkin1-465 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.109: View larger version (57K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(57K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.110: Parkin promotes the aggregation of p38 and protects from p38-induced cell death in SH-SY5Y cells. 

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the aggregation of p38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "and"

Phrase: "protects from p38-induced cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C0205263:Induced [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "in SH-SY5Y cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.111: (A) Laser confocal scanned image illustrating a p38-positive inclusion in SH-SY5Y cells overexpressing myc-p38 and double labeled for ubiquitin and p38. 

Phrase: "(A) Laser confocal scanned image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1704254:Image [Intellectual Product]
   804   C1704922:Image [Entity]
   804   C3542466:Image [Intellectual Product]

Phrase: "illustrating"

Phrase: "a p38-positive inclusion in SH-SY5Y cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0205708:cells inclusion [Cell Component]
   744   C1512693:Inclusion [Qualitative Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "myc-p38"

Phrase: "and"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "labeled for ubiquitin"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "p38."
Processing 00000000.tx.112: (B) Quantification of the percentage of transfected SH-SY5Y and SH-SY5Y-HA-Parkin1-465 cells displaying p38-positive inclusions, after treatment or not with the proteasome inhibitor epoxomicin. 

Phrase: "(B) Quantification of the percentage of transfected SH-SY5Y"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1709793:Quantification [Quantitative Concept]

Phrase: "and"

Phrase: "SH-SY5Y-HA-Parkin1-465 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "p38-positive inclusions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1512693:Inclusion [Qualitative Concept]

Phrase: "after"

Phrase: "treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "or"

Phrase: "not with the proteasome inhibitor epoxomicin."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   790   C2266856:Proteasome Inhibitor [Molecular Function]
   790   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C1325620:proteasome [Cell Component]
   753   C1518422:Not [Functional Concept]
   753   C1752727:Proteasome [Molecular Function]
   753   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.113: aP0.002; 

Phrase: "aP0.002"

Phrase: ";"
Processing 00000000.tx.114: bP<0.02. 

Phrase: "bP<0.02."
Processing 00000000.tx.115: (C) Quantification of the percentage of dead EGFP-positive cells in SH-SY5Y or SH-SY5Y-HA-Parkin1-465 cells overexpressing EGFP or a EGFP-p38 fusion protein. 

Phrase: "(C) Quantification of the percentage of dead EGFP-positive cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1709793:Quantification [Quantitative Concept]

Phrase: "in SH-SY5Y"

Phrase: "or"

Phrase: "SH-SY5Y-HA-Parkin1-465 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "EGFP"

Phrase: "or"

Phrase: "a EGFP-p38 fusion protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C1258415:EGFP protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   861   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]
Processing 00000000.tx.116: Asterisks, P<0.001. 

Phrase: "Asterisks,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisks [Conceptual Entity]

Phrase: "P<0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.117: Results of one representative experiment (n=3) are shown.  

Phrase: "Results of one representative experiment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   745   C2825142:Experimental Result [Finding]
           Result
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.118: To determine whether the accumulation of p38 could be toxic, EGFP or EGFP-p38 were overexpressed in native SH-SY5Y or SH-SY5Y-HA-Parkin1-465 cells, then the viability of EGFP-positive cells was estimated (Fig.5C). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the accumulation of p38"

Phrase: "could"

Phrase: "be"

Phrase: "toxic, EGFP"

Phrase: "or"

Phrase: "EGFP-p38"

Phrase: "were"

Phrase: "overexpressed in native SH-SY5Y"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0038108:SH [Geographic Area]
   760   C0302891:Native [Functional Concept]
   726   C1514559:overexpress [Genetic Function]

Phrase: "or"

Phrase: "SH-SY5Y-HA-Parkin1-465 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the viability of EGFP-positive cells"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0007620:Cell Viability [Cell Function]
   753   C0443348:viability [Qualitative Concept]
   748 E C1441322:Viable cells [Cell]

Phrase: "was"

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "(Fig.5C"

Phrase: ")."
Processing 00000000.tx.119: Levels of cell death were similar in SH-SY5Y and SH-SY5Y-HA-Parkin1-465 cells producing EGFP (about 5%). 

Phrase: "Levels of cell death"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "similar in SH-SY5Y"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "SH-SY5Y-HA-Parkin1-465 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "producing"

Phrase: "EGFP"

Phrase: "(about 5%"

Phrase: ")."
Processing 00000000.tx.120: Cell death increased 6-fold when EGFP-p38 was overepressed in native SH-SY5Y cells. 

Phrase: "Cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "6-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "when"

Phrase: "EGFP-p38"

Phrase: "was"

Phrase: "overepressed in native SH-SY5Y cells."
Processing 00000000.tx.121: The overexpression of Parkin in SH-SY5Y cells partially but significantly protected from p38-induced toxicity, leading to a 2-fold decrease in cell death. 

Phrase: "The overexpression of Parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in SH-SY5Y cells partially"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "significantly"

Phrase: "protected from p38-induced toxicity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0205263:Induced [Functional Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "leading to a 2-fold decrease in cell death."
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   764   C0007587:Cell Death [Cell Function]
   745   C2346661:Lead 2+ [Element, Ion, or Isotope]
   742   C0007634:Cell [Cell]
   742   C0011065:Death [Organism Function]
   742   C0332152:Leading [Temporal Concept]
   742   C0332462:Fold [Spatial Concept]
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]
   742   C1269647:Cell [Cell]
   742   C1306577:Death, NOS [Finding]
   742   C1522538:Leading [Functional Concept]
   742   C1704653:Cell [Medical Device]
   742   C1880834:FOLD [Phenomenon or Process]
   742   C1948049:Cell [Spatial Concept]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.122: p38 is present in LBs in patients with idiopathic PD We next examined the distribution of p38 in the human midbrain, using specific antibodies (Fig.6). 

Phrase: "p38"

Phrase: "is"

Phrase: "present in LBs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with idiopathic PD"

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the distribution of p38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "in the human midbrain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025462:Mid-brain [Body Part, Organ, or Organ Component]
   861   C1280997:Midbrain [Body Part, Organ, or Organ Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig.6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.123: In lysates from SH-SY5Y cells overexpressing myc-p38, these antibodies detected both native endogenous p38 and exogenous myc-p38. 

Phrase: "In lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "from SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "myc-p38,"

Phrase: "these antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "both native endogenous p38"

Phrase: "and"

Phrase: "exogenous myc-p38."
Processing 00000000.tx.124: In homogenates of human cortex (Cx) and caudate putamen (C/P) two p38 immunoreactive bands were visible. 

Phrase: "In homogenates"

Phrase: "of human cortex (Cx)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "and"

Phrase: "caudate putamen (C/P) two p38 immunoreactive bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0175723:Bands [Medical Device]
   766 E C0439645:Band [Spatial Concept]
   766 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "visible."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205379:Visible [Qualitative Concept]
Processing 00000000.tx.125: Their apparent molecular mass was slightly higher than that of endogenous p38 in SH-SY5Y cells (Fig.6, lanes anti-p38). 

Phrase: "Their apparent molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "was"

Phrase: "slightly higher than that of endogenous p38"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "in SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig.6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lanes anti-p38"

Phrase: ")."
Processing 00000000.tx.126: Therefore, these bands are likely to correspond to post-translationally modified isoforms of p38 and/or to products of alternatively spliced mRNAs. 

Phrase: "Therefore,"

Phrase: "these bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "correspond to post-translationally modified isoforms of p38"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0392747:Modified [Functional Concept]
   744   C0597298:Isoforms [Amino Acid, Peptide, or Protein]
   744   C0687676:Post [Temporal Concept]
   744   C1704687:Post [Manufactured Object]

Phrase: "and/or to products of alternatively spliced mRNAs."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C1706528:And/Or [Conceptual Entity]
   744   C1514468:Products [Entity]
   744   C1515981:And [Idea or Concept]
   711   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   711 E C1704444:Product [Quantitative Concept]
Processing 00000000.tx.127: None of these bands were detected when the blots were hybridized with anti-p38 antibodies pre-absorbed with a large excess of recombinant p38 or with pre-immune serum (Fig.6, lanes anti-p38 pre-absorbed and pre-immune serum). 

Phrase: "None of these bands"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0175723:Bands [Medical Device]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   737 E C0439645:Band [Spatial Concept]
   737 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "when"

Phrase: "the blots"

Phrase: "were"

Phrase: "hybridized with anti-p38 antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "pre-absorbed with a large excess of recombinant p38"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0332152:Pre [Temporal Concept]
   742   C0549177:Large [Quantitative Concept]
   742   C0740175:Pre [Qualitative Concept]
   742   C1514798:recombinant [Organism]
   742   C1979886:Excess [Qualitative Concept]
   742   C2257086:PRE [Genetic Function]

Phrase: "or with pre-immune serum"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0020960:immune serum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0229671:Serum [Body Substance]
   760   C0332152:Pre [Temporal Concept]
   760   C0439662:Immune [Functional Concept]
   760   C0740175:Pre [Qualitative Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C2257086:PRE [Genetic Function]

Phrase: "(Fig.6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lanes anti-p38"

Phrase: "pre-absorbed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332152:Pre [Temporal Concept]
   861   C0740175:Pre [Qualitative Concept]
   861   C2257086:PRE [Genetic Function]

Phrase: "and"

Phrase: "pre-immune serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0020960:immune serum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ")."
Processing 00000000.tx.128: Analysis of p38 immunoreactivity in the midbrains of two control subjects and three patients with PD post-mortem, revealed strong labeling in the human SN, predominantly in cells with a neuronal phenotype and in nerve fibers (Fig.7A and B). 

Phrase: "Analysis of p38 immunoreactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in the midbrains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0025462:Midbrains [Body Part, Organ, or Organ Component]
   966 E C1280997:Midbrain [Body Part, Organ, or Organ Component]

Phrase: "of two control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "three patients with PD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:Patients [Patient or Disabled Group]

Phrase: "post-mortem,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0004398:postmortem [Diagnostic Procedure]
  1000   C0580205:Postmortem [Temporal Concept]
  1000   C0848632:post mortem [Finding]
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   789 E C1514253:Postal [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "strong labeling in the human SN,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1167624:Labeling [Mental Process]
   753   C1947902:Labeling [Manufactured Object]
   753   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "predominantly in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "with a neuronal phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "and in nerve fibers"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0027749:Nerve Fibers [Cell Component]
   770   C0027740:Nerve [Tissue]
   770   C0027757:NERVE [Tissue]
   770   C1280541:Nerve [Body Part, Organ, or Organ Component]
   770   C1304649:Fibers [Tissue]
   770   C1515981:And [Idea or Concept]
   737 E C0012173:Fiber [Food]
   737 E C0225326:Fiber [Pharmacologic Substance]
   737 E C0304068:Fiber [Plant]
   737 E C1260603:Fiber [Plant]
   715 E C0599851:Neural [Functional Concept]

Phrase: "(Fig.7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.129: This immunoreactivity was abolished when the antibodies were pre-absorbed with an excess of recombinant p38 (Fig.7C and E). 

Phrase: "This immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "abolished"

Phrase: "when"

Phrase: "the antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "pre-absorbed with an excess of recombinant p38"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0332152:Pre [Temporal Concept]
   744   C0740175:Pre [Qualitative Concept]
   744   C1514798:recombinant [Organism]
   744   C1979886:Excess [Qualitative Concept]
   744   C2257086:PRE [Genetic Function]

Phrase: "(Fig.7C"

Phrase: "and"

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.130: Intense staining was observed in perikarya and processes of melanized dopaminergic neurons and of non-dopaminergic neurons, in the SNc (Fig.7D). 

Phrase: "Intense staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "observed in perikarya"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1441672:Observed [Functional Concept]
   756   C0599444:Perikaryon [Cell Component]

Phrase: "and"

Phrase: "processes of melanized dopaminergic neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0085103:neuron process [Cell Component]
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "and of non-dopaminergic neurons,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1512035:Dopaminergic Neurons [Cell]
   760   C0027882:Neurons [Cell]
   760   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C1515981:And [Idea or Concept]
   760   C1518422:Non [Functional Concept]

Phrase: "in the SNc"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0175412:Substantia nigra pars compacta [Body Part, Organ, or Organ Component]
           Pars compacta
   902   C0222661:Substantia compacta [Tissue]
   861   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   861   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   812   C0032405:PARS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1414437:PARS [Gene or Genome]
   812   C3283876:Compacta [Eukaryote]
   779 E C1417826:PAR [Gene or Genome]
   779 E C1514229:PAR [Quantitative Concept]
   779 E C1705885:PAR [Gene or Genome]

Phrase: "(Fig.7D"

Phrase: ")."
Processing 00000000.tx.131: The p38 immunostaining was heterogeneously distributed and appeared to be associated with discrete granules in the cytoplasm and the perinuclear region (Fig.7D). 

Phrase: "The p38 immunostaining"

Phrase: "was"

Phrase: "heterogeneously"

Phrase: "distributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]

Phrase: "and"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with discrete granules"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0010837:Granules [Cell Component]
   770   C0993609:Granules [Biomedical or Dental Material]
   770   C2699782:Discrete [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and"

Phrase: "the perinuclear region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "(Fig.7D"

Phrase: ")."
Processing 00000000.tx.132: No major differences in the type or intensity of p38 immunoreactivity were observed between control subjects and patients. 

Phrase: "No major differences in the type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "intensity of p38 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:Intensity [Qualitative Concept]

Phrase: "were"

Phrase: "observed between control subjects"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0243148:control [Qualitative Concept]
   770   C1441672:Observed [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.133: However, the number of p38-positive melanized neurons was markedly lower in the SNc of patients with PD, consistent with the neuronal loss associated with the disease (data not shown). 

Phrase: "However,"

Phrase: "the number of p38-positive melanized neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "markedly lower in the SNc of patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0441994:Lower [Spatial Concept]
   739   C1548802:Lower [Body Location or Region]
   739   C2003888:Lower [Activity]

Phrase: "with PD,"

Phrase: "consistent with the neuronal loss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "associated with the disease"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.134: To determine whether p38 immunoreactivity could be associated with nigral pathology and in particular with LBs, we double-labeled midbrain sections from PD subjects for ubiquitin and p38. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "p38 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "could"

Phrase: "be"

Phrase: "associated with nigral pathology"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0030664:Pathology [Biomedical Occupation or Discipline]
   770   C0205469:pathology [Functional Concept]
   770   C0677042:pathology [Pathologic Function]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and in particular"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "with LBs,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "we"

Phrase: "double-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "labeled midbrain sections from PD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "subjects for ubiquitin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0681850:Subject [Group]
   790   C1550501:{Subject} [Idea or Concept]
   790   C1706203:Subject [Idea or Concept]
   790   C2349001:Subject [Human]
   790   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "p38."
Processing 00000000.tx.135: In the three PD patients examined, p38 immunostaining was frequently observed in the cores of classical LBs in pigmented neurons (Fig.7F), as well as in the cores of non-somatic LBs (Fig.7G) and occasionally in ubiquitin-positive neurites (Fig.7H). 

Phrase: "In the three PD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ","

Phrase: "p38 immunostaining"

Phrase: "was"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "observed in the cores of classical LBs"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   783   C3548437:classical Lewy body [Cell Component]
   770   C0085200:Lewy Bodies [Cell Component]
   760   C3546702:Lewy body core [Cell Component]
   744   C0242821:bodies [Human]
   744   C0439858:Classical [Qualitative Concept]
   744   C0443177:Classical [Functional Concept]
   744   C1441672:Observed [Functional Concept]
   744   C1995017:Bodies [Cell Component]
   711   C0444669:Core [Spatial Concept]
   711 E C0460148:Body [Anatomical Structure]
   711   C1167518:core [Cell Component]
   711 E C1268086:Body [Anatomical Structure]
   711   C1706352:Core [Medical Device]
   711   C1882467:Core [Manufactured Object]
   711   C3274653:Core [Body Substance]

Phrase: "in pigmented neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Fig.7F"

Phrase: ")"

Phrase: ","

Phrase: "as well as in the cores of non-somatic LBs"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   756   C0085200:Lewy Bodies [Cell Component]
   738   C0205170:Well [Qualitative Concept]
   738   C0242821:bodies [Human]
   738   C1518422:Non [Functional Concept]
   738   C1995017:Bodies [Cell Component]
   738   C2986476:Somatic [Qualitative Concept]
   738   C3146287:Well [Manufactured Object]
   738   C3546702:Lewy body core [Cell Component]
   704   C0444669:Core [Spatial Concept]
   704 E C0460148:Body [Anatomical Structure]
   704   C1167518:core [Cell Component]
   704 E C1268086:Body [Anatomical Structure]
   704   C1706352:Core [Medical Device]
   704   C1882467:Core [Manufactured Object]
   704   C3274653:Core [Body Substance]

Phrase: "(Fig.7G"

Phrase: ")"

Phrase: "and"

Phrase: "occasionally in ubiquitin-positive neurites"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0085103:Neurites [Cell Component]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1998882:Occasionally [Temporal Concept]
   760   C2825490:Positive [Qualitative Concept]

Phrase: "(Fig.7H"

Phrase: ")."
Processing 00000000.tx.136: View larger version (15K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.137: Specificity of novel polyclonal anti-p38 antibodies. 

Phrase: "Specificity of novel polyclonal anti-p38 antibodies."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   774   C0003264:antibodies specificity [Molecular Function]
   748   C0037791:Specificity [Quantitative Concept]
   748   C1511884:Specificity [Quantitative Concept]
   721 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.138: Western blot analysis of cleared homogenates of (T) SH-SY5Y cells overexpressing myc-p38, (NT) native SH-SY5Y, (Cx) human cortex, (C/P) human caudate-putamen hybridized with anti-myc antibodies, anti-p38 antibodies, anti-p38 antibodies pre-absorbed with recombinant p38, or pre-immune serum.  

Phrase: "Western blot analysis of cleared homogenates of (T) SH-SY5Y cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   775   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   756   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]
   738   C1705493:Western [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "myc-p38,"

Phrase: "(NT) native SH-SY5Y,"

Phrase: "(Cx"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007776:Cortex [Body Part, Organ, or Organ Component]
  1000   C1176472:Cortex [Body Part, Organ, or Organ Component]
  1000   C2700441:Cortex [Plant]

Phrase: ")"

Phrase: "human cortex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "(C/P"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0162512:caudate putamen [Body Part, Organ, or Organ Component]
   861   C0034169:Putamen [Body Part, Organ, or Organ Component]
   861   C1281335:Putamen [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "human caudate-putamen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0162512:caudate putamen [Body Part, Organ, or Organ Component]
   827   C0034169:Putamen [Body Part, Organ, or Organ Component]
   827   C1281335:Putamen [Body Part, Organ, or Organ Component]

Phrase: "hybridized with anti-myc antibodies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "anti-p38 antibodies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "anti-p38 antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "pre-absorbed with recombinant p38,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332152:Pre [Temporal Concept]
   760   C0740175:Pre [Qualitative Concept]
   760   C1514798:recombinant [Organism]
   760   C2257086:PRE [Genetic Function]

Phrase: "or"

Phrase: "pre-immune serum."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0020960:immune serum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]
Processing 00000000.tx.139: View larger version (74K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(74K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.140: Immunohistochemical analysis of the distribution of p38 in the human SN adult post-mortem and its localization in LBs. 

Phrase: "Immunohistochemical analysis of the distribution of p38"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1441616:Immunohistochemical [Laboratory Procedure]
   748   C1524024:analysis [Functional Concept]

Phrase: "in the human SN adult"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001675:Adult [Age Group]
   827   C1706450:Adult [Human]

Phrase: "post-mortem"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0004398:postmortem [Diagnostic Procedure]
  1000   C0580205:Postmortem [Temporal Concept]
  1000   C0848632:post mortem [Finding]
   861   C0687676:Post [Temporal Concept]
   861   C1704687:Post [Manufactured Object]
   789 E C1514253:Postal [Functional Concept]

Phrase: "and"

Phrase: "its localization in LBs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]
Processing 00000000.tx.141: Sections of the SN analyzed after immunolabeling with (A, B) specific anti-p38 antibodies, or (C, E) the same antibodies pre-absorbed with an excess of recombinant p38. 

Phrase: "Sections of the SN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]

Phrase: "analyzed after immunolabeling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "with"

Phrase: "(A,"

Phrase: "B) specific anti-p38 antibodies,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   881   C0368720:B Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   836 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or (C,"

Phrase: "E)"

Phrase: "the same antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "pre-absorbed with an excess of recombinant p38."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0332152:Pre [Temporal Concept]
   744   C0740175:Pre [Qualitative Concept]
   744   C1514798:recombinant [Organism]
   744   C1979886:Excess [Qualitative Concept]
   744   C2257086:PRE [Genetic Function]
Processing 00000000.tx.142: Note that in (C) and (E) only endogenous pigmentation of neuromelanin is visible. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that in (C)"

Phrase: "and ("

Phrase: "E) only endogenous pigmentation of neuromelanin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0031911:Pigmentation [Physiologic Function]

Phrase: "is"

Phrase: "visible."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205379:Visible [Qualitative Concept]
Processing 00000000.tx.143: (D) Granular p38 immunoreactivity in melanized dopaminergic neurons of the SNc. 

Phrase: "("

Phrase: "D)"

Phrase: "Granular p38 immunoreactivity in melanized dopaminergic neurons of the SNc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C0597879:immunoreactivity [Molecular Function]
Processing 00000000.tx.144: Laser confocal scanned images illustrating anti-p38 immunoreactivity in (F) classical intracellular LBs, (G) extracellular LBs, and (H) ubiquitin-positive neurites in the SN of subjects with idiopathic PD, after double labeling for ubiquitin and p38. 

Phrase: "Laser confocal scanned images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C1704254:Image [Intellectual Product]
   779   C1704922:Image [Entity]
   779   C3542466:Image [Intellectual Product]

Phrase: "illustrating"

Phrase: "anti-p38 immunoreactivity in (F) classical intracellular LBs,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C3550006:Intracellular Lewy bodies [Finding]
   817   C3548437:classical Lewy body [Cell Component]
   807   C0085200:Lewy Bodies [Cell Component]
   791   C0242821:bodies [Human]
   791   C1995017:Bodies [Cell Component]
   758 E C0460148:Body [Anatomical Structure]
   758 E C1268086:Body [Anatomical Structure]

Phrase: "(G) extracellular LBs,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0085200:Lewy Bodies [Cell Component]
   812   C0242821:bodies [Human]
   812   C1995017:Bodies [Cell Component]
   779 E C0460148:Body [Anatomical Structure]
   779 E C1268086:Body [Anatomical Structure]

Phrase: "and ("

Phrase: "H) ubiquitin-positive neurites in the SN of subjects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0085103:Neurites [Cell Component]

Phrase: "with idiopathic PD,"

Phrase: "after"

Phrase: "double labeling for ubiquitin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0205173:Double [Functional Concept]
   770   C1167624:Labeling [Mental Process]
   770   C1705764:Double [Activity]
   770   C1705765:Double [Qualitative Concept]
   770   C1947902:Labeling [Manufactured Object]
   770   C2827499:Labeling [Governmental or Regulatory Activity]
   737 E C0181496:Label [Manufactured Object]

Phrase: "and"

Phrase: "p38."
Processing 00000000.tx.145: SNc, SN pars compacta; 

Phrase: "SNc,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0175412:Substantia nigra pars compacta [Body Part, Organ, or Organ Component]
           Pars compacta
   902   C0222661:Substantia compacta [Tissue]
   861   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   861   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   812   C0032405:PARS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1414437:PARS [Gene or Genome]
   812   C3283876:Compacta [Eukaryote]
   779 E C1417826:PAR [Gene or Genome]
   779 E C1514229:PAR [Quantitative Concept]
   779 E C1705885:PAR [Gene or Genome]

Phrase: "SN pars compacta"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0175412:Pars compacta [Body Part, Organ, or Organ Component]
   827   C0032405:PARS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1414437:PARS [Gene or Genome]
   827   C3283876:Compacta [Eukaryote]
   793 E C1417826:PAR [Gene or Genome]
   793 E C1514229:PAR [Quantitative Concept]
   793 E C1705885:PAR [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.146: SNr, SN pars reticulata. 

Phrase: "SNr,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986823:SNR [Quantitative Concept]

Phrase: "SN pars reticulata."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0175413:Pars reticulata [Body Part, Organ, or Organ Component]
   827   C0032405:PARS [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1414437:PARS [Gene or Genome]
   793 E C1417826:PAR [Gene or Genome]
   793 E C1514229:PAR [Quantitative Concept]
   793 E C1705885:PAR [Gene or Genome]
Processing 00000000.tx.147: Scale bar=0.5mm in (A); 

Phrase: "Scale bar=0.5mm in (A"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.148: 0.1mm in (B) and (C); 

Phrase: "0.1mm in (B)"

Phrase: "and ("

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.149: and 20m in (D) and (E).   

Phrase: "and"

Phrase: "20m in (D)"

Phrase: "and ("

Phrase: "E"

Phrase: ")."
Processing 00000000.tx.150: DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  We showed that the p38 subunit of the mammalian multiARS complex is a Parkin substrate. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the p38 subunit of the mammalian multiARS complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "a Parkin substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.151: p38 was isolated in a yeast two-hybrid screen, using a Parkin peptide excluding both the ubiquitin-like and most of the RING-IBR-RING domain as bait. 

Phrase: "p38"

Phrase: "was"

Phrase: "isolated in a yeast two-hybrid screen,"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   778   C0599647:Two Hybrid [Molecular Biology Research Technique]
   748   C0020205:Hybrid [Organism]
   748   C0036025:yeast [Fungus]
   748   C0043392:Yeast [Food]
   748   C0043393:Yeast [Fungus]
   748   C0205409:Isolated [Functional Concept]
   748   C0205448:Two [Quantitative Concept]
   748   C0220908:screen [Health Care Activity]
   748   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   748   C1305399:screen [Functional Concept]
   748   C1548221:Isolated [Idea or Concept]
   748   C1705053:Screen [Medical Device]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Parkin peptide excluding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0332196:Exclude [Functional Concept]
   793   C2828389:Exclude [Activity]

Phrase: "both the ubiquitin-like"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "most of the RING-IBR-RING domain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0021334:IBR [Disease or Syndrome]
   748   C0205393:Most [Quantitative Concept]
   748   C0521164:Ring [Spatial Concept]
   748   C1260969:Ring [Medical Device]
   748   C1705184:Ring [Medical Device]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "as bait."
Processing 00000000.tx.152: This bait was chosen to ensure that we did not isolate components of the ubiquitin-proteasome pathway that interact with these motifs (32,33). 

Phrase: "This bait"

Phrase: "was"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "isolate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370215:Isolate [Substance]
  1000   C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "components of the ubiquitin-proteasome pathway"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "that"

Phrase: "interact with these motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1514562:Motif [Amino Acid Sequence]

Phrase: "(32,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.153: Physical interaction was confirmed in mammalian cells by co-immunoprecipitating p38 with a Parkin variant containing the bait peptide. 

Phrase: "Physical interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1167622:Physical Interaction [Molecular Function]
   861   C1704675:Interaction [Functional Concept]

Phrase: "was"

Phrase: "confirmed in mammalian cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   816   C1512977:Mammalian Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0024660:Mammalian [Mammal]
   770   C0521093:confirmed [Qualitative Concept]
   770   C0750484:Confirmed [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1456348:Confirm [Qualitative Concept]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "by"

Phrase: "co-immunoprecipitating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "p38 with a Parkin variant"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the bait peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.154: Co-localization studies in COS7 cells showed a marked overlap in the intracellular distribution of Parkin and endogenous p38, supporting a physiological interaction between the two proteins. 

Phrase: "Co-localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "studies in COS7 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a marked overlap in the intracellular distribution of Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0185027:overlap [Therapeutic or Preventive Procedure]
   742   C1948020:Overlap [Conceptual Entity]

Phrase: "and"

Phrase: "endogenous p38,"

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "a physiological interaction between the two proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0872079:interaction protein [Molecular Function]
   748   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.155: In the human dopaminergic neuroblastoma-derived SH-SY5Y cell line, full-length Parkin promoted the ubiquitylation and proteasomal degradation of p38. 

Phrase: "In the human dopaminergic neuroblastoma-derived SH-SY5Y cell line,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   897   C0682523:Human Cell Line [Cell]
   878   C0427861:human cell [Laboratory or Test Result]
   864   C1512035:Dopaminergic cell [Cell]
   850   C0815000:neuroblastoma cell [Cell]
   812   C0007600:Cell Line [Cell]
   793   C0007634:Cell [Cell]
   793   C0205132:Line [Spatial Concept]
   793   C1269647:Cell [Cell]
   793   C1550648:Line [Substance]
   793   C1552960:Line [Quantitative Concept]
   793   C1704653:Cell [Medical Device]
   793   C1948049:Cell [Spatial Concept]

Phrase: "full-length Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "the ubiquitylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitylation [Molecular Function]

Phrase: "and"

Phrase: "proteasomal degradation of p38."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
Processing 00000000.tx.156: Importantly, the deletion of either the ubiquitin-like domain or the RING-IBR-RING motif, which are essential for the E3 ubiquitin ligase activity of Parkin (19,20), abrogated the Parkin-mediated ubiquitylation of p38. 

Phrase: "Importantly,"

Phrase: "the deletion of either"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "the ubiquitin-like domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "or"

Phrase: "the RING-IBR-RING motif,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1514562:Motif [Amino Acid Sequence]

Phrase: "which"

Phrase: "are"

Phrase: "essential for the E3 ubiquitin ligase activity of Parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205224:Essential [Qualitative Concept]

Phrase: "(19,"

Phrase: "20"

Phrase: ")"

Phrase: ","

Phrase: "abrogated"

Phrase: "the Parkin-mediated ubiquitylation of p38."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1519751:Ubiquitylation [Molecular Function]
Processing 00000000.tx.157: In contrast, in our experimental conditions the pathogenic point mutant Lys161Asn ubiquitylated p38 to the same extent as normal Parkin. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in our experimental conditions"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the pathogenic point mutant Lys161Asn ubiquitylated p38 to the same extent"

Phrase: "as normal Parkin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.158: Although apparently surprising, this finding is in agreement with other studies reporting at least partial ubiquitin protein ligase activity for several pathogenic Parkin mutants. 

Phrase: "Although"

Phrase: "apparently surprising,"

Phrase: "this finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "reporting at least partial ubiquitin protein ligase activity"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   833   C1150685:ubiquitin-protein ligase activity [Molecular Function]
           ubiquitin-ligase activity
   800   C0077678:ubiquitin-protein ligase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1256818:Ubiquitin Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1307637:Ubiquitin-Protein Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1442769:ubiquitin-protein ligase [Gene or Genome]
   770   C1150651:ligase activity [Molecular Function]
   767   C1325411:ubiquitin activity [Molecular Function]
   767   C1537044:protein activity [Molecular Function]
   744   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0700287:Reporting [Health Care Activity]
   744   C0728938:Partial [Quantitative Concept]
   744   C1550516:partial [Idea or Concept]
   744   C1561536:*Activity [Idea or Concept]
   711 E C0684224:Report [Intellectual Product]
   711 E C3273238:Report [Intellectual Product]

Phrase: "for several pathogenic Parkin mutants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.159: Ubiquitylation of the Parkin substrate synphilin was observed with Parkin mutants Arg275Trp, Gln311Stop and Thr415Asn, whereas this process was compromised with mutants Thr240Arg, Arg256Cys and Trp453Stop (23). 

Phrase: "Ubiquitylation of the Parkin substrate synphilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1519751:Ubiquitylation [Molecular Function]

Phrase: "was"

Phrase: "observed with Parkin mutants Arg275Trp,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0596988:mutants [Cell or Molecular Dysfunction]
   760   C1418270:PARKIN [Gene or Genome]
   760   C1441672:Observed [Functional Concept]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Gln311Stop"

Phrase: "and"

Phrase: "Thr415Asn,"

Phrase: "whereas"

Phrase: "this process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "was"

Phrase: "compromised with mutants Thr240Arg,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0596988:mutants [Cell or Molecular Dysfunction]
   737   C2945640:compromise [Finding]

Phrase: "Arg256Cys"

Phrase: "and"

Phrase: "Trp453Stop"

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.160: Similarly, Imai and colleagues observed ubiquitylation of Parkin substrate PaelR in the presence of Parkin mutant Thr240Arg, but not of an exon 4 deleted mutant (22). 

Phrase: "Similarly,"

Phrase: "Imai"

Phrase: "and"

Phrase: "colleagues"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "ubiquitylation of Parkin substrate PaelR"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1519751:Ubiquitylation [Molecular Function]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of Parkin mutant Thr240Arg,"

Phrase: "but"

Phrase: "not of an exon 4 deleted mutant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0596988:Mutant [Cell or Molecular Dysfunction]
   748   C1518422:Not [Functional Concept]
   748   C1880274:Deleted [Activity]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.161: In another study, Hyun and collaborators (34) reported full ubiquitinprotein ligase activity for an exon 35 deleted mutant of Parkin. 

Phrase: "In another study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "Hyun"

Phrase: "and"

Phrase: "collaborators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827395:Collaborator [Professional Society]

Phrase: "(34"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "full ubiquitinprotein ligase activity for an exon 35 deleted mutant of Parkin."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C1150651:ligase activity [Molecular Function]
   736   C0205177:Activity [Functional Concept]
   736   C0439167:% activity [Quantitative Concept]
   736   C0441655:Activity [Activity]
   736   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.162: Finally, in a pure in vitro ubiquitylation assay developed by Rankin and colleagues (35), E3 ubiquitinprotein ligase activity was measured with normal Parkin, but also with a truncated variant devoid of the N-terminal 35 amino acid residues, and with the point mutants Cys238Ala and Cys332Ala. 

Phrase: "Finally,"

Phrase: "in a pure in vitro ubiquitylation assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   888   C1515653:In Vitro Assay [Research Activity]
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]

Phrase: "developed by Rankin"

Phrase: "and"

Phrase: "colleagues"

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "E3 ubiquitinprotein ligase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1150651:ligase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   708   C0077678:E3 Ligase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured with normal Parkin,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1418270:PARKIN [Gene or Genome]
   770   C2347086:% Normal [Quantitative Concept]
   770   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "but"

Phrase: "also with a truncated variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variant [Qualitative Concept]

Phrase: "devoid of the N-terminal 35 amino acid residues,"

Phrase: "and with the point mutants Cys238Ala"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0596988:mutants [Cell or Molecular Dysfunction]
   753   C1515981:And [Idea or Concept]
   753   C1552961:Point [Quantitative Concept]
   753   C2347617:point [Quantitative Concept]

Phrase: "and"

Phrase: "Cys332Ala."
Processing 00000000.tx.163: It appears therefore that the pathogenic mutations identified so far do not systematically abrogate the enzymatic activity of Parkin, raising the possibility that various molecular mechanisms underlie neuronal degeneration in parkin-related Parkinson's disease (e.g. loss of interaction with essential partners and/or specific substrates). 

Phrase: "It"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "therefore"

Phrase: "that"

Phrase: "the pathogenic mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "so far"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037640:SO [Geographic Area]
   861   C0205108:far [Spatial Concept]

Phrase: "do"

Phrase: "not systematically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "abrogate"

Phrase: "the enzymatic activity of Parkin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2267219:Enzymatic Activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "raising"

Phrase: "the possibility"

Phrase: "that various molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "underlie"

Phrase: "neuronal degeneration in parkin-related Parkinson's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0011164:Degeneration [Pathologic Function]
   748   C1880269:Degeneration [Functional Concept]
   743   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]

Phrase: "("

Phrase: "e.g. loss of interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "with essential partners"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0682323:partners [Family Group]

Phrase: "and/or"

Phrase: "specific substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.164: This hypothesis is also highlighted by the recent finding that Parkin functions in a multiprotein ubiquitin ligase complex that includes the F-box protein h-Sel10 and Cullin 1 (25). 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "also"

Phrase: "highlighted by the recent finding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0037088:Finding [Sign or Symptom]
   760   C0243095:Finding [Finding]
   760   C0332185:Recent [Temporal Concept]
   760   C2825141:Finding [Finding]

Phrase: "that Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "functions in a multiprotein ubiquitin ligase complex"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C1167313:ubiquitin ligase complex [Cell Component]
   748   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031843:function [Physiologic Function]
   748   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439855:Complex [Qualitative Concept]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C1705273:Function [Intellectual Product]

Phrase: "that"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the F-box protein h-Sel10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1333533:SEL10 [Gene or Genome]
   804   C1704938:SEL10 [Gene or Genome]

Phrase: "and"

Phrase: "Cullin 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0390803:Cullin 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332809:CULLIN 1 [Gene or Genome]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.165: Several lines of evidence suggest that the novel Parkin substrate p38 contributes to neurodegeneration in PD. 

Phrase: "Several lines of evidence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205132:lines [Spatial Concept]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the novel Parkin substrate p38"

Phrase: "contributes to neurodegeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   790   C1880177:Contribute [Activity]

Phrase: "in PD."
Processing 00000000.tx.166: The overexpression of p38 resulted in its accumulation in aggresome-like inclusions. 

Phrase: "The overexpression of p38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "resulted in its accumulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "in aggresome-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1167059:aggresome [Cell Component]

Phrase: "like inclusions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.167: These inclusions systematically recruited Parkin, but also the ubiquitin-like deleted Parkin mutant and the pathogenic mutant Lys161Asn, suggesting that these variants maintain the ability to interact with p38. 

Phrase: "These inclusions systematically recruited Parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1418270:PARKIN [Gene or Genome]
   812   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "but"

Phrase: "also"

Phrase: "the ubiquitin-like deleted Parkin mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "the pathogenic mutant Lys161Asn,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these variants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:variants [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "interact with p38."
Processing 00000000.tx.168: In addition, the p38 immunoreactive aggresomes sequestered proteasomal 20S subunit, as well as the molecular chaperones Hsp70 and Hdj-2. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the p38 immunoreactive aggresomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1167059:aggresome [Cell Component]

Phrase: "sequestered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333312:Sequestered [Functional Concept]

Phrase: "proteasomal 20S subunit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "as well as"

Phrase: "the molecular chaperones Hsp70"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1415760:HSP70 [Gene or Genome]
   827   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   734   C0243041:Molecular Chaperones [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Hdj-2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415754:hdj-2 [Gene or Genome]
Processing 00000000.tx.169: A propensity to form aggregates upon overexpression has already been reported for two other Parkin substrates: the -synuclein-interacting protein, synphilin and the unfolded putative transmembrane protein, Pael-R (22,23). 

Phrase: "A propensity to"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "aggregates upon overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205418:aggregates [Qualitative Concept]

Phrase: "has"

Phrase: "already"

Phrase: "been"

Phrase: "reported for two"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0205448:Two [Quantitative Concept]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "other Parkin substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: ":"

Phrase: "the -synuclein-interacting protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synphilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420277:synphilin [Gene or Genome]

Phrase: "and"

Phrase: "the unfolded putative transmembrane protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1167322:transmembrane [Cell Component]
   812   C2752508:transmembrane [Cell Component]

Phrase: "Pael-R (22,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.170: Pael-R, in particular, forms multiprotein complexes with Parkin, the E4-like protein CHIP, Hsp70 and Hdj-2 in cells, and these proteins appear to regulate its folding and degradation (36). 

Phrase: "Pael-R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "in particular,"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "multiprotein complexes with Parkin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0751283:Multiprotein Complexes [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1704241:Complexes [Chemical Viewed Structurally]
   737 E C0439855:Complex [Qualitative Concept]

Phrase: "the E4-"

Phrase: "like protein CHIP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1136348:Protein Chip [Medical Device,Research Device]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0600596:Chip [Research Device]

Phrase: "Hsp70"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243043:HSP 70 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1415760:HSP70 [Gene or Genome]
  1000   C1527149:HSP70 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "Hdj-2 in cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C1415754:hdj-2 [Gene or Genome]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "its folding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.171: Similarly, a finely tuned balance between protein synthesis, folding and degradation may be required to maintain appropriate p38 levels in the cell. 

Phrase: "Similarly,"

Phrase: "a finely tuned balance between protein synthesis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0014653:Balance [Organism Function]
   748   C0205415:Balance [Functional Concept]
   748   C0560184:Balance [Finding]

Phrase: "folding"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185026:Folding [Therapeutic or Preventive Procedure]
   966 E C0332462:Fold [Spatial Concept]
   966 E C1880834:FOLD [Phenomenon or Process]

Phrase: "and"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "may"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "appropriate p38 levels in the cell."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.172: In the simian kidney-derived COS7 cell line, numerous ubiquitylated p38-positive inclusions formed in the absence of exogenous Parkin. 

Phrase: "In the simian kidney-derived COS7 cell line,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   858   C0553257:kidney cell [Cell]
   827   C0007600:Cell Line [Cell]
   799   C0007634:Cell [Cell]
   799   C0205132:Line [Spatial Concept]
   799   C1269647:Cell [Cell]
   799   C1550648:Line [Substance]
   799   C1552960:Line [Quantitative Concept]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "numerous ubiquitylated p38-positive inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1512693:Inclusion [Qualitative Concept]

Phrase: "formed in the absence of exogenous Parkin."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   748   C0205101:Exogenous [Spatial Concept]
   748   C0205228:Exogenous [Functional Concept]
   748   C0205431:Formed [Functional Concept]
   748   C0332197:absence [Quantitative Concept]
   748   C1418270:PARKIN [Gene or Genome]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   714 E C0348078:Form [Qualitative Concept]
   714 E C0376315:Form [Manufactured Object]
   714 E C1522492:Form [Functional Concept]
Processing 00000000.tx.173: In contrast, in neural SH-SY5Y cells, the overexpression of Parkin promoted their formation. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in neural SH-SY5Y cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   886   C0027882:Neural cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "the overexpression of Parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "their formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]
Processing 00000000.tx.174: Therefore, in SH-SY5Y cells, the Parkin-mediated ubiquitylation of p38 appears to be required both for its proteasomal degradation and for its aggregation. 

Phrase: "Therefore,"

Phrase: "in SH-SY5Y cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "the Parkin-mediated ubiquitylation of p38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1519751:Ubiquitylation [Molecular Function]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "both for its proteasomal degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0238767:Both [Spatial Concept]
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
   760   C1706086:Both [Qualitative Concept]

Phrase: "and for its aggregation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.175: As suggested by the significant increase in the number of p38-positive inclusions observed following inhibition of proteasome activity, the aggregation of p38 may reflect the overwhelming of the cellular protein degradation machinery. 

Phrase: "As"

Phrase: "suggested by the significant increase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0237881:significant [Quantitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726   C1705535:Suggest [Idea or Concept]

Phrase: "in the number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of p38-positive inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1512693:Inclusion [Qualitative Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "inhibition of proteasome activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "the aggregation of p38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the overwhelming of the cellular protein degradation machinery."
Processing 00000000.tx.176: Remarkably, p38 immunoreactivity was observed in LBs in patients with idiopathic PD, demonstrating that p38 aggregates in humans and suggesting that this process contributes to dopaminergic neurodegeneration. 

Phrase: "Remarkably,"

Phrase: "p38 immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "observed in LBs"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C1441672:Observed [Functional Concept]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with idiopathic PD,"

Phrase: "demonstrating"

Phrase: "that p38"

Phrase: "aggregates in humans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0086418:Humans [Human]
   790   C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "contributes to dopaminergic neurodegeneration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   770   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   770   C1880177:Contribute [Activity]
Processing 00000000.tx.177: p38 was frequently observed in the central cores of LBs, a localization that is also typical of Parkin and the Parkin substrate, synphilin (17,37). 

Phrase: "p38"

Phrase: "was"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "observed in the central cores of LBs,"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   770   C0085200:Lewy Bodies [Cell Component]
   770   C0333763:Central cores [Cell Component]
   760   C3546702:Lewy body core [Cell Component]
   744   C0205099:Central [Spatial Concept]
   744   C0242821:bodies [Human]
   744   C1441672:Observed [Functional Concept]
   744   C1879652:Central - [Laboratory Procedure]
   744   C1995017:Bodies [Cell Component]
   711   C0444669:Core [Spatial Concept]
   711 E C0460148:Body [Anatomical Structure]
   711   C1167518:core [Cell Component]
   711 E C1268086:Body [Anatomical Structure]
   711   C1706352:Core [Medical Device]
   711   C1882467:Core [Manufactured Object]
   711   C3274653:Core [Body Substance]

Phrase: "a localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "that"

Phrase: "is"

Phrase: "also typical of Parkin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3538928:Typical [Qualitative Concept]

Phrase: "and"

Phrase: "the Parkin substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "synphilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1420277:synphilin [Gene or Genome]

Phrase: "(17,"

Phrase: "37"

Phrase: ")."
Processing 00000000.tx.178: This localization is indicative of a primary accumulation in inclusions rather than a deposition on pre-existing LBs, and suggests that the Parkin-mediated ubiquitylation of p38 is an early event in LB formation. 

Phrase: "This localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0475264:Localisation [Functional Concept]
  1000   C1744691:localisation [Biologic Function]

Phrase: "is"

Phrase: "indicative of a primary accumulation"

Phrase: "in inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]

Phrase: "rather than"

Phrase: "a deposition on pre-existing LBs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0333562:Deposition [Functional Concept]

Phrase: "and"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the Parkin-mediated ubiquitylation of p38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1519751:Ubiquitylation [Molecular Function]

Phrase: "is"

Phrase: "an early event in LB formation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441471:Event [Event]
Processing 00000000.tx.179: Whether LBs are actively involved in the degenerative process, represent a mere epiphenomenon, or play a neuroprotective role in PD is still unclear. 

Phrase: "Whether"

Phrase: "LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "are"

Phrase: "actively"

Phrase: "involved in the degenerative process,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0011164:Degenerative [Pathologic Function]
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1314939:Involved [Functional Concept]
   760   C1522240:Process [Phenomenon or Process]
   760   C1880269:Degenerative [Functional Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a mere epiphenomenon,"

Phrase: "or"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a neuroprotective role in PD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "is"

Phrase: "still unclear."
Processing 00000000.tx.180: The general absence of LBs in parkin-related parkinsonism (1416) suggests that these inclusions are not the cause of dopaminergic cell death in PD. 

Phrase: "The general absence of LBs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "in parkin-related parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "(1416"

Phrase: ")"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "these inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512693:Inclusion [Qualitative Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the cause of dopaminergic cell death"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C0007465:Cause of Death [Finding]
           Death Cause
   820   C0804771:Cause of death [Clinical Attribute]
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "in PD."
Processing 00000000.tx.181: This hypothesis is also supported by the absence of LBs in most dopaminergic neurons undergoing apoptosis in PD, and the lack of correlation between the presence of LBs and the occurrence of apoptotic features in these neurons (38). 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "also"

Phrase: "supported by the absence of LBs"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0085200:Lewy Bodies [Cell Component]
   748   C0242821:bodies [Human]
   748   C0332197:absence [Quantitative Concept]
   748   C1521721:Supported [Conceptual Entity]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1995017:Bodies [Cell Component]
   741   C0438854:Body support [Medical Device]
   714 E C0183683:Support [Medical Device]
   714 E C0460148:Body [Anatomical Structure]
   714 E C1268086:Body [Anatomical Structure]

Phrase: "in most dopaminergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1512035:Dopaminergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "undergoing"

Phrase: "apoptosis in PD,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "the lack of correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "between the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of LBs"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "the occurrence of apoptotic features"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243132:occurrence [Functional Concept]
   760   C1554210:occurrence [Idea or Concept]
   760   C2745955:Occurrence [Temporal Concept]

Phrase: "in these neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.182: Interestingly, the overexpression of p38 in native SH-SY5Y cells induced significant cell death, providing evidence that the accumulation of non-ubiquitylated, non-aggregated p38 could be deleterious. 

Phrase: "Interestingly,"

Phrase: "the overexpression of p38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "in native SH-SY5Y cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "significant cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the accumulation of non-ubiquitylated,"

Phrase: "non-aggregated p38"

Phrase: "could"

Phrase: "be"

Phrase: "deleterious."
Processing 00000000.tx.183: Notably, exogenous Parkin promoted the accumulation of p38 in ubiquitin-positive inclusions and also partially prevented p38-induced cell death, suggesting that, in this model, the aggregation of p38 has a protective effect. 

Phrase: "Notably,"

Phrase: "exogenous Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "promoted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0033414:Promote [Activity]

Phrase: "the accumulation of p38"

Phrase: "in ubiquitin-positive inclusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1838318:Ubiquitin-positive inclusions [Finding]
   793   C1512693:Inclusion [Qualitative Concept]

Phrase: "and"

Phrase: "also partially prevented p38-induced cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   818   C0007587:Cell Death [Cell Function]
   795   C0007634:Cell [Cell]
   795   C0011065:Death [Organism Function]
   795   C1269647:Cell [Cell]
   795   C1306577:Death, NOS [Finding]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "in this model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "the aggregation of p38"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]

Phrase: "has"

Phrase: "a protective effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.184: Our results provide a link between a protein involved in the degeneration of dopaminergic nigral neurons through a loss of function mechanism, and a key structural component of ARS complexes that is essential for protein biosynthesis. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a link between a protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0065011:link protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1517892:Link [Intellectual Product]
   760   C1704666:Link [Intellectual Product]

Phrase: "involved in the degeneration of dopaminergic nigral neurons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   767   C1512035:Dopaminergic Neurons [Cell]
   744   C0011164:Degeneration [Pathologic Function]
   744   C0027882:Neurons [Cell]
   744   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   744   C1314939:Involved [Functional Concept]
   744   C1880269:Degeneration [Functional Concept]

Phrase: "through a loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517945:Loss [Quantitative Concept]

Phrase: "of function mechanism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "a key structural component of ARS complexes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449432:Component [Manufactured Object]
   742   C1705248:Component [Conceptual Entity]

Phrase: "that"

Phrase: "is"

Phrase: "essential for protein biosynthesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.185: ARSs belong to a family of ubiquitous enzymes that catalyze the esterification of amino acids with their cognate tRNA. 

Phrase: "ARSs"

Phrase: "belong to a family of ubiquitous enzymes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0014442:Enzymes [Enzyme,Organic Chemical]
   748   C0014445:enzymes [Functional Concept]
   748   C0015576:Family [Family Group]
   748   C1704727:Family [Conceptual Entity]

Phrase: "that"

Phrase: "catalyze"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007382:catalyse [Natural Phenomenon or Process]

Phrase: "the esterification of amino acids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0014895:Esterification [Natural Phenomenon or Process]

Phrase: "with their cognate tRNA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1537998:trnA [Gene or Genome]
Processing 00000000.tx.186: In mammals, at least 10 of these enzymes assemble into two distinct high molecular mass complexes (39,40). 

Phrase: "In mammals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024660:Mammals [Mammal]

Phrase: "at least 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]

Phrase: "of these enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "assemble into two distinct high molecular mass complexes"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   770   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   744   C0205250:High [Qualitative Concept]
   744   C0205448:Two [Quantitative Concept]
   744   C0577559:Mass [Finding]
   744   C1299351:High [Qualitative Concept]
   744   C1306372:*Mass [Quantitative Concept]
   744   C1521991:Molecular [Qualitative Concept]
   744   C1704241:Complexes [Chemical Viewed Structurally]
   744   C1706853:Assemble [Activity]
   744   C2700149:HIGH [Intellectual Product]
   711 E C0439855:Complex [Qualitative Concept]

Phrase: "(39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.187: The multiARS complex integrates nine ARS activities and the three auxiliary proteins, p18, p38 and p43. 

Phrase: "The multiARS complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "integrates"

Phrase: "nine ARS activities"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   921   C1817222:aminoacyl-tRNA synthetase activity [Molecular Function]
   823   C1150651:synthetase activity [Molecular Function]
   804   C0441655:Activities [Activity]
   771 E C0205177:Activity [Functional Concept]
   771 E C0439167:% activity [Quantitative Concept]
   771 E C1561536:*Activity [Idea or Concept]
   717   C0002529:Aminoacyl-tRNA Synthetase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the three auxiliary proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "p18,"

Phrase: "p38"

Phrase: "and"

Phrase: "p43."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419881:p43 [Gene or Genome]
Processing 00000000.tx.188: p38 is a key scaffold subunit that plays a central role in the in vivo assembly of this supramolecular structure (26,27). 

Phrase: "p38"

Phrase: "is"

Phrase: "a key scaffold subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "that"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a central role in the in vivo assembly of this supramolecular structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0035820:Role [Social Behavior]
   736   C1705810:Role [Conceptual Entity]

Phrase: "(26,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.189: This essential function is illustrated by the dramatic consequences of the deficiency of p38 in homozygous mutant mice, leading to the complete disintegration of the ARS complex, instability of the component enzymes and auxiliary proteins, and early post-natal lethality (41). 

Phrase: "This essential function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "illustrated by the dramatic consequences of the deficiency of p38"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   743   C0686907:Consequence of [Functional Concept]
           consequences
   739   C0011155:Deficiency [Functional Concept]
   739   C0162429:Deficiency [Disease or Syndrome]
   739   C1623416:deficiency [Qualitative Concept]

Phrase: "in homozygous mutant mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "leading to the complete disintegration of the ARS complex,"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   775   C0002529:Aminoacyl-tRNA Synthetase [Amino Acid, Peptide, or Protein,Enzyme]
           tRNA Synthetase
   756   C0035714:Amino Acyl T RNA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0023689:Synthetase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   738   C0205197:Complete [Qualitative Concept]
   738   C0332152:Leading [Temporal Concept]
   738   C0439855:Complex [Qualitative Concept]
   738   C0725685:COMPLEAT [Food]
   738   C1265875:Disintegration [Acquired Abnormality]
   738   C1522538:Leading [Functional Concept]
   738   C1537998:trnA [Gene or Genome]
   738   C1704241:Complex [Chemical Viewed Structurally]
   704 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   704 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   704 E C2348269:Lead [Element, Ion, or Isotope]
   704 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "instability of the component enzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1444783:Instability [Finding]

Phrase: "and"

Phrase: "auxiliary proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "early post-natal lethality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1836107:Early lethality [Finding]
   741   C3151529:Lethal [Finding]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.190: Considerable evidence has accumulated suggesting that components of the ARS complex have non-canonical functions and that they are involved in cell death pathways (42). 

Phrase: "Considerable evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "has"

Phrase: "accumulated"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that components of the ARS complex"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0449432:Components [Manufactured Object]
   711 E C1705248:Component [Conceptual Entity]

Phrase: "have"

Phrase: "non-canonical functions"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   871   C0205300:Non-functional [Functional Concept]
   827   C0542341:Functions [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "that"

Phrase: "they"

Phrase: "are"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in cell death pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.191: Human glutaminyl-RS has been proposed to be a negative regulator of the apoptosis signal-regulating kinase 1, a protein kinase that plays a crucial role in Fas-activated apoptosis (43). 

Phrase: "Human glutaminyl-RS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539879:RS [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a negative regulator of the apoptosis signal-regulating kinase 1,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   777   C1564881:Regulator of Apoptosis [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Apoptosis Regulator
   739   C0182953:REGULATOR [Medical Device]
   739   C0205160:Negative [Qualitative Concept]
   739   C1513916:Negative [Finding]
   739   C1704734:Regulator [Medical Device]
   739   C1704735:Regulator [Conceptual Entity]
   739   C2825415:Negative [Conceptual Entity]
   739   C2825491:Negative [Qualitative Concept]

Phrase: "a protein kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a crucial role in Fas-activated apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.192: In the presence of apoptotic stimuli, mammalian tyrosyl-RS is secreted and split into two fragments with distinct potent pro-apoptotic cytokine activities (44,45). 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of apoptotic stimuli,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "mammalian tyrosyl-RS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3539879:RS [Idea or Concept]

Phrase: "is"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "and"

Phrase: "split into two fragments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1534709:Split [Functional Concept]
   770   C1881714:SPLIT [Phenomenon or Process]

Phrase: "with distinct potent pro-apoptotic cytokine activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   810   C1149384:cytokine activity [Molecular Function]
   799   C0441655:Activities [Activity]
   766 E C0205177:Activity [Functional Concept]
   766 E C0439167:% activity [Quantitative Concept]
   766 E C1561536:*Activity [Idea or Concept]

Phrase: "(44,"

Phrase: "45"

Phrase: ")."
Processing 00000000.tx.193: Similarly, p43, a tRNA-binding protein that functions as a co-factor of aminoacylation is the precursor of the inflammatory cytokine EMAPII (endothelial monocyte-activating peptide II) (4650). 

Phrase: "Similarly,"

Phrase: "p43,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419881:p43 [Gene or Genome]

Phrase: "a tRNA-binding protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1148901:tRNA binding [Genetic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "that functions as a co-factor of aminoacylation"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0542341:Functions [Functional Concept]
   711 E C0031843:function [Physiologic Function]
   711 E C0700205:FUNCTION [Classification]
   711 E C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "the precursor of the inflammatory cytokine EMAPII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709634:Precursor [Idea or Concept]

Phrase: "(endothelial monocyte-activating peptide II"

Phrase: ")"

Phrase: "(4650"

Phrase: ")."
Processing 00000000.tx.194: EMAPII is a substrate of caspase 7, which is cleaved off p43 and released from the multisynthetase complex in apoptotic conditions, before being secreted into the extracellular matrix where it activates the cell death signaling pathway (49,50). 

Phrase: "EMAPII"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0173372:EMAP II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1419881:EMAP II [Gene or Genome]

Phrase: "is"

Phrase: "a substrate of caspase 7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710236:Substrate [Manufactured Object]

Phrase: "which"

Phrase: "is"

Phrase: "cleaved off p43"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205242:Cleaved [Spatial Concept]
   790   C0333853:Cleaved [Cell]
   790   C1419881:p43 [Gene or Genome]

Phrase: "and"

Phrase: "released from the multisynthetase complex"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   806   C1167421:multisynthetase complex [Cell Component]
   760   C0391871:Released [Functional Concept]
   760   C0439855:Complex [Qualitative Concept]
   760   C1283071:Released [Functional Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "in apoptotic conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "before"

Phrase: "being"

Phrase: "secreted into the extracellular matrix where"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0015350:Extracellular Matrix [Tissue]
   753   C0521119:Extracellular [Cell Component]
   753   C1327616:Secreted [Cell Function]
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]

Phrase: "it"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the cell death signaling pathway"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0037083:signaling pathway [Cell Function]
           Cell Signaling
   861   C0086982:Signaling Pathway [Molecular Function]
   844 E C0037080:Signal Pathway [Molecular Function]
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]
   756   C1516341:Cell Death Signaling [Molecular Function]

Phrase: "(49,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.195: EMAP-II immunoreactivity was recently detected in activated microglial cells after the neurotoxic lesion of the rat hippocampus, suggesting that it plays a role in neurodegenerative processes (51). 

Phrase: "EMAP-II immunoreactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0597879:immunoreactivity [Molecular Function]
   734   C0173372:EMAP II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1419881:EMAP II [Gene or Genome]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "detected in activated microglial cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   851   C0001280:Activated microglial cell [Cell]
   790   C0206116:Microglial cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0442726:Detected [Finding]
   760   C0521398:Microglial [Body Location or Region]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1879547:Activated [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1515877:Activate [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "after the neurotoxic lesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0221198:Lesion [Finding]
   861   C1546698:Lesion [Intellectual Product]

Phrase: "of the rat hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in neurodegenerative processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.196: Our observations suggest that the loss of Parkin function in parkin-related parkinsonism results in the accumulation of non-ubiquitylated p38 above a toxicity threshold that could be deleterious via an as yet unidentified molecular mechanism. 

Phrase: "Our observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the loss of Parkin function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "in parkin-related parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "results in the accumulation of non-ubiquitylated p38"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1274040:Result [Functional Concept]
   744   C1518422:Non [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "above a toxicity threshold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "deleterious via an as yet unidentified molecular mechanism."
Processing 00000000.tx.197: This threshold may be reached more rapidly in neurons, a cell type in which p38 immunoreactivity was particularly intense. 

Phrase: "This threshold"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449864:Threshold [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "more rapidly in neurons,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027882:Neurons [Cell]
   770   C0205172:More [Functional Concept]
   770   C1637379:Rapidly [Qualitative Concept]

Phrase: "a cell type in which p38 immunoreactivity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0007634:Cell Type [Cell]
   778   C0449475:cell type [Intellectual Product]
   748   C0332307:Type [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "was"

Phrase: "particularly intense."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intense [Qualitative Concept]
Processing 00000000.tx.198: By contributing to the detrimental effects of other Parkin substrates, p38 may induce dopaminergic neuronal degeneration. 

Phrase: "By contributing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contributing [Activity]

Phrase: "to the detrimental effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "of other Parkin substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "p38"

Phrase: "may"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "dopaminergic neuronal degeneration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   865   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   827   C0011164:Degeneration [Pathologic Function]
   827   C1880269:Degeneration [Functional Concept]
Processing 00000000.tx.199: Alternatively, the uncontrolled intracellular accumulation of p38 may alter multiARS complex assembly and/or spatially dislocate components of this complex from the subcellular compartments of the protein synthesis machinery (52,53), thereby directly impairing the cellular translational potential. 

Phrase: "Alternatively,"

Phrase: "the uncontrolled intracellular accumulation of p38"

Phrase: "may"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "multiARS complex assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "and/or"

Phrase: "spatially"

Phrase: "dislocate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332766:dislocate [Spatial Concept]

Phrase: "components of this complex"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0449432:Components [Manufactured Object]
   737 E C1705248:Component [Conceptual Entity]

Phrase: "from the subcellular compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]

Phrase: "of the protein synthesis machinery"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0337076:machinery [Manufactured Object]
   734   C0597295:Protein Synthesis [Molecular Function]

Phrase: "(52,"

Phrase: "53"

Phrase: ")"

Phrase: ","

Phrase: "thereby directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947931:Directly [Qualitative Concept]

Phrase: "impairing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221099:impairing [Functional Concept]

Phrase: "the cellular translational potential."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.200: Conversely, the cleavage and subsequent release of components of the multiARS complex under apoptotic conditions (49,50) may destabilize the complex and favor the aggregation of p38. 

Phrase: "Conversely,"

Phrase: "the cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "subsequent release of components of the multiARS complex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0030685:Release [Health Care Activity]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "under apoptotic conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(49,"

Phrase: "50"

Phrase: ")"

Phrase: "may"

Phrase: "destabilize"

Phrase: "the complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "the aggregation of p38."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]
Processing 00000000.tx.201: This aggregation may also be promoted by a decrease in proteasomal enzymatic activities, which is observed in the SNc of patients with sporadic PD (54,55). 

Phrase: "This aggregation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "promoted by a decrease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   737   C0033414:Promote [Activity]

Phrase: "in proteasomal enzymatic activities,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C2267219:Enzymatic Activity [Molecular Function]
   861   C1622946:proteasome activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "is"

Phrase: "observed in the SNc of patients"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   818   C0175412:Substantia nigra pars compacta [Body Part, Organ, or Organ Component]
           Pars compacta
   764   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   764   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   762   C0222661:Substantia compacta [Tissue]
   742   C0030705:Patients [Patient or Disabled Group]
   742   C0032405:PARS [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1414437:PARS [Gene or Genome]
   742   C1441672:Observed [Functional Concept]
   742   C3283876:Compacta [Eukaryote]
   708 E C1417826:PAR [Gene or Genome]
   708 E C1514229:PAR [Quantitative Concept]
   708 E C1705885:PAR [Gene or Genome]

Phrase: "with sporadic PD (54,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205422:Sporadic [Temporal Concept]

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.202: As is the case for several pathological proteins that form inclusions in neurodegenerative diseases (56), and consistent with our observations in cultured cells, the sequestration of key cellular components (i.e. proteasomal subunits, ubiquitin, Parkin, chaperones) in p38-positive aggregates may perturb the cellular metabolism and amplify cellular stress. 

Phrase: "As is"

Phrase: "the case for several pathological proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0868928:Case [Functional Concept]
   753   C1706255:CASE [Medical Device]
   753   C1706256:Case [Conceptual Entity]

Phrase: "that"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "inclusions in neurodegenerative diseases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0010823:Inclusion Diseases [Disease or Syndrome]
   737   C1512693:Inclusion [Qualitative Concept]

Phrase: "(56"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "consistent with our observations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in cultured cells,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "the sequestration of key cellular components"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443301:Sequestration [Functional Concept]

Phrase: "(i.e. proteasomal subunits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1711351:Subunit [Quantitative Concept]

Phrase: "ubiquitin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "chaperones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0243041:Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "in p38-positive aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]

Phrase: "may"

Phrase: "perturb"

Phrase: "the cellular metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1524026:cellular metabolism [Cell Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "amplify"

Phrase: "cellular stress."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1516373:Cellular Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   789 E C0231297:Stressful [Functional Concept]
Processing 00000000.tx.203: In conclusion, we have provided evidence for a functional interaction between Parkin and the p38 component of the multiARS complex and suggest that p38 contributes to dopaminergic cell death in PD. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "we"

Phrase: "have"

Phrase: "provided evidence for a functional interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "between Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the p38 component of the multiARS complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that p38"

Phrase: "contributes to dopaminergic cell death"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0007587:Cell Death [Cell Function]
   806   C1512035:Dopaminergic cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1880177:Contribute [Activity]
   760   C1948049:Cell [Spatial Concept]

Phrase: "in PD."
Processing 00000000.tx.204: Further studies will be required to determine whether and by which mechanisms p38 plays a dual function in protein biosynthesis and in the pathogenesis of PD.  

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "will"

Phrase: "be"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "and by which mechanisms p38"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0441712:Mechanisms [Functional Concept]
   760   C1515981:And [Idea or Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a dual function in protein biosynthesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "and in the pathogenesis of PD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0543483:pathogenesis [Functional Concept]
   753   C0699748:Pathogenesis [Pathologic Function]
   753   C1515981:And [Idea or Concept]
Processing 00000000.tx.205: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Yeast two-hybrid screening The bait plasmid pLex-Parkin135-290 was generated by subcloning the human Parkin cDNA sequence corresponding to protein residues 135290 into pLex9/pBTM11. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Yeast two-hybrid screening"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   861   C0599647:Two Hybrid [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0220908:Screening [Health Care Activity]
   812   C0220909:screening [Functional Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C1698960:screening [Intellectual Product]
   812   C1710031:Screening [Diagnostic Procedure]
   812   C1710477:SCREENING [Research Activity]
   779 E C1305399:screen [Functional Concept]
   779 E C1705053:Screen [Medical Device]

Phrase: "The bait plasmid pLex-Parkin135-290"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "generated by subcloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3146294:Generated [Activity]

Phrase: "the human Parkin cDNA sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "corresponding to protein residues 135290"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "into pLex9/pBTM11."
Processing 00000000.tx.206: The yeast strain L40 was transformed with pBTM116-lexA-Parkin135-290, then the HeLa cDNA library in pGAD-GH (Clontech) was introduced into it. 

Phrase: "The yeast strain L40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1421257:L40 [Gene or Genome]

Phrase: "was"

Phrase: "transformed with pBTM116-lexA-Parkin135-290,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510411:Transformed [Pathologic Function]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the HeLa cDNA library in pGAD-GH (Clontech"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   744   C0023621:Library [Manufactured Object,Organization]
   744   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "was"

Phrase: "introduced into it."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1292748:introduce [Functional Concept]
Processing 00000000.tx.207: We screened 3.5x106 yeast transformants for their ability to grow on Trp- Leu- His- selection medium. 

Phrase: "We"

Phrase: "screened"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0220908:screen [Health Care Activity]
   966   C1305399:screen [Functional Concept]
   966   C1705053:Screen [Medical Device]

Phrase: "3.5x106 yeast transformants for their ability to"

Phrase: "grow on Trp- Leu-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1699992:Trp-Leu [Amino Acid, Peptide, or Protein]
   770   C0023401:Leu [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "His- selection medium."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]
Processing 00000000.tx.208: The specificity of the interaction was confirmed by co-transforming L40 yeast with each of the selected plasmids and with the control vectors pLex9-cAPP (A. Fournier) or pLex9-RasVal12 (a generous gift from A. Vojtek). 

Phrase: "The specificity of the interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "was"

Phrase: "confirmed by"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   833   C0750484:Confirmed [Idea or Concept]
   799 E C1456348:Confirm [Qualitative Concept]

Phrase: "co-transforming"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510411:Transforming [Pathologic Function]

Phrase: "L40 yeast with each of the selected plasmids"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0036025:yeast [Fungus]
   744   C0043392:Yeast [Food]
   744   C0043393:Yeast [Fungus]
   744   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "and with the control vectors pLex9-cAPP"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   762   C0031249:control vector [Occupational Activity]
   748   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243148:control [Qualitative Concept]
   748   C0442335:Vectors [Spatial Concept]
   748   C1515981:And [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714 E C1705099:Vector [Idea or Concept]

Phrase: "(A. Fournier"

Phrase: ")"

Phrase: "or"

Phrase: "pLex9-RasVal12"

Phrase: "("

Phrase: "a generous gift from A. Vojtek"

Phrase: ")."
Processing 00000000.tx.209: Plasmids, cell culture and transfections The Parkin cDNAs were subcloned into the EcoRI and XbaI sites of pcDNA3-HA (A. Fournier). 

Phrase: "Plasmids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "The Parkin cDNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "subcloned into the EcoRI"

Phrase: "and"

Phrase: "XbaI sites of pcDNA3-HA (A. Fournier"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   762   C2945843:Site of [Qualitative Concept]
   748   C0205145:Sites [Spatial Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.210: The p38 cDNA was inserted into the BamHI and NotI sites of pcDNA3-myc (L. Pradier), and into the BglII and ApaI sites of pEGFP-C1 (Clontech). 

Phrase: "The p38 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "inserted into the BamHI"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0441587:Inserted [Health Care Activity]
   737 E C1743766:Insert [Medical Device]
   737 E C1883719:Insert [Functional Concept]

Phrase: "and"

Phrase: "NotI sites of pcDNA3-myc (L. Pradier"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   762   C2945843:Site of [Qualitative Concept]
   748   C0205145:Sites [Spatial Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and into the BglII"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "ApaI sites of pEGFP-C1 (Clontech"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   773   C2945843:Site of [Qualitative Concept]
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.211: The integrity of the constructs was confirmed by sequencing. 

Phrase: "The integrity of the constructs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205266:integrity [Qualitative Concept]
   760   C0872403:integrity [Individual Behavior]
   760   C1947912:Integrity [Qualitative Concept]

Phrase: "was"

Phrase: "confirmed by sequencing."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   756 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.212: pEGFP-C1 was purchased from Clontech and p6his-ubiquitin (pMT107) provided by G. 

Phrase: "pEGFP-C1"

Phrase: "was"

Phrase: "purchased from Clontech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "and"

Phrase: "p6his-ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(pMT107"

Phrase: ")"

Phrase: "provided by G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439267:g% [Quantitative Concept]
   790   C1999230:Provided [Activity]
Processing 00000000.tx.213: Bossis. 

Phrase: "Bossis."
Processing 00000000.tx.214: Cells were grown in DMEM (Invitrogen) with 10% fetal calf serum (FCS) in a 5% CO2 atmosphere. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in DMEM"

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "with 10% fetal calf serum (FCS)"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "in a 5% CO2 atmosphere."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0004178:Atmosphere [Natural Phenomenon or Process]
   827   C0678214:atmosphere [Quantitative Concept]
Processing 00000000.tx.215: Transfections were performed with DMRIE-C (Invitrogen) according to the manufacturer's instructions. 

Phrase: "Transfections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfections [Genetic Function,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "performed with DMRIE-C (Invitrogen"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0254812:DMRIE [Lipid]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.216: Stable clones were obtained by cotransfecting SH-SY5Y cells with pcDNA3-HA-Parkin1-465 and with pTK-Hyg (Clontech), at a 1:10 molar ratio. 

Phrase: "Stable clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "obtained by cotransfecting SH-SY5Y cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0038108:SH [Geographic Area]
   753   C1301820:Obtained [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1706701:Obtain [Activity]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "with pcDNA3-HA-Parkin1-465"

Phrase: "and with pTK-Hyg (Clontech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1515981:And [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "at a 1"

Phrase: ":"

Phrase: "10 molar ratio."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2825550:Molar Ratio [Quantitative Concept]
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.217: Cells were plated out at a low density (28x105/10cm Petri dish) in a medium containing hygromycin (90g/ml, Invitrogen). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005971:Plate [Medical Device]
   966   C1139930:plate [Medical Device]
   966   C3537155:Plate [Manufactured Object]

Phrase: "out at a low density"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0178587:density [Quantitative Concept]
   760   C0205251:low [Qualitative Concept]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]

Phrase: "(28x105/10cm Petri dish"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1322960:Petri dish [Medical Device]
   812   C0020498:DISH [Disease or Syndrome]

Phrase: ")"

Phrase: "in a medium containing hygromycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0063201:hygromycin [Organic Chemical]

Phrase: "(90g/ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Invitrogen"

Phrase: ")."
Processing 00000000.tx.218: The expression of the transgene in the selected hygromycin-resistant clones was verified by western blot using anti-HA (clone 16B12, BabCO, 1:1000) and anti-Parkin antibodies (1:400) (57,58). 

Phrase: "The expression of the transgene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the selected hygromycin-resistant clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0009013:Clones [Cell]
   779 E C1522642:Clone [Tissue]
   729 E C1704387:Clonal [Qualitative Concept]
   706 E C0796368:clonality [Diagnostic Procedure]

Phrase: "was"

Phrase: "verified by western blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   770   C1711411:Verified [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-HA (clone 16B12,"

Phrase: "BabCO,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ")"

Phrase: "and"

Phrase: "anti-Parkin antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "400"

Phrase: ")"

Phrase: "(57,"

Phrase: "58"

Phrase: ")."
Processing 00000000.tx.219: Co-immunoprecipitation and ubiquitylation assays Forty-eight hours after transfection, cells were lysed in co-IP buffer [50mM TrisHCl pH 8, 150mM NaCl, 5% glycerol, 0.5% NP40, 0.2mM Na3VO4, 4mg/ml NaF, complete protease inhibitors (Roche)]. 

Phrase: "Co-immunoprecipitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "ubiquitylation assays Forty-eight hours after transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0439227:hours [Temporal Concept]
   714 E C0564385:/hour [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed in co-IP buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:lysed [Pathologic Function]

Phrase: "[50mM TrisHCl pH 8,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450400:50mm [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "5% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "0.5% NP40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "0.2mM Na3VO4,"

Phrase: "4mg/ml NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   827   C1366571:NAF [Gene or Genome]
   827   C1705592:NAF [Gene or Genome]

Phrase: "complete protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.220: Lysates were centrifuged at 4C for 30min at 13000g. 

Phrase: "Lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "centrifuged at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   756   C0179834:centrifuge [Medical Device]

Phrase: "for 30min"

Phrase: "at 13000g."
Processing 00000000.tx.221: Supernatants were pre-cleared with protein G Sepharose (Amersham) for 1h at 4C, combined with 2g monoclonal protein G Sepharose-coupled anti-HA antibodies (clone 16B12, BAbCO), and gently rocked for 2h at 4C. 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "pre-cleared with protein G Sepharose"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0060916:protein g [Amino Acid, Peptide, or Protein]
   783 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0036681:Sepharose [Carbohydrate]
   753   C0332152:Pre [Temporal Concept]
   753   C0439267:g% [Quantitative Concept]
   753   C0521097:cleared [Functional Concept]
   753   C0740175:Pre [Qualitative Concept]
   753   C2257086:PRE [Genetic Function]
   719 E C2963144:Clear [Qualitative Concept]

Phrase: "(Amersham"

Phrase: ")"

Phrase: "for 1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: "at 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "combined with 2g monoclonal protein G Sepharose-coupled anti-HA antibodies"
Meta Candidates (Total=20; Excluded=6; Pruned=0; Remaining=14)
   756   C0060916:protein g [Amino Acid, Peptide, or Protein]
   756   C0443737:Monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   756   C0700271:monoclonal protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   754 E C1317659:Protein.monoclonal [Laboratory or Test Result]
   754   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0036681:Sepharose [Carbohydrate]
   738   C0205195:Combined [Qualitative Concept]
   738   C0439267:g% [Quantitative Concept]
   738   C0746619:monoclonal [Finding]
   738   C1948027:Coupled [Functional Concept]
   737 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   737   C0369247:G Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   737   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   704 E C0010222:couple [Family Group]
   704 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   704 E C0336789:Combine [Manufactured Object]

Phrase: "(clone 16B12,"

Phrase: "BAbCO"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "gently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1638411:Gently [Qualitative Concept]

Phrase: "rocked for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292425:2H [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.222: Immunoprecipitated proteins were washed four times in co-IP buffer and once in PBS, and analyzed by western blot with monoclonal anti-myc antibodies (clone 9E10, Santa-Cruz, 1:400) or monoclonal anti-HA antibodies (clone 16B12, BabCO, 1:1000). 

Phrase: "Immunoprecipitated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "four times in co-IP buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "once in PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720092:Once [Intellectual Product]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C1948045:Once [Temporal Concept]

Phrase: "and"

Phrase: "analyzed by western blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "with monoclonal anti-myc antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   902   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(clone 9E10,"

Phrase: "Santa-Cruz,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "400"

Phrase: ")"

Phrase: "or"

Phrase: "monoclonal anti-HA antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   902   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(clone 16B12,"

Phrase: "BabCO,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ")."
Processing 00000000.tx.223: For ubiquitylation assays, cells were treated with 1M epoxomicin (Affiniti) for 8h, 36h after transfection, and lysed in denaturing lysis buffer (6M guanidiumHCl, 0.1M Na2HPO4/NaH2PO4, 0.01M TrisHCl, pH 8). 

Phrase: "For ubiquitylation assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 1M epoxomicin"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0470296:1M [Quantitative Concept]
   770   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(Affiniti"

Phrase: ")"

Phrase: "for 8h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292429:8H [Temporal Concept]

Phrase: "36h after transfection,"

Phrase: "and"

Phrase: "lysed in denaturing lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0024348:Lysis [Pathologic Function]
           lysed
   760   C1536403:lysis [Cell Function]

Phrase: "(6M guanidiumHCl,"

Phrase: "0.1M Na2HPO4/NaH2PO4,"

Phrase: "0.01M TrisHCl,"

Phrase: "pH 8"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.224: Six-his ubiquitylated proteins were affinity purifed in denaturing conditions (ProBond resin, Invitrogen), according to the manufacturer's instructions, then eluted from beads with 200mM imidazole in 5% SDS, 0.15M TrisHCl pH 6.7, 30% glycerol, 0.72M -mercaptoethanol. 

Phrase: "Six-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205452:Six [Quantitative Concept]

Phrase: "his ubiquitylated proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "affinity purifed in denaturing conditions"

Phrase: "(ProBond resin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035191:Resin [Biomedical or Dental Material]

Phrase: "Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "according to the manufacturer's instructions,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "eluted from beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0991566:Beads [Biomedical or Dental Material]
   756 E C2346972:Bead [Spatial Concept]

Phrase: "with 200mM imidazole"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020923:Imidazole [Organic Chemical,Pharmacologic Substance]
   861   C0020924:imidazole [Organic Chemical,Pharmacologic Substance]

Phrase: "in 5% SDS,"

Phrase: "0.15M TrisHCl pH 6.7,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   839   C1882074:pH 7 [Qualitative Concept]
   799   C0020283:[pH] [Quantitative Concept]
   799   C0450407:ph+ [Finding]
   799   C0450408:ph++ [Finding]
   799   C0450409:ph+++ [Finding]
   799   C1442447:15M [Temporal Concept]

Phrase: "30% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "0.72M -mercaptoethanol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025402:Mercaptoethanol [Organic Chemical]
Processing 00000000.tx.225: Purified proteins and aliquots from cell lysates were analyzed by western blot for myc-p38, HA-CDCrel-1, HA-Parkin or EGFP (monoclonal anti-GFP, Roche, 0.4g/ml). 

Phrase: "Purified proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "aliquots from cell lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by western blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   833   C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "for myc-p38,"

Phrase: "HA-CDCrel-1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C1825516:HA-1 [Gene or Genome]
   913   C1825747:Ha-1 [Gene or Genome]
   901   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
   901   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   827   C1539748:CDCREL [Gene or Genome]

Phrase: "HA-Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418270:PARKIN [Gene or Genome]
   861   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "EGFP"

Phrase: "(monoclonal anti-GFP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0120285:GFP [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "Roche,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: "0.4g/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.226: Proteins were visualized using enhanced chemioluminescence (Pierce). 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "enhanced chemioluminescence"

Phrase: "(Pierce"

Phrase: ")."
Processing 00000000.tx.227: Pulse-chase analysis of p38 turnover Pulse-chase experiments were performed 36h after the transfection of cells with pcDNA3-myc-p38. 

Phrase: "Pulse-chase analysis of p38 turnover Pulse-chase experiments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "36h after the transfection of cells"

Phrase: "with pcDNA3-myc-p38."
Processing 00000000.tx.228: Cells were starved in methionine/cysteine-free DMEM2% FCS (1h), pulsed with 200Ci/ml of [35S]-methionine/cysteine (Perkin Elmer, 30min), rinsed and chased for the indicated periods of time in DMEM10% FCS. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "starved in methionine/cysteine-free DMEM2% FCS"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   762   C2927891:Cysteine / Methionine [Pharmacologic Substance]
   742   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0015965:Fetal [Embryonic Structure]
   742   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0229671:Serum [Body Substance]
   742   C0230445:Calf [Body Location or Region]
   742   C0332296:free [Functional Concept]
   742   C0521457:Fetal [Functional Concept]
   742   C1305418:Calf [Body Part, Organ, or Organ Component]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   742   C1880497:Free [Qualitative Concept]
   742   C1996904:Free [Qualitative Concept]
   708   C2348531:Starve [Activity]

Phrase: "(1h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442450:1H [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "pulsed with 200Ci/ml of [35S"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0439526:/mL [Quantitative Concept]
   753   C1947910:Pulsed [Phenomenon or Process]
   719 E C0232117:PULSE [Clinical Attribute]
   719 E C0391850:Pulse [Physiologic Function]

Phrase: "]-methionine/cysteine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Perkin Elmer,"

Phrase: "30min"

Phrase: ")"

Phrase: ","

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "chased for the indicated periods of time"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   774   C0439582:Time periods [Temporal Concept]
   748   C0040223:Time [Temporal Concept]
   748   C1444656:Indicated [Finding]
   748   C3541383:Time [Temporal Concept]
   746 E C0585019:Temporal periods [Temporal Concept]
   714   C0439531:/period [Temporal Concept]
   714   C1948053:Period [Temporal Concept]

Phrase: "in DMEM10% FCS."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]
Processing 00000000.tx.229: Cell lysates obtained in co-IP buffer were immunoprecipitated with anti-myc antibodies (clone 9E10, Santa Cruz; 4g). 

Phrase: "Cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "obtained in co-IP buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "were"

Phrase: "immunoprecipitated with anti-myc antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(clone 9E10,"

Phrase: "Santa Cruz"

Phrase: "; 4g"

Phrase: ")."
Processing 00000000.tx.230: Immunoprecipitates were resolved by SDSPAGE, visualized by phosphoimaging and quantified with Aida analysis software. 

Phrase: "Immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "resolved by SDSPAGE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514893:Resolved [Idea or Concept]
   790   C2699488:Resolved [Conceptual Entity]

Phrase: "visualized by phosphoimaging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0234621:Visualized [Functional Concept]

Phrase: "and"

Phrase: "quantified with Aida analysis software."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0037585:Software [Intellectual Product,Manufactured Object]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1823700:AIDA [Gene or Genome]
   726   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.231: Quantification of p38-positive inclusions and viability assays Cells were plated on collagen-coated coverslips in 24-well culture clusters. 

Phrase: "Quantification of p38-positive inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantification [Quantitative Concept]

Phrase: "and"

Phrase: "viability assays Cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   877   C1441322:Viable cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "plated on collagen-coated coverslips"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   760   C1167364:collagen [Cell Component]
   760   C1522408:Coated [Qualitative Concept]
   726   C0005971:Plate [Medical Device]
   726 E C0453946:Coat [Manufactured Object]
   726   C1139930:plate [Medical Device]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]
   726   C3537155:Plate [Manufactured Object]

Phrase: "in 24-well culture clusters."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1555715:Cluster [Idea or Concept]
   779   C1704332:Cluster [Quantitative Concept]
Processing 00000000.tx.232: To determine the number of cells containing p38-positive aggregates, 48h after transfection, cells were treated or not with 0.5M epoxomicin over-night, then processed for anti-myc immunocytochemistry. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the number of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "p38-positive aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205418:aggregates [Qualitative Concept]

Phrase: "48h after transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442464:48H [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "not with 0.5M epoxomicin over-night, then"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0439583:Overnight [Temporal Concept]
   744   C0240526:Night [Temporal Concept]
   744   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C1518422:Not [Functional Concept]
   744   C1883708:Then [Temporal Concept]

Phrase: "processed for anti-myc immunocytochemistry."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0242349:Immunocytochemistry [Laboratory Procedure]
   760   C1522240:Processed [Phenomenon or Process]
   726 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.233: For each condition, at least 150 p38-positive cells were counted from each of four independent wells. 

Phrase: "For each condition,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]

Phrase: "at least 150 p38-positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0439178:% positive cells [Quantitative Concept]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "counted from each of four independent wells."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0332291:Independent of [Functional Concept]
   748   C0085862:Independent [Idea or Concept]
   748   C0205450:Four [Quantitative Concept]
   748   C1299583:Independent [Finding]
   714   C0205170:Well [Qualitative Concept]
   714   C0750480:Count [Activity]
   714   C1705566:Count [Quantitative Concept]
   714   C3146287:Well [Manufactured Object]
Processing 00000000.tx.234: For viability assays, cells from three wells were transfected with pEGFP-C1 and cells from 10 wells with pEGFP-C1-p38. 

Phrase: "For viability assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "cells from three wells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   802   C2347578:Cells/well [Quantitative Concept]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with pEGFP-C1"

Phrase: "and"

Phrase: "cells from 10 wells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   802   C2347578:Cells/well [Quantitative Concept]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "with pEGFP-C1-p38."
Processing 00000000.tx.235: Thirty-six hours after transfection, cells were labeled with ethidium homodimer 1 (EthD-1, Viability/Cytotoxicity Kit, Molecular Probes), then at least 200 EGFP-positive cells were counted blindly from coded coverslips. 

Phrase: "Thirty-six hours after transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled with ethidium homodimer 1"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   862   C1172361:ethidium homodimer-1 [Organic Chemical]
   806   C0059713:ethidium homodimer [Organic Chemical,Pharmacologic Substance]
   760   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(EthD-1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1172361:EthD-1 [Organic Chemical]

Phrase: "Viability/Cytotoxicity Kit,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0812225:KIT [Medical Device]
   827   C1150635:KIT [Molecular Function]
   827   C1705212:Kit [Medical Device]
   827   C1705213:KIT [Medical Device]
   827   C3273202:Kit [Manufactured Object]

Phrase: "Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "then at least 200 EGFP-positive cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0439178:% positive cells [Quantitative Concept]
           % Positive
   748   C0007634:Cells [Cell]
   748   C1446409:Positive [Qualitative Concept]
   748   C1514241:Positive [Finding]
   748   C1883708:Then [Temporal Concept]
   748   C2825490:Positive [Qualitative Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "blindly from coded coverslips."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0009219:code [Occupational Activity]
   737   C0805701:Code [Intellectual Product]
Processing 00000000.tx.236: The percentage cell death was calculated as the ratio of double-labeled EthD-1/EGFP-positive cells to EGFP-positive cells. 

Phrase: "The percentage cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "calculated as the ratio"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0444686:Calculated [Functional Concept]
   770   C0456603:Ratio [Quantitative Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   770   C1547037:Ratio [Intellectual Product]

Phrase: "of double-labeled EthD-1/EGFP-positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   818   C0439178:% positive cells [Quantitative Concept]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "to EGFP-positive cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0439178:% positive cells [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.237: Immunochemistry Thirty-six hours after transfection, cells were treated or not with nocodazole (15g/ml, over-night) or cytochalasin D (200nM, over-night), fixed in 4% paraformaldehyde and analyzed by standard immunocytochemical procedures. 

Phrase: "Immunochemistry Thirty-six hours after transfection,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0439227:hours [Temporal Concept]
   719 E C0564385:/hour [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "not with nocodazole"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0028247:Nocodazole [Organic Chemical,Pharmacologic Substance]
   790   C1518422:Not [Functional Concept]

Phrase: "(15g/ml,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "over-night"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439583:Overnight [Temporal Concept]
   861   C0240526:Night [Temporal Concept]

Phrase: ")"

Phrase: "or"

Phrase: "cytochalasin D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010738:Cytochalasin D [Biologically Active Substance,Organic Chemical]
   861   C0010739:Cytochalasin [Biologically Active Substance,Pharmacologic Substance]

Phrase: "(200nM,"

Phrase: "over-night"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439583:Overnight [Temporal Concept]
   861   C0240526:Night [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "fixed in 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "analyzed by standard immunocytochemical procedures."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   790   C0242349:Immunocytochemical procedure [Laboratory Procedure]
   760   C0025664:procedures [Intellectual Product]
   760   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   760   C0936012:Analyzed [Research Activity]
   760   C1442989:Standard [Qualitative Concept]
   760   C2700391:procedures [Activity]
   760   C2828392:Standard [Intellectual Product]
   726 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   726 E C3274430:PROCEDURE [Health Care Activity]
   726 E C3538935:Procedure [Idea or Concept]
   726 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.238: Primary antibodies were monoclonal anti-myc (clone 9E10, Santa Cruz, 1:400), monoclonal anti--tubulin (clone GTU-88, Sigma, 1:10000), monoclonal anti-vimentin (clone V9, Dako, 1:100), polyclonal anti-p38 (1:20000), polyclonal anti-20S proteasome (Affiniti, 1:2500), polyclonal anti-ubiquitin (Dako, 1:100), polyclonal anti-Hsp70 (Stressgen, 1:2500), and polyclonal anti-Parkin (1:400) (57,58). 

Phrase: "Primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "monoclonal anti-myc (clone 9E10,"

Phrase: "Santa Cruz,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "400"

Phrase: ")"

Phrase: ","

Phrase: "monoclonal anti--tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C2937342:tubulin [Cell Component]

Phrase: "(clone GTU-88,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10000"

Phrase: ")"

Phrase: ","

Phrase: "monoclonal anti-vimentin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0042666:Vimentin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1325833:vimentin [Cell Component]
   827   C1421451:VIMENTIN [Gene or Genome]

Phrase: "(clone V9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0507131:V9 [Body Part, Organ, or Organ Component]

Phrase: "Dako,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100"

Phrase: ")"

Phrase: ","

Phrase: "polyclonal anti-p38"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "20000"

Phrase: ")"

Phrase: ","

Phrase: "polyclonal anti-20S proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0208355:20S Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
           Proteasome
   861   C1166808:20S proteasome [Cell Component]
   812   C1325620:proteasome [Cell Component]
   812   C1752727:Proteasome [Molecular Function]

Phrase: "(Affiniti,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2500"

Phrase: ")"

Phrase: ","

Phrase: "polyclonal anti-ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041538:Ubiquitin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Dako,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100"

Phrase: ")"

Phrase: ","

Phrase: "polyclonal anti-Hsp70 (Stressgen,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2500"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "polyclonal anti-Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418270:PARKIN [Gene or Genome]
   827   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "400"

Phrase: ")"

Phrase: "(57,"

Phrase: "58"

Phrase: ")."
Processing 00000000.tx.239: Secondary antibodies were Alexa Fluor 488-conjugated goat anti-mouse IgG (Interchim, 1:200) and CY3-conjugated goat anti-rabbit IgG (Jackson ImmunoResearch, 1:600). 

Phrase: "Secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "Alexa Fluor 488-conjugated goat anti-mouse IgG (Interchim,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: "and"

Phrase: "CY3-conjugated goat anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0034493:Rabbit [Mammal]

Phrase: "(Jackson ImmunoResearch,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "600"

Phrase: ")."
Processing 00000000.tx.240: Polyclonal anti-p38 antibodies were raised in rabbit against hamster p38 expressed in E. coli and purified to homogeneity as previously described (27). 

Phrase: "Polyclonal anti-p38 antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   886   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "raised in rabbit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034493:Rabbit [Mammal]
   790   C0442818:Raised [Quantitative Concept]

Phrase: "against hamster p38"

Phrase: "expressed in E. coli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0014834:E coli [Bacterium]

Phrase: "and"

Phrase: "purified to homogeneity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1881065:Homogeneity [Qualitative Concept]
   790   C1998793:Purified [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.241: Mono-specific antibodies were affinity-purified on p38 immobilized on CNBr-activated Sepharose 4B. 

Phrase: "Mono-specific antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "affinity-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified on p38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1998793:Purified [Functional Concept]

Phrase: "immobilized on CNBr-activated Sepharose 4B."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0036682:Sepharose 4B [Biomedical or Dental Material,Carbohydrate]
   753   C0010511:CNBr [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   753   C0036681:Sepharose [Carbohydrate]
   753   C0450375:4b [Intellectual Product]
   753   C1879547:Activated [Activity]
   719 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.242: The specificity of these antibodies was assessed by western blot analysis of cleared homogenates of human brain tissue. 

Phrase: "The specificity of these antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C0003264:antibodies specificity [Molecular Function]
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]
   745 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "assessed by western blot analysis of cleared homogenates of human brain tissue."
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   770   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   753   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0440746:Brain tissue [Tissue]
   753   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   751   C0440744:Human tissue [Tissue]
   751   C0521097:Cleared by [Functional Concept]
           cleared
   736   C0002778:Analysis [Laboratory Procedure]
   736   C0006104:Brain [Body Part, Organ, or Organ Component]
   736   C0040300:Tissue [Tissue]
   736   C0086418:Human [Human]
   736   C0936012:Analysis [Research Activity]
   736   C1269537:Brain [Body Part, Organ, or Organ Component]
   736   C1516048:Assessed [Activity]
   736   C1524024:analysis [Functional Concept]
   736   C1547928:Tissue [Intellectual Product]
   736   C1705493:Western [Spatial Concept]
   703 E C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.243: Homogenates, generated by disrupting the tissue in 50mM Hepes, pH 7.5, 150mM NaCl, 150mM MgCl2, 10% glycerol, 1% Triton-X100, 10mM Na pyrophosphate, 100mM NaF, 1mM EDTA, complete protease inhibitors (Roche), were centrifuged at 15000g, for 30min at 4C. 

Phrase: "Homogenates,"

Phrase: "generated by disrupting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332454:disrupting [Qualitative Concept]
   790   C3146294:Generated [Activity]

Phrase: "the tissue in 50mM Hepes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "150mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "1% Triton-X100,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0146951:Triton X100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "10mM Na pyrophosphate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034320:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C3252566:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "100mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   861   C1366571:NAF [Gene or Genome]
   861   C1705592:NAF [Gene or Genome]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "complete protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "centrifuged at 15000g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "for 30min"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.244: Supernatants (30g) were immunoblotted using anti-p38 antibodies (1:100000) or pre-immune serum (1:5000). 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "(30g"

Phrase: ")"

Phrase: "were"

Phrase: "immunoblotted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-p38 antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100000"

Phrase: ")"

Phrase: "or"

Phrase: "pre-immune serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0020960:immune serum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5000"

Phrase: ")."
Processing 00000000.tx.245: Human brain tissue was selected and prepared as previously described (59). 

Phrase: "Human brain tissue"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0440744:Human tissue [Tissue]
   901   C0440746:Brain tissue [Tissue]
   901   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0040300:Tissue [Tissue]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "and"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(59"

Phrase: ")."
Processing 00000000.tx.246: Conventional immunohistochemistry was carried out with polyclonal anti-p38 antibodies (1:20000) on free-floating human brain sections, as described previously (58). 

Phrase: "Conventional immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with polyclonal anti-p38 antibodies"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   783   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0439787:Out [Spatial Concept]
   753   C0849355:Out [Qualitative Concept]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "20000"

Phrase: ")"

Phrase: "on free-floating human brain sections,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   771   C0205155:Section [Spatial Concept]
   771   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   771   C1522472:Section [Substance]
   771   C1552923:Section [Quantitative Concept]
   771   C1705191:Section [Physical Object]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.247: Immunoreactivity was revealed using the avidinbiotin peroxidase complex (Vectastain, Vector) with diaminobenzidine as the chromogenic substrate. 

Phrase: "Immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the avidinbiotin peroxidase complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0439855:Complex [Qualitative Concept]
   827   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(Vectastain,"

Phrase: "Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "with diaminobenzidine"

Phrase: "as the chromogenic substrate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.248: For pre-absorptions, antibodies were incubated with a 2000-fold excess of recombinant his-p38 (26) prior to use. 

Phrase: "For pre-absorptions,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0000854:Absorptions [Natural Phenomenon or Process]
   827 E C0220777:absorption [Functional Concept]
   827 E C2347023:Absorption [Phenomenon or Process]
   827 E C2347080:Absorption [Phenomenon or Process]
   827 E C2698776:ABSORPTION [Biomedical Occupation or Discipline]
   827 E C2825050:Absorption [Phenomenon or Process]

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "incubated with a 2000-fold excess of recombinant"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0332462:Fold [Spatial Concept]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1514798:recombinant [Organism]
   744   C1880834:FOLD [Phenomenon or Process]
   744   C1979886:Excess [Qualitative Concept]

Phrase: "his-p38"

Phrase: "(26"

Phrase: ")"

Phrase: "prior to use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.249: After antigen retrieval (microwave method), immunofluorescent labeling was performed with polyclonal anti-p38 (1:5000) and monoclonal anti-ubiquitin antibodies (clone ubi-1, Zymed, 1:50), as described previously (60). 

Phrase: "After antigen retrieval"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0003320:Antigen [Immunologic Factor]
   861   C1514918:Retrieval [Health Care Activity]
   761 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "(microwave method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "immunofluorescent labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "performed with polyclonal anti-p38"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5000"

Phrase: ")"

Phrase: "and"

Phrase: "monoclonal anti-ubiquitin antibodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   902   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(clone ubi-1,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "Zymed,"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "50"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.250: Secondary antibodies were as above. 

Phrase: "Secondary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "as"

Phrase: "above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]
Processing 00000000.tx.251: Statistical analyses ANOVA and the Fisher LSD test were used to determine whether differences between groups were significant. 

Phrase: "Statistical analyses ANOVA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0871424:statistical analysis [Research Activity]

Phrase: "and"

Phrase: "the Fisher LSD test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1708064:Fisher's Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "differences between groups"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C1705241:*Difference [Quantitative Concept]
   756   C1705242:Difference [Qualitative Concept]
   706 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "significant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.252: Data are expressed as meansSEM. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as meansSEM."
Processing 00000000.tx.253: Statistical significance was defined as P<0.05.  

Phrase: "Statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "defined as P<0.05."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.254: ACKNOWLEDGEMENTS  We thank Y. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Y."
Processing 00000000.tx.255: Zhang for kindly providing pRK-HA-CDCrel-1, and G. 

Phrase: "Zhang for kindly"

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "pRK-HA-CDCrel-1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C1825516:HA-1 [Gene or Genome]
   875   C1825747:Ha-1 [Gene or Genome]
   861   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
   861   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   812   C1539748:CDCREL [Gene or Genome]

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.256: Bossis for providing phis-Ubi and for excellent advice on ubiquitylation experiments in cultured cells. 

Phrase: "Bossis for providing phis-Ubi"

Phrase: "and for excellent advice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0150600:Advice [Health Care Activity]
   770   C1515981:And [Idea or Concept]
   770   C1548784:Excellent [Qualitative Concept]
   770   C1961136:Excellent [Qualitative Concept]

Phrase: "on ubiquitylation experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "in cultured cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.257: This work was supported by INSERM, Aventis-Pharma, the Association France Parkinson, the Fondation de France and the GIP Fonds de Recherche Aventis.  

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by INSERM,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]

Phrase: "Aventis-Pharma,"

Phrase: "the Association France Parkinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   727   C1021144:Parkinsonia [Plant]

Phrase: "the Fondation de France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0016674:France [Geographic Area]

Phrase: "and"

Phrase: "the GIP Fonds de Recherche Aventis."
Processing 00000000.tx.258: FOOTNOTES  * To whom correspondence should be addressed. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.259: Tel: +33 142162183; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+33 142162183"

Phrase: ";"
Processing 00000000.tx.260: Fax: +33 144243658; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+33 144243658"

Phrase: ";"
Processing 00000000.tx.261: Email: brice{at}ccr.jussieu.fr The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.  

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "brice{at}ccr.jussieu.fr"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C2348513:Fr. [Conceptual Entity]
   804   C3538902:FR [Gene or Genome]

Phrase: "The authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "wish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1423524:WISH [Gene or Genome]
  1000   C3273411:WISH [Gene or Genome]
  1000   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "it to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that,"

Phrase: "in their opinion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871010:opinion [Mental Process]

Phrase: "the first two authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0221193:Authors [Professional or Occupational Group]

Phrase: "should"

Phrase: "be"

Phrase: "regarded as joint First Authors."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0022417:Joint [Body Space or Junction]
   760   C0205435:First [Quantitative Concept]
   760   C0221193:Authors [Professional or Occupational Group]
   760   C0392905:Joint, NOS [Body System]
   760   C1269611:Joint [Body Space or Junction]
   760   C1279901:First [Qualitative Concept]
   760   C1706309:Joint [Medical Device]
   704 E C0521339:Articular [Functional Concept]
Processing 00000000.tx.262: REFERENCES TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS REFERENCES  Forno, L.S. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION RESULTS DISCUSSION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Forno,"

Phrase: "L.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439394:L/s [Quantitative Concept]
           l's
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.263: (1996) Neuropathology of Parkinson's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Neuropathology of Parkinson's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1540677:neuropathology disease [Pathologic Function]
           neuropathology
   770   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   770   C1555824:Neuropathology [Intellectual Product]
Processing 00000000.tx.264: J. 

Phrase: "J."
Processing 00000000.tx.265: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.266: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.267: Neurol., 55, 259272.[ISI][Medline] Brice, A. and Lansbury, P.T.J. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "259272."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brice,"

Phrase: "A."

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P.T.J."
Processing 00000000.tx.268: (2002) Genetics of Parkinson's disease and biochemical studies of implicated gene products. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Genetics of Parkinson's disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0019247:genetics disease [Disease or Syndrome]
   770   C0017398:Genetics [Biomedical Occupation or Discipline]
   770   C0017399:genetics [Biologic Function]

Phrase: "and"

Phrase: "biochemical studies of implicated gene products."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   783   C1273305:Gene studies [Laboratory Procedure]
   753   C0205474:Biochemical [Functional Concept]
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]
Processing 00000000.tx.269: Curr. 

Phrase: "Curr."
Processing 00000000.tx.270: Opin. 

Phrase: "Opin."
Processing 00000000.tx.271: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.272: Devel., 12, 229306. 

Phrase: "Devel.,"

Phrase: "12,"

Phrase: "229306."
Processing 00000000.tx.273: Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. 

Phrase: "Polymeropoulos,"

Phrase: "M."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R. et al."
Processing 00000000.tx.274: (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Mutation in the alpha-synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015576:Families [Family Group]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.275: Science, 276, 20452047.[Abstract/Free FullText] Krger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. and Riess, O. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "276,"

Phrase: "20452047."

Phrase: "[Abstract/Free FullText"

Phrase: "] Krger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Muller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Graeber,"

Phrase: "M."

Phrase: ","

Phrase: "Kosel,"

Phrase: "S."

Phrase: ","

Phrase: "Przuntek,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Epplen,"

Phrase: "J.T.,"

Phrase: "Schols,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Riess,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.276: (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ala30Pro mutation in the gene encoding alpha-synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0596611:Gene Mutation [Genetic Function]
   744   C0026882:Mutation [Genetic Function]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.277: Nat. 

Phrase: "Nat."
Processing 00000000.tx.278: Genet., 18, 106108.[ISI][Medline] Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R. and Goedert, M. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "18,"

Phrase: "106108."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Spillantini,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Schmidt,"

Phrase: "M.L.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lee,"

Phrase: "V.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Trojanowski,"

Phrase: "J.Q., Jakes,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.279: (1997) Alpha-synuclein in Lewy bodies. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Alpha-synuclein in Lewy bodies."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439095:Alpha [Intellectual Product]
   760   C2003941:Alpha [Intellectual Product]
   760   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.280: Nature, 388, 839840. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "388,"

Phrase: "839840."
Processing 00000000.tx.281: Trojanowski, J.Q. and Lee, V.M. 

Phrase: "Trojanowski,"

Phrase: "J.Q."

Phrase: "and"

Phrase: "Lee,"

Phrase: "V.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.282: (1998) Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Aggregation of neurofilament"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332621:Aggregation [Functional Concept]
   790   C0439168:% aggregation [Quantitative Concept]
   718 E C0205418:Aggregate [Qualitative Concept]

Phrase: "and"

Phrase: "alpha-synuclein proteins in Lewy bodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1158819:alpha protein [Genetic Function]
   767   C2362546:Alpha protein [Amino Acid, Peptide, or Protein]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C1325683:protein body [Cell Component]

Phrase: ":"

Phrase: "implications for the pathogenesis of Parkinson disease"

Phrase: "and"

Phrase: "Lewy body dementia."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0752347:Dementia, Lewy Body [Disease or Syndrome]
  1000   C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   901   C0085200:Lewy Body [Cell Component]
   827   C0011265:dementia [Mental or Behavioral Dysfunction]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C0497327:Dementia [Mental or Behavioral Dysfunction]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]
   727 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.283: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.284: Neurol., 55, 151152.[Free FullText] Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M.J., Jonnalagada, S., Chernova, T. et al. 

Phrase: "Neurol.,"

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "151152."

Phrase: "[Free FullText"

Phrase: "] Leroy,"

Phrase: "E.,"

Phrase: "Boyer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Auburger,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Leube,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Ulm,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mezey,"

Phrase: "E.,"

Phrase: "Harta,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Brownstein,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Jonnalagada,"

Phrase: "S."

Phrase: ","

Phrase: "Chernova,"

Phrase: "T. et al."
Processing 00000000.tx.285: (1998) The ubiquitin pathway in Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "The ubiquitin pathway in Parkinson's disease."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1521736:Parkinson's Disease Pathway [Functional Concept]
   783   C1511986:Disease Pathway [Conceptual Entity]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.286: Nature, 395, 451452.[CrossRef][ISI][Medline] Bonifati, V., Rizzu, P., Van Baren, M.J., Schaap, O., Breedveld, G.J., Krieger, E., Dekker, M.C., Squitieri, F., Ibanez, P., Joosse, M. et al. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "395,"

Phrase: "451452."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bonifati,"

Phrase: "V.,"

Phrase: "Rizzu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Van Baren,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Schaap,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Breedveld,"

Phrase: "G.J.,"

Phrase: "Krieger,"

Phrase: "E.,"

Phrase: "Dekker,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Squitieri,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Ibanez,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Joosse,"

Phrase: "M. et al."
Processing 00000000.tx.287: (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Mutations in the DJ-1 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with autosomal recessive early-onset parkinsonism."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   814   C1838631:Parkinsonism, early-onset [Finding]
   804   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C0441748:Autosomal recessive [Intellectual Product]
   778   C1833334:Early-onset [Finding]
   748   C0242422:Parkinsonism [Disease or Syndrome]
   748   C0332162:Onset [Qualitative Concept]
   748   C0596142:autosomal [Cell Component]
   748   C1279919:Early [Temporal Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.288: Science, 299, 256259.[Abstract/Free FullText] Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "299,"

Phrase: "256259."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kitada,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yamamura,"

Phrase: "Y.,"

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Shimizu,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.289: (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mutations in the parkin gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "autosomal recessive juvenile parkinsonism."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1868675:Parkinsonism, Juvenile, Autosomal Recessive [Disease or Syndrome]
   923   C0752100:Autosomal Recessive Parkinsonism [Disease or Syndrome]
   861   C0752105:Parkinsonism, Juvenile [Disease or Syndrome]
   812   C0242422:Parkinsonism [Disease or Syndrome]
Processing 00000000.tx.290: Nature, 392, 605608.[CrossRef][ISI][Medline] Leroy, E., Anastasopoulos, D., Konitsiotis, S., Lavedan, C. and Polymeropoulos, M.H. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "392,"

Phrase: "605608."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Leroy,"

Phrase: "E.,"

Phrase: "Anastasopoulos,"

Phrase: "D."

Phrase: ","

Phrase: "Konitsiotis,"

Phrase: "S."

Phrase: ","

Phrase: "Lavedan,"

Phrase: "C."

Phrase: "and"

Phrase: "Polymeropoulos,"

Phrase: "M."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.291: (1998) Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson's disease. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Deletions in the Parkin gene"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   797   C0017260:Gene Deletions [Genetic Function]
   781 E C1442161:Gene Deletion [Cell or Molecular Dysfunction]
       E   Deletion
   760   C1880274:Deletions [Activity]
   726 E C1511760:Deletion [Genetic Function]

Phrase: "and"

Phrase: "genetic heterogeneity in a Greek family"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0242960:Genetic Heterogeneity [Organism Attribute]
   756   C0870545:family origins [Family Group]
   753   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   753   C0019409:Heterogeneity [Qualitative Concept]
   753   C0314603:Genetic [Functional Concept]

Phrase: "with early onset Parkinson's disease."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   902   C0679245:early disease [Temporal Concept]
   861   C0030567:Parkinson Disease [Disease or Syndrome]
   861   C1521736:Parkinson's Disease [Functional Concept]
   861   C2681933:PARKINSON DISEASE [Gene or Genome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   712   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.292: Hum. 

Phrase: "Hum."
Processing 00000000.tx.293: Genet., 103, 424427.[CrossRef][ISI][Medline] Abbas, N., Lcking, C.B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J.R., Gasser, T., Marconi, R. et al. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "103,"

Phrase: "424427."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Abbas,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lcking,"

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Ricard,"

Phrase: "S."

Phrase: ","

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "De Michele,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bouley,"

Phrase: "S."

Phrase: ","

Phrase: "Vaughan,"

Phrase: "J.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Gasser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Marconi,"

Phrase: "R. et al."
Processing 00000000.tx.294: (1999) A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. 

Phrase: "(1999"

Phrase: ")"

Phrase: "A wide variety of mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "in the parkin gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "are"

Phrase: "responsible for autosomal recessive parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "in Europe."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015176:Europe [Geographic Area]
Processing 00000000.tx.295: French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. 

Phrase: "French Parkinson's Disease Genetics Study Group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0441833:Group [Idea or Concept]
   799   C0557651:Study [Manufactured Object]
   799   C0687744:group [Population Group]
   799   C1257890:Group [Population Group]
   799   C1552516:Group [Health Care Related Organization]
   799   C1705428:Group [Conceptual Entity]
   799   C1705429:Group [Population Group]
   799   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "the European Consortium on Genetic Susceptibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1513822:Consortium [Professional or Occupational Group]
   753   C1880171:Consortium [Professional or Occupational Group]

Phrase: "in Parkinson's Disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.296: Hum. 

Phrase: "Hum."
Processing 00000000.tx.297: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.298: Genet., 8, 567574.[Abstract/Free FullText] Lcking, C.B., Abbas, N., Durr, A., Bonifati, V., Bonnet, A.M., de Broucker, T., De Michele, G., Wood, N.W., Agid, Y. and Brice, A. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "8,"

Phrase: "567574."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lcking,"

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Abbas,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Durr,"

Phrase: "A.,"

Phrase: "Bonifati,"

Phrase: "V.,"

Phrase: "Bonnet,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "de Broucker,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "De Michele,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "N.W., Agid,"

Phrase: "Y."

Phrase: "and"

Phrase: "Brice,"

Phrase: "A."
Processing 00000000.tx.299: (1998) Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Homozygous deletions in parkin gene"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   797   C0017260:Gene Deletions [Genetic Function]
   781 E C1442161:Gene Deletion [Cell or Molecular Dysfunction]
       E   Deletion
   760   C1880274:Deletions [Activity]
   726 E C1511760:Deletion [Genetic Function]

Phrase: "in European"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0239307:European [Population Group]
  1000   C1535514:European [Population Group]

Phrase: "and"

Phrase: "North African families with autosomal recessive juvenile parkinsonism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   765   C0752104:Familial Juvenile Parkinsonism [Disease or Syndrome]
   744   C0015576:Families [Family Group]
   744   C1704727:Family [Conceptual Entity]
Processing 00000000.tx.300: The European Consortium on Genetic Susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetics Study Group. 

Phrase: "The European Consortium on Genetic Susceptibility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1513822:Consortium [Professional or Occupational Group]
   753   C1880171:Consortium [Professional or Occupational Group]

Phrase: "in Parkinson's Disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "the French Parkinson's Disease Genetics Study Group."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   799   C0441833:Group [Idea or Concept]
   799   C0557651:Study [Manufactured Object]
   799   C0687744:group [Population Group]
   799   C1257890:Group [Population Group]
   799   C1552516:Group [Health Care Related Organization]
   799   C1705428:Group [Conceptual Entity]
   799   C1705429:Group [Population Group]
   799   C2603343:Study [Research Activity]
Processing 00000000.tx.301: Lancet, 352, 13551356.[CrossRef][ISI][Medline] Klein, C., Pramstaller, P.P., Kis, B., Page, C.C., Kann, M., Leung, J., Woodward, H., Castellan, C.C., Scherer, M., Vieregge, P. et al. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "352,"

Phrase: "13551356."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Klein,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pramstaller,"

Phrase: "P.P.,"

Phrase: "Kis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1540160:KIS [Gene or Genome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Page,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "C.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Kann,"

Phrase: "M."

Phrase: ","

Phrase: "Leung,"

Phrase: "J.,"

Phrase: "Woodward,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Castellan,"

Phrase: "C.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Scherer,"

Phrase: "M."

Phrase: ","

Phrase: "Vieregge,"

Phrase: "P. et al."
Processing 00000000.tx.302: (2000) Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Parkin deletions in a family"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C1880274:Deletions [Activity]
   726 E C1442161:Deletion [Cell or Molecular Dysfunction]
   726 E C1511760:Deletion [Genetic Function]

Phrase: "with adult-onset,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1836537:Adult onset [Finding]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "tremor-dominant parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: ":"

Phrase: "expanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:Expanding [Spatial Concept]

Phrase: "the phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.303: Ann. 

Phrase: "Ann."
Processing 00000000.tx.304: Neurol., 48, 6571.[CrossRef][ISI][Medline] Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Suda, K. and Mizuno, Y. 

Phrase: "Neurol.,"

Phrase: "48,"

Phrase: "6571."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mori,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kondo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yokochi,"

Phrase: "M."

Phrase: ","

Phrase: "Matsumine,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nakagawa-Hattori,"

Phrase: "Y.,"

Phrase: "Miyake,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Suda,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Mizuno,"

Phrase: "Y."
Processing 00000000.tx.305: (1998) Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Pathologic"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1521733:Pathologic [Functional Concept]
   928 E C0030664:Pathologies [Biomedical Occupation or Discipline]
   928 E C0205469:pathology [Functional Concept]
   928 E C0677042:pathology [Pathologic Function]

Phrase: "and"

Phrase: "biochemical studies of juvenile parkinsonism"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   797   C2699049:JUVENILE STUDIES [Regulation or Law]
   760   C0205474:Biochemical [Functional Concept]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "linked to chromosome 6q."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0008633:Chromosome [Cell Component]
   770   C1521554:6q [Nucleotide Sequence]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
Processing 00000000.tx.306: Neurology, 51, 890892.[Abstract] Hayashi, S., Wakabayashi, K., Ishikawa, A., Nagai, H., Saito, M., Maruyama, M., Takahashi, T., Ozawa, T., Tsuji, S. and Takahashi, H. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "51,"

Phrase: "890892."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hayashi,"

Phrase: "S."

Phrase: ","

Phrase: "Wakabayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ishikawa,"

Phrase: "A.,"

Phrase: "Nagai,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saito,"

Phrase: "M."

Phrase: ","

Phrase: "Maruyama,"

Phrase: "M."

Phrase: ","

Phrase: "Takahashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Ozawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tsuji,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.307: (2000) An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene. 

Phrase: "(2000"

Phrase: ")"

Phrase: "An autopsy case of autosomal-recessive juvenile parkinsonism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004398:Autopsy [Diagnostic Procedure]
   744   C0868928:Case [Functional Concept]
   744   C1706255:CASE [Medical Device]
   744   C1706256:Case [Conceptual Entity]

Phrase: "with a homozygous exon 4 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1442161:Deletion [Cell or Molecular Dysfunction]
   812   C1511760:Deletion [Genetic Function]
   812   C1880274:Deletion [Activity]

Phrase: "in the parkin gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1418270:parkin gene [Gene or Genome]
  1000   C2983548:Parkin Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.308: Mov. 

Phrase: "Mov."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825516:MOV [Quantitative Concept]
Processing 00000000.tx.309: Disord., 15, 884888.[CrossRef][ISI][Medline] van de Warrenburg, B.P., Lammens, M., Lcking, C.B., Denefle, P., Wesseling, P., Booij, J., Praamstra, P., Quinn, N., Brice, A. and Horstink, M.W. 

Phrase: "Disord.,"

Phrase: "15,"

Phrase: "884888."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] van de Warrenburg,"

Phrase: "B.P.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347469:/B [Quantitative Concept]

Phrase: "Lammens,"

Phrase: "M."

Phrase: ","

Phrase: "Lcking,"

Phrase: "C.B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Denefle,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wesseling,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Booij,"

Phrase: "J.,"

Phrase: "Praamstra,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Quinn,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Brice,"

Phrase: "A."

Phrase: "and"

Phrase: "Horstink,"

Phrase: "M."

Phrase: "W."
Processing 00000000.tx.310: (2001) Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "pathologic abnormalities in a family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: "with parkinsonism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242422:Parkinsonism [Disease or Syndrome]

Phrase: "and"

Phrase: "parkin gene mutations."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0596611:gene mutations [Genetic Function]
   901   C1418270:parkin gene [Gene or Genome]
   901   C2983548:Parkin Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.311: Neurology, 56, 555557.[Abstract/Free FullText] Schlossmacher, M.G., Frosch, M.P., Gai, W.P., Medina, M., Sharma, N., Forno, L., Ochiishi, T., Shimura, H., Sharon, R., Hattori, N. et al. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "56,"

Phrase: "555557."

Phrase: "[Abstract/Free FullText"

Phrase: "] Schlossmacher,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Frosch,"

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517505:GAI [Research Activity]

Phrase: "W.P.,"

Phrase: "Medina,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2767010:Medina [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Sharma,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Forno,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ochiishi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sharon,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hattori,"

Phrase: "N. et al."
Processing 00000000.tx.312: (2002) Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies Am. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "localizes to the Lewy bodies of Parkinson disease"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   812   C0030567:bodies disease lewy parkinson's [Disease or Syndrome]
           Parkinson Disease
   789   C0752347:bodies disease lewy [Disease or Syndrome]
   770   C0085200:Lewy Bodies [Cell Component]
   770   C1521736:Parkinson's Disease [Functional Concept]
   770   C2681933:PARKINSON DISEASE [Gene or Genome]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0242821:bodies [Human]
   744   C0392752:localize [Spatial Concept]
   744   C1995017:Bodies [Cell Component]
   711 E C0460148:Body [Anatomical Structure]
   711 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "dementia with Lewy bodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]

Phrase: "Am."
Processing 00000000.tx.313: J. 

Phrase: "J."
Processing 00000000.tx.314: Pathol., 160, 16551667.[Abstract/Free FullText] Joazeiro, C.A. and Weissman, A.M. 

Phrase: "Pathol.,"

Phrase: "160,"

Phrase: "16551667."

Phrase: "[Abstract/Free FullText"

Phrase: "] Joazeiro,"

Phrase: "C."

Phrase: "A."

Phrase: "and"

Phrase: "Weissman,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.315: (2000) RING finger proteins: mediators of ubiquitin ligase activity. 

Phrase: "(2000"

Phrase: ")"

Phrase: "RING finger proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C1313794:RING Finger Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0230398:Finger, ring [Body Part, Organ, or Organ Component]
   734   C1521759:Ring Finger [Cell Component]

Phrase: ":"

Phrase: "mediators of ubiquitin ligase activity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   726 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.316: Cell, 102, 549552.[ISI][Medline] Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K. et al. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "102,"

Phrase: "549552."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kubo,"

Phrase: "S."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Asakawa,"

Phrase: "S."

Phrase: ","

Phrase: "Minoshima,"

Phrase: "S."

Phrase: ","

Phrase: "Shimizu,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Iwai,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Chiba,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tanaka,"

Phrase: "K. et al."
Processing 00000000.tx.317: (2000) Familial Parkinson disease gene product, parkin, is a ubiquitinprotein ligase. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Familial Parkinson disease gene product,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1416989:MAL gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]

Phrase: "parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a ubiquitinprotein ligase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.318: Nat. 

Phrase: "Nat."
Processing 00000000.tx.319: Genet, 25, 302305.[CrossRef][ISI][Medline] Imai, Y., Soda, M. and Takahashi, R. 

Phrase: "Genet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "25,"

Phrase: "302305."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.320: (2000) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitinprotein ligase activity. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "unfolded protein stress-induced cell death through its E3 ubiquitinprotein ligase activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0007587:Cell Death [Cell Function]
   736   C0007634:Cell [Cell]
   736   C0011065:Death [Organism Function]
   736   C1269647:Cell [Cell]
   736   C1306577:Death, NOS [Finding]
   736   C1704653:Cell [Medical Device]
   736   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.321: J. 

Phrase: "J."
Processing 00000000.tx.322: Biol. 

Phrase: "Biol."
Processing 00000000.tx.323: Chem., 275, 3566135664.[Abstract/Free FullText] Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. and Dawson, T.M. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "275,"

Phrase: "3566135664."

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhang,"

Phrase: "Y.,"

Phrase: "Gao,"

Phrase: "J.,"

Phrase: "Chung,"

Phrase: "K.K.,"

Phrase: "Huang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.324: (2000) Parkin functions as an E2-dependent ubiquitinprotein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "functions as an E2-dependent ubiquitinprotein ligase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C1705273:Function [Intellectual Product]
   748   C3244310:dependent [Functional Concept]
   748   C3539520:E2 [Gene or Genome]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the degradation of the synaptic vesicle-associated protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0597297:Protein Degradation [Molecular Function]
   767   C0597304:Protein Degradation [Molecular Function]
   767   C1623036:Protein Degradation [Molecular Function]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "CDCrel-1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3273594:CDCREL-1 [Gene or Genome]
           CDCREL
  1000   C3273595:CDCrel-1 [Amino Acid, Peptide, or Protein]
   861   C1539748:CDCREL [Gene or Genome]
Processing 00000000.tx.325: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.326: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.327: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.328: USA, 97, 1335413359.[Abstract/Free FullText] Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y. and Takahashi, R. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "1335413359."

Phrase: "[Abstract/Free FullText"

Phrase: "] Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."

Phrase: ","

Phrase: "Inoue,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mizuno,"

Phrase: "Y."

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.329: (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. 

Phrase: "(2001"

Phrase: ")"

Phrase: "An unfolded putative transmembrane polypeptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "can"

Phrase: "lead to endoplasmic reticulum stress,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   806   C0014239:Endoplasmic Reticulum [Cell Component]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   760   C0038435:Stress [Finding]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "a substrate of Parkin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.330: Cell, 105, 891902.[CrossRef][ISI][Medline] Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. and Dawson, T.M. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "105,"

Phrase: "891902."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chung,"

Phrase: "K.K.,"

Phrase: "Zhang,"

Phrase: "Y.,"

Phrase: "Lim,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449205:LIM [Body Location or Region]
  1000   C1538613:LIM [Gene or Genome]

Phrase: "K.L., Tanaka,"

Phrase: "Y.,"

Phrase: "Huang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gao,"

Phrase: "J.,"

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.331: (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "ubiquitinates"

Phrase: "the alpha-synuclein-interacting protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3541909:Alpha-Synuclein-Interacting Protein [Amino Acid, Peptide, or Protein]
   902   C1158819:alpha protein [Genetic Function]
   902   C2362546:Alpha protein [Amino Acid, Peptide, or Protein]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "implications for Lewy-body formation"

Phrase: "in Parkinson disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.332: Nat. 

Phrase: "Nat."
Processing 00000000.tx.333: Med., 7, 11441150.[CrossRef][ISI][Medline] Shimura, H., Schlossmacher, M.G., Hattori, N., Frosch, M.P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K.S. and Selkoe, D.J. 

Phrase: "Med.,"

Phrase: "7,"

Phrase: "11441150."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Shimura,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schlossmacher,"

Phrase: "M."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Frosch,"

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Trockenbacher,"

Phrase: "A.,"

Phrase: "Schneider,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Kosik,"

Phrase: "K.S."

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.334: (2001) Ubiquitylation of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Ubiquitylation of a new form of alpha-synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1519751:Ubiquitylation [Molecular Function]

Phrase: "by parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "from human brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "implications for Parkinson's disease."
Processing 00000000.tx.335: Science, 293, 263269.[Abstract/Free FullText] Staropoli, J.F., McDermott, C., Martinat, C., Schulman, B., Demireva, E. and Abeliovich, A. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "293,"

Phrase: "263269."

Phrase: "[Abstract/Free FullText"

Phrase: "] Staropoli,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "McDermott,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Martinat,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Schulman,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Demireva,"

Phrase: "E."

Phrase: "and"

Phrase: "Abeliovich,"

Phrase: "A."
Processing 00000000.tx.336: (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "a component of an SCF-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "like ubiquitin ligase complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1167313:ubiquitin ligase complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "protects"

Phrase: "postmitotic neurons from kainate excitotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]
Processing 00000000.tx.337: Neuron, 37, 735749.[ISI][Medline] Quevillon, S., Robinson, J.C., Berthonneau, E., Siatecka, M. and Mirande, M. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "37,"

Phrase: "735749."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Quevillon,"

Phrase: "S."

Phrase: ","

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "J.C., Berthonneau,"

Phrase: "E.,"

Phrase: "Siatecka,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Mirande,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.338: (1999) Macromolecular assemblage of aminoacyl-tRNA synthetases: identification of proteinprotein interactions and characterization of a core protein. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Macromolecular assemblage of aminoacyl-tRNA synthetases"

Phrase: ":"

Phrase: "identification of proteinprotein interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020792:Identification [Mental Process]
   770   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "characterization of a core protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]
Processing 00000000.tx.339: J. 

Phrase: "J."
Processing 00000000.tx.340: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.341: Biol., 285, 183195.[CrossRef][ISI][Medline] Robinson, J.C., Kerjan, P. and Mirande, M. 

Phrase: "Biol.,"

Phrase: "285,"

Phrase: "183195."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "J.C., Kerjan,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Mirande,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.342: (2000) Macromolecular assemblage of aminoacyl-tRNA synthetases: quantitative analysis of proteinprotein interactions and mechanism of complex assembly. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Macromolecular assemblage of aminoacyl-tRNA synthetases"

Phrase: ":"

Phrase: "quantitative analysis of proteinprotein interactions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C0237688:Interaction Analysis [Quantitative Concept]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "mechanism of complex assembly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.343: J. 

Phrase: "J."
Processing 00000000.tx.344: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.345: Biol., 304, 983994.[CrossRef][ISI][Medline] Nicolaides, N.C., Kinzler, K.W. and Vogelstein, B. 

Phrase: "Biol.,"

Phrase: "304,"

Phrase: "983994."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nicolaides,"

Phrase: "N.C.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2349138:N/C [Quantitative Concept]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "Kinzler,"

Phrase: "K.W."

Phrase: "and"

Phrase: "Vogelstein,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.346: (1995) Analysis of the 5' region of PMS2 reveals heterogeneous transcripts and a novel overlapping gene. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Analysis of the 5' region of PMS2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "heterogeneous transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "a novel overlapping gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0017359:Overlapping gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.347: Genomics, 29, 329334.[CrossRef][ISI][Medline] Meng, L., Mohan, R., Kwok, B.H., Elofsson, M., Sin, N. and Crews, C.M. 

Phrase: "Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "29,"

Phrase: "329334."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Meng,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Mohan,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kwok,"

Phrase: "B.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Elofsson,"

Phrase: "M."

Phrase: ","

Phrase: "Sin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0815304:sin [Idea or Concept]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Crews,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.348: (1999) Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Epoxomicin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "a potent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "selective proteasome inhibitor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   901   C2266856:Proteasome Inhibitor [Molecular Function]
   901   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325620:proteasome [Cell Component]
   827   C1752727:Proteasome [Molecular Function]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "in vivo antiinflammatory activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.349: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.350: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.351: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.352: USA, 96, 1040310408.[Abstract/Free FullText] Johnston, J.A., Ward, C.L. and Kopito, R.R. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "96,"

Phrase: "1040310408."

Phrase: "[Abstract/Free FullText"

Phrase: "] Johnston,"

Phrase: "J."

Phrase: "A.,"

Phrase: "Ward,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1305702:Ward [Health Care Related Organization,Manufactured Object]
  1000   C1547134:Ward [Idea or Concept]
  1000   C2355574:Ward [Population Group]

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Kopito,"

Phrase: "R.R."
Processing 00000000.tx.353: (1998) Aggresomes: a cellular response to misfolded proteins. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Aggresomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1167059:aggresome [Cell Component]

Phrase: ":"

Phrase: "a cellular response to misfolded proteins."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   931   C2754420:cellular response to misfolded protein [Cell Function]
   874   C1656420:response to misfolded protein [Physiologic Function]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.354: J. 

Phrase: "J."
Processing 00000000.tx.355: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.356: Biol., 143, 18831898.[Abstract/Free FullText] Kopito, R.R. 

Phrase: "Biol.,"

Phrase: "143,"

Phrase: "18831898."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kopito,"

Phrase: "R.R."
Processing 00000000.tx.357: (2000) Aggresomes, inclusion bodies and protein aggregation. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Aggresomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1167059:aggresome [Cell Component]

Phrase: "inclusion bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0007637:Inclusion Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1512693:Inclusion [Qualitative Concept]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "protein aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332621:Aggregation [Functional Concept]
   861   C0439168:% aggregation [Quantitative Concept]
   789 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.358: Trends Cell. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.359: Biol., 10, 524530.[CrossRef][ISI][Medline] Walters, K.J., Kleijnen, M.F., Goh, A.M., Wagner, G. and Howley, P.M. 

Phrase: "Biol.,"

Phrase: "10,"

Phrase: "524530."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Walters,"

Phrase: "K.J.,"

Phrase: "Kleijnen,"

Phrase: "M."

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Goh,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wagner,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Howley,"

Phrase: "P.M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.360: (2002) Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Structural studies of the interaction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0678594:Structural [Spatial Concept]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "between ubiquitin family proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "proteasome subunit S5a."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1419034:S5A [Gene or Genome]
Processing 00000000.tx.361: Biochemistry, 41, 17671777.[CrossRef][ISI][Medline] Elsasser, S., Gali, R.R., Schwickart, M., Larsen, C.N., Leggett, D.S., Muller, B., Feng, M.T., Tubing, F., Dittmar, G.A. and Finley, D. 

Phrase: "Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "41,"

Phrase: "17671777."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Elsasser,"

Phrase: "S."

Phrase: ","

Phrase: "Gali,"

Phrase: "R.R.,"

Phrase: "Schwickart,"

Phrase: "M."

Phrase: ","

Phrase: "Larsen,"

Phrase: "C.N., Leggett,"

Phrase: "D.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Muller,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Feng,"

Phrase: "M.T.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tubing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184165:tubing [Medical Device]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Dittmar,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A."

Phrase: "and"

Phrase: "Finley,"

Phrase: "D."
Processing 00000000.tx.362: (2002) Proteasome subunit Rpn1 binds ubiquitin-like protein domains. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Proteasome subunit Rpn1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0140512:RPN1 [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   827   C1419032:Rpn1 [Gene or Genome]
   827   C1419697:RPN1 [Gene or Genome]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "ubiquitin-like protein domains."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0162808:Protein Domains [Spatial Concept]
   844 E C1514562:Protein Domain [Amino Acid Sequence]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.363: Nat. 

Phrase: "Nat."
Processing 00000000.tx.364: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.365: Biol., 4, 725730.[CrossRef][ISI][Medline] Hyun, D.H., Lee, M., Hattori, N., Kubo, S., Mizuno, Y., Halliwell, B. and Jenner, P. 

Phrase: "Biol.,"

Phrase: "4,"

Phrase: "725730."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hyun,"

Phrase: "D."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Hattori,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kubo,"

Phrase: "S."

Phrase: ","

Phrase: "Mizuno,"

Phrase: "Y.,"

Phrase: "Halliwell,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Jenner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.366: (2002) Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Effect of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "mutant Parkin on oxidative damage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1418270:PARKIN [Gene or Genome]
   760   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "nitric oxide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "antioxidant defenses,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003402:Antioxidant [Pharmacologic Substance]
   861   C1880266:Defense [Conceptual Entity]

Phrase: "and"

Phrase: "the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.367: J. 

Phrase: "J."
Processing 00000000.tx.368: Biol. 

Phrase: "Biol."
Processing 00000000.tx.369: Chem., 277, 2857228577.[Abstract/Free FullText] Rankin, C.A., Joazeiro, C.A., Floor, E. and Hunter, T. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "277,"

Phrase: "2857228577."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rankin,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Joazeiro,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Floor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016249:Floor [Manufactured Object]
  1000   C1547707:Floor [Geographic Area]

Phrase: "E."

Phrase: "and"

Phrase: "Hunter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.370: (2001) E3 ubiquitinprotein ligase activity of Parkin is dependent on cooperative interaction of RING finger (TRIAD) elements. 

Phrase: "(2001"

Phrase: ")"

Phrase: "E3 ubiquitinprotein ligase activity of Parkin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1150651:ligase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "dependent on cooperative interaction of RING finger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "(TRIAD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0076994:triad [Biomedical or Dental Material,Organic Chemical]
  1000   C1179122:triad [Cell Component]

Phrase: ")"

Phrase: "elements."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013879:Elements [Element, Ion, or Isotope]
   966 E C1705248:Element [Conceptual Entity]
Processing 00000000.tx.371: J. 

Phrase: "J."
Processing 00000000.tx.372: Biomed. 

Phrase: "Biomed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332030:Biomed [Health Care Related Organization]
Processing 00000000.tx.373: Sci., 8, 421429.[CrossRef][ISI][Medline] Imai, Y., Soda, M., Hatakeyama, S., Akagi, T., Hashikawa, T., Nakayama, K.I. and Takahashi, R. 

Phrase: "Sci.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]

Phrase: "8,"

Phrase: "421429."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Imai,"

Phrase: "Y.,"

Phrase: "Soda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683086:soda [Food]

Phrase: "M."

Phrase: ","

Phrase: "Hatakeyama,"

Phrase: "S."

Phrase: ","

Phrase: "Akagi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hashikawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakayama,"

Phrase: "K.I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.374: (2002) CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. 

Phrase: "(2002"

Phrase: ")"

Phrase: "CHIP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600596:Chip [Research Device]

Phrase: "is"

Phrase: "associated with Parkin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1418270:PARKIN [Gene or Genome]
   790   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "responsible for familial Parkinson's disease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "its ubiquitin ligase activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150685:ubiquitin-ligase activity [Molecular Function]
   913   C1325411:ubiquitin activity [Molecular Function]
   901   C1150651:ligase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.375: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.376: Cell, 10, 5567.[ISI][Medline] Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C.A. and Takahashi, H. 

Phrase: "Cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "10,"

Phrase: "5567."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wakabayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Engelender,"

Phrase: "S."

Phrase: ","

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Tsuji,"

Phrase: "S."

Phrase: ","

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "C."

Phrase: "A."

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.377: (2000) Synphilin-1 is present in Lewy bodies in Parkinson's disease. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Synphilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420277:SYNPHILIN 1 [Gene or Genome]
           synphilin
  1000   C3541909:Synphilin-1 [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "present in Lewy bodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.378: Ann. 

Phrase: "Ann."
Processing 00000000.tx.379: Neurol., 47, 13.[CrossRef][ISI] Tompkins, M.M. and Hill, W.D. 

Phrase: "Neurol.,"

Phrase: "47,"

Phrase: "13."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI] Tompkins,"

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Hill,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442532:Hill [Spatial Concept]

Phrase: "W.D."
Processing 00000000.tx.380: (1997) Contribution of somal Lewy bodies to neuronal death. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Contribution of somal Lewy bodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "to neuronal death."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C2754100:neuron death [Cell Function]
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]
Processing 00000000.tx.381: Brain Res., 775, 2429.[CrossRef][ISI][Medline] Mirande, M. 

Phrase: "Brain Res.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]

Phrase: "775,"

Phrase: "2429."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mirande,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.382: (1991) Aminoacyl-tRNA synthetase family from prokaryotes and eukaryotes: structural domains and their implications. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Aminoacyl-tRNA synthetase family from prokaryotes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015576:Family [Family Group]
   753   C1704727:Family [Conceptual Entity]

Phrase: "and"

Phrase: "eukaryotes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0684063:Eukaryotes [Eukaryote]
   966 E C0015161:eukaryote [Cell]

Phrase: ":"

Phrase: "structural domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "their implications."
Processing 00000000.tx.383: Prog. 

Phrase: "Prog."
Processing 00000000.tx.384: Nucl. 

Phrase: "Nucl."
Processing 00000000.tx.385: Acid Res. 

Phrase: "Acid Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.386: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.387: Biol., 40, 95142.[ISI][Medline] Kisselev, L.L. and Wolfson, A.D. 

Phrase: "Biol.,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "95142."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kisselev,"

Phrase: "L.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539687:L/L [Quantitative Concept]

Phrase: "and"

Phrase: "Wolfson,"

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.388: (1994) AminoacyltRNA synthetases from higher eucaryotes. 

Phrase: "(1994"

Phrase: ")"

Phrase: "AminoacyltRNA synthetases from higher eucaryotes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0023689:Synthetases [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.389: Prog. 

Phrase: "Prog."
Processing 00000000.tx.390: Nucl. 

Phrase: "Nucl."
Processing 00000000.tx.391: Acid Res. 

Phrase: "Acid Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.392: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.393: Biol., 48, 83142.[ISI][Medline] Kim, J.Y., Kang, Y.S., Lee, J.W., Kim, H.J., Ahn, Y.H., Park, H., Ko, Y.G. and Kim, S. 

Phrase: "Biol.,"

Phrase: "48,"

Phrase: "83142."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kim,"

Phrase: "J.Y.,"

Phrase: "Kang,"

Phrase: "Y.S.,"

Phrase: "Lee,"

Phrase: "J.W., Kim,"

Phrase: "H.J.,"

Phrase: "Ahn,"

Phrase: "Y.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ko,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416746:KO [Gene or Genome]
  1000   C1862225:Ko [Body System]

Phrase: "Y.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Kim,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.394: (2002) p38 is essential for the assembly and stability of macromolecular tRNA synthetase complex: implications for its physiological significance. 

Phrase: "(2002"

Phrase: ")"

Phrase: "p38"

Phrase: "is"

Phrase: "essential for the assembly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "and"

Phrase: "stability of macromolecular tRNA synthetase complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205360:Stability [Qualitative Concept]
   753   C2347098:Stability [Qualitative Concept]

Phrase: ":"

Phrase: "implications for its physiological significance."
Processing 00000000.tx.395: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.396: Natl Acad. 

Phrase: "Natl Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268596:ACAD [Disease or Syndrome]
   861   C2700624:ACAD [Cell Function]
Processing 00000000.tx.397: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.398: USA, 99, 79127916.[Abstract/Free FullText] Ivanov, K.A., Moor, N.A. and Lavrik, O.I. 

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "99,"

Phrase: "79127916."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ivanov,"

Phrase: "K.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Moor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555202:Moor [Population Group]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "A."

Phrase: "and"

Phrase: "Lavrik,"

Phrase: "O.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.399: (2000) Non-canonical functions of aminoacyltRNA synthetases. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Non-canonical functions of aminoacyltRNA synthetases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0542341:Functions [Functional Concept]
   742   C0205300:Non-functional [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.400: Biochemistry (Mosc.), 65, 888897.[Medline] Ko, Y.G., Kim, E.Y., Kim, T., Park, H., Park, H.S., Choi, E.J. and Kim, S. 

Phrase: "Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "(Mosc."

Phrase: ")"

Phrase: ","

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "888897."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ko,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416746:KO [Gene or Genome]
  1000   C1862225:Ko [Body System]

Phrase: "Y.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Kim,"

Phrase: "E.Y.,"

Phrase: "Kim,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "H.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Choi,"

Phrase: "E.J."

Phrase: "and"

Phrase: "Kim,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.401: (2001) Glutamine-dependent antiapoptotic interaction of human glutaminyltRNA synthetase with apoptosis signal-regulating kinase 1. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Glutamine-dependent antiapoptotic interaction of human glutaminyltRNA synthetase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1704675:Interaction [Functional Concept]

Phrase: "with apoptosis signal-regulating kinase 1."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0532128:Apoptosis Signal-Regulating Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417014:APOPTOSIS SIGNAL-REGULATING KINASE 1 [Gene or Genome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0162638:Apoptosis [Cell Function]
   804   C1710082:Signal [Phenomenon or Process]
   733 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.402: J. 

Phrase: "J."
Processing 00000000.tx.403: Biol. 

Phrase: "Biol."
Processing 00000000.tx.404: Chem., 276, 60306036.[Abstract/Free FullText] Wakasugi, K. and Schimmel, P. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "276,"

Phrase: "60306036."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wakasugi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Schimmel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.405: (1999) Highly differentiated motifs responsible for two cytokine activities of a split human tRNA synthetase. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Highly differentiated motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1514562:Motif [Amino Acid Sequence]

Phrase: "responsible for two cytokine activities of a split human tRNA synthetase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1273518:Responsible [Finding]
Processing 00000000.tx.406: J. 

Phrase: "J."
Processing 00000000.tx.407: Biol. 

Phrase: "Biol."
Processing 00000000.tx.408: Chem., 274, 2315513159.[Abstract/Free FullText] Wakasugi, K. and Schimmel, P. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "274,"

Phrase: "2315513159."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wakasugi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Schimmel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.409: (1999) Two distinct cytokines released from a human aminoacyl-tRNA synthetase. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Two distinct cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "released from a human aminoacyl-tRNA synthetase."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   814   C0002529:Aminoacyl-tRNA Synthetase [Amino Acid, Peptide, or Protein,Enzyme]
           tRNA Synthetase
   778   C0035714:Amino Acyl T RNA [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0023689:Synthetase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0035711:tRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0086418:Human [Human]
   748   C0391871:Released [Functional Concept]
   748   C1283071:Released [Functional Concept]
   748   C1537998:trnA [Gene or Genome]
   714 E C0030685:Release [Health Care Activity]
   714 E C0439180:% release [Quantitative Concept]
   714 E C0680255:release [Health Care Activity]
   714 E C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.410: Science, 284, 147151.[Abstract/Free FullText] Kao, J., Ryan, J., Brett, G., Chen, J., Shen, H., Fan, Y.G., Godman, G., Familletti, P.C., Wang, F., Pan, Y.C. et al. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "284,"

Phrase: "147151."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kao,"

Phrase: "J.,"

Phrase: "Ryan,"

Phrase: "J.,"

Phrase: "Brett,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "J.,"

Phrase: "Shen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fan,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441039:Fan [Manufactured Object]
  1000   C1705854:Fan [Manufactured Object]
  1000   C3540815:FAN [Gene or Genome]

Phrase: "Y.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Godman,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Familletti,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Wang,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Pan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085999:Pan [Mammal]

Phrase: "Y.C. et al."
Processing 00000000.tx.411: (1992) Endothelial monocyte-activating polypeptide II. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Endothelial monocyte-activating polypeptide II."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0173372:endothelial monocyte-activating polypeptide II [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1419881:ENDOTHELIAL MONOCYTE-ACTIVATING POLYPEPTIDE 2 [Gene or Genome]
   804   C0014257:Endothelial [Tissue]
   804   C0026473:Monocyte [Cell]
   804   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   804   C1879547:activating [Activity]
   771 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.412: A novel tumor-derived polypeptide that activates host-response mechanisms. 

Phrase: "A novel tumor-derived polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "host-response mechanisms."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]
   734   C0301872:Host response [Organ or Tissue Function]
Processing 00000000.tx.413: J. 

Phrase: "J."
Processing 00000000.tx.414: Biol. 

Phrase: "Biol."
Processing 00000000.tx.415: Chem., 267, 2023920247.[Abstract/Free FullText] Quevillon, S., Agou, F., Robinson, J.C. and Mirande, M. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "267,"

Phrase: "2023920247."

Phrase: "[Abstract/Free FullText"

Phrase: "] Quevillon,"

Phrase: "S."

Phrase: ","

Phrase: "Agou,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Robinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443050:Robinson [Intellectual Product]

Phrase: "J.C."

Phrase: "and"

Phrase: "Mirande,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.416: (1997) The p43 component of the mammalian multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine. 

Phrase: "(1997"

Phrase: ")"

Phrase: "The p43 component of the mammalian multi-synthetase complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449432:Component [Manufactured Object]
   742   C1705248:Component [Conceptual Entity]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "the precursor of the endothelial monocyte-activating polypeptide II cytokine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.417: J. 

Phrase: "J."
Processing 00000000.tx.418: Biol. 

Phrase: "Biol."
Processing 00000000.tx.419: Chem., 272, 3257332579.[Abstract/Free FullText] Park, S.G., Jung, K.H., Lee, J.S., Jo, Y.J., Motegi, H., Kim, S. and Shiba, K. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "272,"

Phrase: "3257332579."

Phrase: "[Abstract/Free FullText"

Phrase: "] Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "S.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Jung,"

Phrase: "K.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lee,"

Phrase: "J.S.,"

Phrase: "Jo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022418:JO [Geographic Area]

Phrase: "Y.J.,"

Phrase: "Motegi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kim,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Shiba,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1632313:shiba [Plant]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.420: (1999) Precursor of pro-apoptotic cytokine modulates aminoacylation activity of tRNA synthetase. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Precursor of pro-apoptotic cytokine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709634:Precursor [Idea or Concept]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "aminoacylation activity of tRNA synthetase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1150651:synthetase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.421: J. 

Phrase: "J."
Processing 00000000.tx.422: Biol. 

Phrase: "Biol."
Processing 00000000.tx.423: Chem., 274, 1667316676.[Abstract/Free FullText] Shalak, V., Kaminska, M., Mitnacht-Kraus, R., Vandenabeele, P., Clauss, M. and Mirande, M. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "274,"

Phrase: "1667316676."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shalak,"

Phrase: "V.,"

Phrase: "Kaminska,"

Phrase: "M."

Phrase: ","

Phrase: "Mitnacht-Kraus,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vandenabeele,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Clauss,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Mirande,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.424: (2001) The EMAPII cytokine is released from the mammalian multisynthetase complex after cleavage of its p43/proEMAPII component. 

Phrase: "(2001"

Phrase: ")"

Phrase: "The EMAPII cytokine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "released from the mammalian multisynthetase complex"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   790   C1167421:multisynthetase complex [Cell Component]
   753   C0024660:Mammalian [Mammal]
   753   C0391871:Released [Functional Concept]
   753   C0439855:Complex [Qualitative Concept]
   753   C1283071:Released [Functional Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]
   719 E C0030685:Release [Health Care Activity]
   719 E C0439180:% release [Quantitative Concept]
   719 E C0680255:release [Health Care Activity]
   719 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "after cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "of its p43/proEMAPII component."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.425: J. 

Phrase: "J."
Processing 00000000.tx.426: Biol. 

Phrase: "Biol."
Processing 00000000.tx.427: Chem., 276, 2376923776.[Abstract/Free FullText] Ko, Y.G., Park, H., Kim, T., Lee, J.W., Park, S.G., Seol, W., Kim, J.E., Lee, W.H., Kim, S.H., Park, J.E. and Kim, S. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "276,"

Phrase: "2376923776."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ko,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416746:KO [Gene or Genome]
  1000   C1862225:Ko [Body System]

Phrase: "Y.G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kim,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lee,"

Phrase: "J.W., Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0562547:Park [Manufactured Object]
   827   C3160718:PARK [Disease or Syndrome]

Phrase: "S.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439267:g% [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Seol,"

Phrase: "W.,"

Phrase: "Kim,"

Phrase: "J.E.,"

Phrase: "Lee,"

Phrase: "W.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kim,"

Phrase: "S."

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "J.E."

Phrase: "and"

Phrase: "Kim,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.428: (2001) A cofactor of tRNA synthetase, p43, is secreted to up-regulate proinflammatory genes. 

Phrase: "(2001"

Phrase: ")"

Phrase: "A cofactor of tRNA synthetase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0178555:Cofactor [Biologically Active Substance]

Phrase: "p43,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419881:p43 [Gene or Genome]

Phrase: "is"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "up-regulate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "proinflammatory genes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.429: J. 

Phrase: "J."
Processing 00000000.tx.430: Biol. 

Phrase: "Biol."
Processing 00000000.tx.431: Chem., 276, 2302823033.[Abstract/Free FullText] Brabeck, C., Michetti, F., Geloso, M.C., Corvino, V., Goezalan, F., Meyermann, R. and Schluesener, H.J. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "276,"

Phrase: "2302823033."

Phrase: "[Abstract/Free FullText"

Phrase: "] Brabeck,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Michetti,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Geloso,"

Phrase: "M.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Corvino,"

Phrase: "V.,"

Phrase: "Goezalan,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Meyermann,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Schluesener,"

Phrase: "H.J."
Processing 00000000.tx.432: (2002) Expression of EMAP-II by activated monocytes/microglial cells in different regions of the rat hippocampus after trimethyltin-induced brain damage. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Expression of EMAP-II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by activated monocytes/microglial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   912   C0001280:Activated microglial cell [Cell]
   844   C0206116:Microglial cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "in different regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   777 E C0205276:Regional [Spatial Concept]
   777 E C1947913:Regional [Spatial Concept]

Phrase: "of the rat hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "after trimethyltin-induced brain damage."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0270611:Brain damage [Injury or Poisoning]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0010957:Damage [Injury or Poisoning]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1883709:Damage [Functional Concept]
Processing 00000000.tx.433: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.434: Neurol., 177, 341346.[CrossRef][ISI][Medline] Popenko, V.I., Ivanova, J.L., Cherny, N.E., Filonenko, V., Beresten, S.F., Wolfson, A.D. and Kisselev, L.L. 

Phrase: "Neurol.,"

Phrase: "177,"

Phrase: "341346."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Popenko,"

Phrase: "V.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ivanova,"

Phrase: "J.L., Cherny,"

Phrase: "N.E.,"

Phrase: "Filonenko,"

Phrase: "V.,"

Phrase: "Beresten,"

Phrase: "S.F.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Wolfson,"

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "Kisselev,"

Phrase: "L.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539687:L/L [Quantitative Concept]
Processing 00000000.tx.435: (1994) Compartmentalization of certain components of the protein synthesis apparatus in mammalian cells. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Compartmentalization of certain components of the protein synthesis apparatus"

Phrase: "in mammalian cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.436: Eur. 

Phrase: "Eur."
Processing 00000000.tx.437: J. 

Phrase: "J."
Processing 00000000.tx.438: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.439: Biol., 65, 6069.[ISI][Medline] Hovland, R., Hesketh, J.E. and Pryme, I.F. 

Phrase: "Biol.,"

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "6069."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hovland,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hesketh,"

Phrase: "J.E."

Phrase: "and"

Phrase: "Pryme,"

Phrase: "I.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.440: (1996) The compartmentalization of protein synthesis: importance of cytoskeleton and role in mRNA targeting. 

Phrase: "(1996"

Phrase: ")"

Phrase: "The compartmentalization of protein synthesis"

Phrase: ":"

Phrase: "importance of cytoskeleton"

Phrase: "and"

Phrase: "role in mRNA targeting."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.441: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.442: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.443: Biol., 28, 10891105.[CrossRef] McNaught, K.S. and Jenner, P. 

Phrase: "Biol.,"

Phrase: "28,"

Phrase: "10891105."

Phrase: "[CrossRef"

Phrase: "] McNaught,"

Phrase: "K.S."

Phrase: "and"

Phrase: "Jenner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.444: (2001) Proteasomal function is impaired in substantia nigra in Parkinson's disease. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Proteasomal function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "impaired in substantia nigra"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   833   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   770   C0221099:Impaired [Functional Concept]
   770   C0684336:Impaired [Pathologic Function]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.445: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.446: Lett., 297, 191194.[CrossRef][ISI][Medline] McNaught, K.S., Belizaire, R., Jenner, P., Olanow, C.W., Isacson, O. 

Phrase: "Lett.,"

Phrase: "297,"

Phrase: "191194."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McNaught,"

Phrase: "K.S.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Belizaire,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Jenner,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Olanow,"

Phrase: "C.W., Isacson,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.447: (2002) Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Selective loss of 20S proteasome alpha-subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1517945:Loss [Quantitative Concept]

Phrase: "in the substantia nigra pars compacta"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0175412:Substantia nigra pars compacta [Body Part, Organ, or Organ Component]
           Pars compacta
   902   C0222661:Substantia compacta [Tissue]
   861   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   861   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   812   C0032405:PARS [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1414437:PARS [Gene or Genome]
   812   C3283876:Compacta [Eukaryote]
   779 E C1417826:PAR [Gene or Genome]
   779 E C1514229:PAR [Quantitative Concept]
   779 E C1705885:PAR [Gene or Genome]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.448: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.449: Lett., 326, 155158.[CrossRef][ISI][Medline] Chung, K.K., Dawson, V.L. and Dawson, T.M. 

Phrase: "Lett.,"

Phrase: "326,"

Phrase: "155158."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chung,"

Phrase: "K.K.,"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V.L."

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.450: (2001) The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders. 

Phrase: "(2001"

Phrase: ")"

Phrase: "The role of the ubiquitin-proteasomal pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "other neurodegenerative disorders."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]
Processing 00000000.tx.451: Trends Neurosci., 24, S7S14.[CrossRef][ISI][Medline] Gu, W.J., Abbas, N., Lagunes, M.Z., Parent, A., Pradier, L., Bohme, G.A., Agid, Y., Hirsch, E.C., Raisman-Vozari, R. and Brice, A. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci.,"

Phrase: "24,"

Phrase: "S7S14."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gu,"

Phrase: "W.J.,"

Phrase: "Abbas,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Lagunes,"

Phrase: "M."

Phrase: "Z.,"

Phrase: "Parent,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030551:parent [Family Group]
  1000   C2699423:Parent [Conceptual Entity]

Phrase: "A.,"

Phrase: "Pradier,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Bohme,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A.,"

Phrase: "Agid,"

Phrase: "Y.,"

Phrase: "Hirsch,"

Phrase: "E.C.,"

Phrase: "Raisman-Vozari,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Brice,"

Phrase: "A."
Processing 00000000.tx.452: (2000) Cloning of rat parkin cDNA and distribution of parkin in rat brain. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Cloning of rat parkin cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "distribution of parkin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520511:distribution [Idea or Concept]
   790   C1704711:Distribution [Functional Concept]

Phrase: "in rat brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.453: J. 

Phrase: "J."
Processing 00000000.tx.454: Neurochem., 74, 17731776.[CrossRef][ISI][Medline] Zarate-Lagunes, M., Gu, W.J., Blanchard, V., Francois, C., Muriel, M.P., Mouatt-Prigent, A., Bonici, B., Parent, A., Hartmann, A., Yelnik, J. et al. 

Phrase: "Neurochem.,"

Phrase: "74,"

Phrase: "17731776."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zarate-Lagunes,"

Phrase: "M."

Phrase: ","

Phrase: "Gu,"

Phrase: "W.J.,"

Phrase: "Blanchard,"

Phrase: "V.,"

Phrase: "Francois,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Muriel,"

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Mouatt-Prigent,"

Phrase: "A.,"

Phrase: "Bonici,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Parent,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030551:parent [Family Group]
  1000   C2699423:Parent [Conceptual Entity]

Phrase: "A.,"

Phrase: "Hartmann,"

Phrase: "A.,"

Phrase: "Yelnik,"

Phrase: "J. et al."
Processing 00000000.tx.455: (2001) Parkin immunoreactivity in the brain of human and non-human primates: an immunohistochemical analysis in normal conditions and in Parkinsonian syndromes. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Parkin immunoreactivity in the brain of human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "non-human primates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0033147:Primates [Mammal]
   827   C0086418:Human [Human]
   827   C1518422:Non [Functional Concept]

Phrase: ":"

Phrase: "an immunohistochemical analysis in normal conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1441616:Immunohistochemical [Laboratory Procedure]
   753   C1524024:analysis [Functional Concept]

Phrase: "and in Parkinsonian syndromes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0242422:Parkinsonian Syndromes [Disease or Syndrome]
   770   C0039082:Syndromes [Disease or Syndrome]
   770   C1515981:And [Idea or Concept]
   770   C1558916:SYNDROMES [Finding]
Processing 00000000.tx.456: J. 

Phrase: "J."
Processing 00000000.tx.457: Comp. 

Phrase: "Comp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056167:COMP [Therapeutic or Preventive Procedure]
  1000   C1456376:COMP [Gene or Genome]
Processing 00000000.tx.458: Neurol., 432, 184196.[CrossRef][ISI][Medline] Hunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debre, P., Agid, Y., Dugas, B. and Hirsch, E.C. 

Phrase: "Neurol.,"

Phrase: "432,"

Phrase: "184196."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hunot,"

Phrase: "S."

Phrase: ","

Phrase: "Dugas,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Faucheux,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hartmann,"

Phrase: "A.,"

Phrase: "Tardieu,"

Phrase: "M."

Phrase: ","

Phrase: "Debre,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Agid,"

Phrase: "Y.,"

Phrase: "Dugas,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Hirsch,"

Phrase: "E.C."
Processing 00000000.tx.459: (1999) FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. 

Phrase: "(1999"

Phrase: ")"

Phrase: "FcepsilonRII/CD23"

Phrase: "is"

Phrase: "expressed in Parkinson's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: ","

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "production of nitric oxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "tumor necrosis factor-alpha in glial cells."
Meta Candidates (Total=26; Excluded=3; Pruned=0; Remaining=23)
   853   C0041368:tumor necrosis factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           tumor necrosis factor
   853   C1168005:Tumor Necrosis Factor alpha [Laboratory Procedure]
   853   C1456820:Tumor Necrosis Factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Tumour necrosis factor
   840 E C0812246:TUMOR NECROSIS FACTOR, ALPHA [Gene or Genome]
   814   C1323304:tumor necrosis factor [Molecular Function]
   789   C0017689:Alpha cell tumour [Neoplastic Process]
   789   C1336835:Tumor Cell Necrosis [Finding]
   788   C0017638:Tumor, Glial Cell [Neoplastic Process]
           Glial Tumor
   778   C0333516:Tumor necrosis [Neoplastic Process]
   774   C0431085:Tumor cells [Cell]
   757   C0030280:Alpha cell [Cell]
   757 E C0597032:Tumor Cell [Cell]
   748   C0027540:Necrosis [Organ or Tissue Function]
   748   C0027651:Tumor [Neoplastic Process]
   748   C0439095:Alpha [Intellectual Product]
   748   C1334928:Necrosis [Finding]
   748   C1521761:Factor [Functional Concept]
   748   C1578706:Tumor [Intellectual Product]
   748   C2003941:Alpha [Intellectual Product]
   748   C2350010:Alpha [Qualitative Concept]
   748   C2827422:Factor [Conceptual Entity]
   748   C3273930:Tumor [Finding]
   738 E C1300818:Necrotic tumor [Neoplastic Process]
Processing 00000000.tx.460: J. 

Phrase: "J."
Processing 00000000.tx.461: Neurosci., 19, 34403447.[Abstract/Free FullText] Lebre, A.S., Jamot, L., Takahashi, J., Spassky, N., Leprince, C., Ravise, N., Zander, C., Fujigasaki, H., Kussel-Andermann, P., Duyckaerts, C. et al. 

Phrase: "Neurosci.,"

Phrase: "19,"

Phrase: "34403447."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lebre,"

Phrase: "A.S.,"

Phrase: "Jamot,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "J.,"

Phrase: "Spassky,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Leprince,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ravise,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Zander,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Fujigasaki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kussel-Andermann,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Duyckaerts,"

Phrase: "C. et al."
Processing 00000000.tx.462: (2001) Ataxin-7 interacts with a Cbl-associated protein that it recruits into neuronal intranuclear inclusions. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Ataxin-7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0665827:ataxin-7 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1538303:ATAXIN 7 [Gene or Genome]

Phrase: "interacts with a Cbl-associated protein"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C1422760:CBL-ASSOCIATED PROTEIN [Gene or Genome]
   783   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   783   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C1367374:CBL Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "it"

Phrase: "recruits into neuronal intranuclear inclusions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1366904:Intranuclear Inclusions [Cell Component]
   760   C0521390:Neuronal [Immunologic Factor]
   726   C1512693:Inclusion [Qualitative Concept]
Processing 00000000.tx.463: Hum. 

Phrase: "Hum."
Processing 00000000.tx.464: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.465: Genet., 10, 201213.[Abstract/Free FullText]

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "10,"

Phrase: "201213."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

